>UU001 dnaA chromosomal replication initiator protein
MANNYQTLYDSAIKRIPYDLISDQAYAILQNAKTHKVCDGVLYIIVANAFEKSIINGNFI
NIISKYLSEEFKKENIVNFEFIIDNEKLLINSNFLIKETNIKNRFNFSDELLRYNFNNLV
ISNFNQKAIKAIENLFSNNYDNSSMCNPLFLFGKVGVGKTHIVAAAGNRFANSNPNLKIY
YYEGQDFFRKFCSASLKGTSYVEEFKKEIASADLLIFEDIQNIQSRDSTAELFFNIFNDI
KLNGGKIILTSDRTPNELNGFHNRIISRLASGLQCKISQPDKNEAIKIINNWFEFKKKYQ
ITDEAKEYIAEGFHTDIRQMIGNLKQICFWADNDTNKDLIITKDYVIECSVENEIPLNIV
VKKQFKPEQIIEIVAKELNIKTDLIKSSIRKNNIVWARDIVCYILKNKLNLTLTDIGKLL
NGREHTTISHSISKVQKILDDENSQEALQINLIINKF
>UU002 rpL31 ribosomal protein L31
MRDIHPVSKPCVYNCVTCKKEFIIDSAAKNTEVAIEVCSNCHTFFIGKQNATTTLRGRAE
KLNNRFEAGLNNINKKPEKKKIQGKSEPRKSLNEL
>UU003 prfA peptide chain release factor 1
MEYNKKLYEAIERVAIKNDALKKELETVVTDFKKIKEINIQLKKTTKIAEAFAKYKQKLD
TGIAAEKILNTEKDLELIELAQMDLDEAKINIPIIENDLKIMLLPTDPNDDKNVIVEMRP
AAGGDESSIFVGNLFDTYRAYAENNNWKMKIIEMTPNAVGFSFISFMISGEEVYSRMKFE
SGVHRVQRVPATESKGRVHTSTITVAVLPEQDEVDVVINPTELRIDTYRASGAGGQHVNR
TESAVRITHIPTGVVAACQEGKSQIENRETAMKMLRAKLWEAAQEQQNAEFANLRKNQVG
TGDRSEKIRTYNYPQNRVTDHRINLTLNKLDQIMMGELDEIIDALIADEQTGLMANLDI
>UU004 hemK protoporphyrinogen oxidase N-term
MTYHQLIFQAYSLLEKKLRNPQVAFQLLYGLDNKINDSYSFSNNRLTIVNSNLEYTYFKL
LDEFINGKPLVRILGYGYFCAKRFYVDKNVFAFRVETELLIDVVNKVIQQSTYKIKNVID
VCCGSGVLGLSTKMNFNQLNVSLLDISIDAINNCKKNAKYHNLTDVNFIHKSMQEYFLNT
KKRFDLIICNPPYIKSNYELNREVLDYDPINALIDFDHKDGISFYLFIINNIKSIANEKF
TIIFEIGFDQKEILEKVIKKNEFPLFYYFINDYNNLCRILIISNIKYENL
>UU005 hemK protoporphyrinogen oxidase C-term
VILNMKIYRITNLNVIYDALMANKCVLIPTDTIIGLLAKNQDVIYEIKQRDRNKKIIRFV
ADYKLLGDLTVEQKQFLDLFWPGSVTIIKNGISYRMPNSPYILKLIQKLGPLYCSSANIS
GEEPIKNHNEAIFKFGANSKLIYVEAQQQIGVPSTIVDIDKWEYIRRGANVEMVDMFIKE
LKDNKTGK
>UU006 lacA galactoside O-acetyltransferase
MIKKIYFGNDHAAYEIKDQIITHLKQKGYQIIDEGAQAALGSVDYSTYALKVANDVVNDT
KNDSIGILLCGTGIGMNIAASKVHGTRVALVYNESSAKLAKEHNNANIITIGARENSLNQ
ILKMIDDFLTSKFLGERHQKRLDIIAKYEKEQNS
>UU007 unique hypothetical unique hypothetical
MLNILNNVSNSSLYSAASNATAQTGSNLINDLVPETLTASGISIAISVFSVIGTIVIALS
VLPQTIKTLREKDTASLSLLLFLLNGIATAFLTLYGIGLVTVHPNSFSFLVDIKNGMFIY
NREEWVAGYLICGIFLIMGEALCSVTSFIVLFCKVNNMIKAKKMGMSEEEYYEKQIKPFL
KVKGAN
>UU008 unique hypothetical unique hypothetical
MNFTSLLQDGIYEVGNGAIVTDQSPYLGITPDYQGAYGFPTHPWGIFFQVVGAILVFGAY
LPAVIKVLISKRTENLAIGMWIISIAGLGLLAIFAWLGVSVNPGGFILVALSETLSCIAS
IIVFALKIANKAKAKAAGMTELEYCNLHYPIVKKLPKR
>UU009 mgtE Mg2+ ion transporter
MENKQSTLNLNNNTNINQNFLTQNILKTYEHKDITGLKKLLKSKRIDKIVESLETINDTQ
IILFVLVATKDGICGDIFKYLNTELKSKIINDASLQQLRIILFELYNDDVIILKNDFPMY
TKKILLSLDSQQRAAIKQLSEFDEDEAGSIINSDFFTINQNLSIKEALIEIKRMYNDFEQ
SNIIYVVDNYNRLKGYVTIHSLLFADSFELKISNVIQEDVFYVRSDEDIDAVLDIFRKYQ
IEQLAVVDKDNQLIGYISDNDILPVINAETTTDIYKMYGISELDFPYIKSSVFVLFKSRL
LWLAVLMISATCTGFLIDKFQDVGQLVTAGLSTLVIVPIIPAMTGTSGNAGSQAAASVIR
ALSVGEITLKEYNKVLAKEFLVGALIGLVLAIINFARLIIYFAIIKPDLQQYNVLYENIT
NNPHTKMIVGAIVSAGSSVALFFAIVISKLLGGTLPLLATKLKIDPTIMSTPILSTLLDM
VTTIILFGFGIIFLLIIVDKVKVEQLNNIREHIHAIKNVNSWLPNQNFLLNNLNYSKHFA
>UU010 rpL10 ribosomal protein L10
MANVRPSVVFKQQEVNHMADILKNSKSFIVFEYHGLTAANILALRNVLHSSNSKLYVLKN
NITARAFEKAGVSGFENQLTGPNAVAVAMDDEIAAIKAVNDVAKEFDFVKIKGAYLENKF
ADTHKIDQLAAIPGREGLYSMLLSCFTAPLRNVMYGLKAVAEQKGE
>UU011 rpL7/L12 ribosomal protein L7/L12
MSKLTIEQFIAAIKEMSMLELNDLVKAIETEFGVSAAAPVAAAAAPVAAEAPTEVTIKLV
EAGTNKVGVIKLIREITGLGLMEAKTAAETAGSVIKEDVKTEEANEIKKKFDELGAKVQL
V
>UU012 unique hypothetical unique hypothetical membrane lipoprotein
MKKLNKKVLFLAIGSVFALGTIITVATSCTQKSTLNYSQFYWTSPTSDDDEGFQTKYKSM
ASDGKRALLMPGYQHPERLQNALVNDKFDPNLIALILDGVYNNDNKAEFYKGADRVADVY
FKVDEAAFLGGIAAAYMLNSNQAVFGADNKLTWGGYVGINAKNTTNYLAGFDLGVKWANE
KLKDKNIKQEGTQETKKWINVEQVYASESSAGGFQSDSANAKKIIQELITKGADLILPVA
IPQVGIAVTEAIATTSHNVGVIGVDVEIENDQAINKKTDKFINTHLSGNKNGVIRFSITK
RLDTATIKLLENAIKGESLSKKSDQIVIGSEIDPKDKYKLGVNTVGNLSDGVVGISPSAY
HYVIDAFNLAQTNQSDKVSTYDELVNKITNDDLFKTLDKKPVVDGYLDVKKETDNEASLL
NNKTIDPRVNGGTFYKSAKGTYYFYPVAKSTYISNTSSKKFKEIWDNTKSNDEKQALIGL
LLSYAGAKVKDGGYSENTYNGLKEFYAKHGIKIPQL
>UU013 rbsC-2 ribose/galactose ABC transporter
MPSLSLINDASIYAAILILGALSGFFCERVGIANISINGQMIIGALVFTLFSTIIYKYMG
TKTETEYTFIVCLIIAGILTIPTSLLFGFLTIKLKTNQIIAGTAINLLASGVATFVTYPL
GDKIADKTSLSSDYLGLMKIGDGINTIYIGSILILIAVVLITIGLMIMMKKTPFGLRLYA
IGENPNAADAQGINVYKYQWIAVSISGFIAGIGGGLYMYASRSPFAGEVGGIGFLALAIL
IAGAWRIPLIAVVSIAFAVITKTFSQIDKIPQEIGKLIPYVITLIALISFSKYSVAPKNV
GIPFDKTKR
>UU014 rbsC-1 ribose/galactose ABC transporter (N-term domain)
MLKFKTLLSYDSFLKGQERKTITKKFLSTVFAIFVAIVVSAILVGILGYNIRDFFIRLFT
KWIGSPDIYLTKVAILGIAALSFIFAFKAGLFNIGISGQMLGSGLIMLLVVKNMQIANIN
MPNVLGQFFLLIIAMLAGAMFAVFIGILKVFLKINEVVSSILLNWIMFYITRYVVFTAQS
KMYNPTPDQVGSRSIPFADNYSLFHLASGYGYLFALLIFISLSIIIWVILKYTVFGHKVL
SVGKSFDAAKYAGYRTKIISLATFAISGALAGALAMVNYTSTTTNAIVISQAADALPTQG
YDGIAMGLISLAHPLATIPVSFLMGLLQQSADNLGGSFPQDLSGIIISFVMLGAAMFILF
ERISPVYWIYHLIYTYKGKDYYRDYENKNNNIISEYKAIYSEINKKRNQYLQELKKLRKE
LDQFKNHEQYNKVNQQYEYTISYIKTTYNAWLKVEYDKYLKQLKNNAMQLKKHLIIERAT
LVYYPEINTTRKIKNKLKHFENISAKKLSRIKDKIHNEDFLIKNLVAKEISKYAQSKSFD
YNKLKYLLQEYENNNSVLTTELVNELSLVLKDEQAQLMFSEFKQASFENNLDHMIDLKNQ
IMTYINSLLDSRLEQLSITLKSKNLVHDEQMDKIILLLNPNDKILNKIIISRNKHLENYT
KEITKLELRNISQDDEIKKNTKQRSSSYLTKHYEKTKQHINKINLDQEQKLLLEDWLTTA
YQKAIINQQNMKEVIS
>UU015 mglA methylgalactoside permease ATP-binding protein
MEIKTNQCPYAIEMHEITKTFLNGTVIANKDVNLFVKKNEIHAIIGENGAGKSTLMSILF
GIYKQDSGSIKINGRIVNFSSAKDASKTGIGMVHQHFKLIDTLSVLDNVILGSEGATQLG
IINRKKITKELKKIIQEYGLNINLKSKISKITVGQQQKTEILKLLYRDIDILIFDEPTAV
LSEDEIQAFLQMLKDFKAAGKTIIIITHKLNEIKEVADSATVIRRGHYIDSFDVKQKTIA
EMAELMVGRKLVEVKNIDPITSNEKVFEVQNLDIQSIVKKQKDIVKVKSSPKGDDVSLLS
TKNNNFINFSIRKGEIFAIAGVEGNGQSELAQIISGLLKGNKEAKIMLDNQEIEHASIRK
RYQLGLSHVPEDRHKHGLVLDDTIAMNAILQQVDDKPYSNLGFFNNNEISKHAINIIKKY
DVRGTTRGTSDARGLSGGNQQKLIIGREFERSHKLILLVQPTRGLDLGAIEFIHEQTLEE
KRKGNAILLISYELDEILSLADTIAVIHNGYFISVGDRFSMTRQKIGELMAGEKI
>UU016 conserved hypothetical hypothetical membrane lipoprotein
MKKSKINKKILFASLAGVVTLTSVAAIAASCNDSNKDDGKTNKDGNYISKLSLEDFYAKP
AGDDSLGYHRTYNSLYDDGARMLGLISFSHSIPIKEYFGSSSDKKDLSAVLIDDKFSGTV
GKDRIASVSYRVDQAAFLTGIAAAYYLNANQKTFAADGKLTWGGYVGLHFTSTSTFIQGF
KLGVQWANEKLKDKEINQEDANGSKKKWMNVEQVFASKYVAGSFKPDEEGATNIINDLIT
KKADVILPVAGPQTNLATSIVSNATDPSVIIGVDTAQELDDVTNRKRITNKTVNDGKTIL
FSIVKRVDLAMKGAIENASKGAQLTNDINKDAYKLGTHTEASLDKSTYVDDTPLVELSNA
GRVYLEQAAKLAGLKAITYAQIVNVIQNEELFKLLSTKGTTKLEDLATKTSDGWVLKDSE
KNKSFSELQKLLGGEVYINESDKKLYPYSLTGSSYLEEDPKKRSASQEFKKYWDAATTPE
AKEKLAKVVLGQNNAVLKDKSFSESAYNGLAAFYKSKKIIIPKI
>UU017 conserved hypothetical hypothetical
MLEKIKIIDTHTHPNIEPLIEEFDDIIFKCYEQGIGLNIVGVDLKTSQTAIQQAKKFKFL
TCSVAIHPNDLHNIENDFVALEKLIAENIDYISCIGECGLDYYHEQNYDHDFQKHWFKKH
IELAKKYHKPLMLHIRNAHDDAIAILKELAVQDVIIHCFTDKKEYAQQYIEMGYYISYPG
VITFKPTKNNQLHELYEAIKITPLDKILVETDAPYLTPVPKRGQTNYPYYVLYTSAFIAN
LLGITHEKMQKILLENSLRILNFKK
>UU018 thdF GTP-binding protein in thiophene and furan oxidation
MSTIVALATAPMNCAIHIIRVSGPKAFEIINKISTIKIKKETFKIWYTILKDDNQILDEV
LINTFVAPKTFTGEDLVEINCHGGIVVANLIIKTLIKYGCQPAQRGEFSRRALLNKKMDL
SKIEAINNLVNAKNELSVKGVIGALLGRVSQSIAEFRHELFMIIGQIEVNIDYPEYDDVE
QVDAIILKQRLLSLDKKITKIIDQSKKFLPINKGIRVLIIGKPNVGKSTLLNALCNEQKA
IVTDIPGTTRDVIESSINIDNITLNILDTAGIHLTNDFVENLGINKAKALIDKVDLILYL
IPANEQQDLELYDLIKKQKHLLVYTKKDLVDQYDDKQIYINAKNNDIQSLIDEIKKLFYV
QEFDNANIDVLQSQRQIGILENVHYLINNAILNLEKGDTLDLIVADLEFCNLRLNELLGI
SSEYDFLDDLFKNFCIGK
>UU019 dnaH DNA polymerase III delta subunit
MKYSFANLLIQSPKTSLESGIEEIMLAFIYEKNHKEQSFYVTKVKNKQYFDLKIYDGLSM
KKSDVIDLQNTFLCDGVEDINLKFYLIKNIDLASKYVLNALLKFIEEPPKNTIAIFSTKN
LNQVLKTIKSRCQLFYLPTNHDLYKKLINQINQPIDLVECDLMFDDLDELKILLENKEIN
DVLTYYGKLSDLRSFEILNDLKEIFKNLSTLQIHYLLKLIFIRINNVNSKEIILDLMRAN
LKININKNNLFTIIYTIINKNKGD
>UU020 tmk thymidylate kinase
MITMILTKNSNEKKPLKKGLFIVFEGIDGAGKTSILKQLLEVLKEPKLVNKIFLTREPGG
KNNNAAEMIREFFLKNLEVFDPLTLAYLYASSRAEHVKKTINPHLEKDHIVISDRFVHSS
YIYQGIVQNQSLDVIYQINQQAIGELEIDYVFYFDVNVNNALNRMKNRFDNTNAFDSQNK
QFYEKLLKQYPSVFKVYNQPKKIIFIDANKNENEVLCEVKEQLLKIFKEHKYI
>UU021 lip3 triacylglycerol lipase
MIMELIKTNTLNFYFEPSKSELKKGSIVFIHGLDASPHYFFLINKDLSDYDCYFVGLPAH
GLTPINNKKDLNIKVFAELFINWINEIDLKEFHLLGHSLGAGIASLVSFIIPQRIEKLIL
VCPYHYQYLNPFLNKKLFNAWVLFPNPFLKFKTDVVLKKLYIDYRNNYKTLIETRWESIS
REYPRIARDVLFLCLSLLNIKINHELKMAQRNLIMPTLIMVSRHDQLIDFNLAIKVFKNN
NKVNQYIFNNSGHIPFIEEPKLFTNILLSFLEDRFVEQEENDNNDINEK
>UU022 fatC ferrichrome ABC transporter
MSIKIKHDQNLKHQFEQKLFFRFKKNKFFLSLSLLIITIILTLIAVAGASRFINVFSYLS
DWKIITQLLFSGIALGISGYILQRLTKNRLADSSLLGMGNINLVILTILFLIFDFGQLQI
QKRMEYVLPFIYLIGSTMICFFIHFLCNSSTGYIFKRIIVSGIIINLITIVIAQSLRILM
SKESSMYLKTILLGNIESRSDFCFYFCFGMLTISVIWLMLNATKFKIMVTNQQISGQLGI
NNKSLTIQTFICISLLVSVSYSLSGNVIFVGIVAANFSFNYVKNNISNGIINAGLIGGIV
LLISYIFVVLILNLSTDQTILLVPIISGPYFLYQVILLKN
>UU023 fatD ferrichrome ABC transporter
MKIKLKFENKLNFKKYLIYKWSVFVVLVLLTSFIFIFNIIYTNKTFIWESFYFQNASFEE
VFLLFFYSPIVLLVCGAGLVCSGFSLQSTTRNGLAGPSTLGIFPLAALGNILSQLITKSF
SNIFIGYVFGIIFSLFALGINFLFIRISPHKKTFKPIIFGFSLGAIITAVNILIANFNSS
IVASPIQLLGSIGVYNSIERFYIGTPIVFISTIILLCYAKKIQILDTDHYLAKSLGIDVN
KVFWITSTCSIFIAISTTFLIGGLSLIAIVMPHLVRLLFKRTNYLFQMIIAIFLTTFLLE
LLGIIVEFFSKFNIVFLVATVFAIPMIVLLKWELGWKVNKN
>UU024 ABC sbp putative ABC substrate-binding protein - iron
MVLIMKISFKFRLINVISMLGLSIIFTTLSSCKNLQQQKPYDTNWLFKNKNWRLNNFFRD
PYKIHLEFARQLDNVLNFNELKKRLPKPMQNVHSFTEWSLKIARLLKNDINNVAMLDSIQ
KMRNHKATVLVIENRNELVNNKENYNKFSILTPSDFPLIYSNPYTEVPGLGLNFPKPINN
DISDIIDRYQSIGYNALRTNPLESVLKQTSSFYKTADYVFYMYDSNLFTNNKYKTDGQKR
EDLFKEILSNKNFYAHKFLRNSRSKIIFIDRSLFWWGSFTMVGQSLIIKELLKIFTNKKT
IKKQWSYLPFNKEELINLFDHKPTIKERNLIIKPHYINKNFKLTYGYKIVGTWADSIDHL
ISFGLKPDAIVDYESFNNINLKTQGVGNYLKELINYDKLEKINKAPNDSEKAEFVDKNFA
IYMGPSHLLNSMNKLIMIKNTGSWIISSTQGINDPKTQFKTRINTAKSDF
>UU025 fecC ferrichrome ABC transporter
MQNYTFRFKLFKQIKNQQVKKLKPLILIGATVFLIIAIFSIWVWNISYANFYDQQLNKYV
YFPLHESLKLIFNGHFLDPTNIKYLNLQATFWASISSILSGISLAIAGCVTQALTKNPLA
DSSTLGIVQSSVFMIVIAFSYNMISFGELFGFAIIGGIIASIILLILVFATRSRLSYIKI
TLAGLAIGVFFNTISYFIRIQSAKGSSINFKYVLGGSENIYTTHIDPFLTLWVSAILILI
GVILACFLAYKLTLLEIGDEKAKNLGSSIIIIKILAIISTIFLVSPTILLVGNIAFVGLF
GPHIVRKIFSIRDYRYVMPLSGLLGAMITSLGLILYRETIYINSSIWMSFIGAPVLAYLG
WKHWNRA
>UU026 rpS2 ribosomal protein S2
MSQMENSTKKVESVANVEVVTTENAKVEQKPTSPADAIQLKVNANSTIKNLKTLVSIVKL
TESGAHIGLNPKKWNPKMASYIHAKRSNNHVIDILKTILFLDRAYKFLQEVSQNGGTVMF
VGTRGRVVKELIKAEAERTNSFYVTQRWLGGTLTNFTNISRSLKKFNSNLALLESEEINK
YSKKEQIAINKETAKLEKFYGGIKNMKQRPDVLILVDPVNDVNAIKEARKLNIPVIALAN
TNADPQLIDYIIPVNNYSVKSITLILGVLADSIAELHGEPTKIVGRPDSEIVLPETKSNW
KQNNYDPSKRGYNPKYVNHKSTFNKFNNKKPVDSTTNEIKTNVIKAETK
>UU027 ABC sbp putative ABC substrate-binding protein - iron
MNKKIKTVFISSLIVGLLGLITTSGVACSSSIKSKQENEIYPTIKGYDQHDFSKILASEF
IKIIKTNIQFLAPNKDIKYELYDARLNELDEDVIDLIIRYHFKGQTHTYKKILKGFKNAK
QYRLFLENKKYLEDEKNHNTLYLMPIVNSSINISKTTVDEALKWQNSYLNINNSNNDLKY
EILKITKSKTANSIDIEIKISKGNGENLASITYNKTLNGFISEADKKIYLANLEAIKQDK
NQLEPQLIDEKTKQKTIKEVIENYKTLFKLPFQTGFIYEIQSVEPDVNNKTAVVFKILIK
KGNGSQEAVLEYLKTIKGFNQNK
>UU028 ABC sbp putative ABC substrate-binding protein - iron
MKIKLKKIIMSFLGLPILAIPLIVSACSQFKINQDVILTYRPTVSLAKEFANDNNTIDDV
LKKVKINKDGSNNLLVYDLSRNPKNVQYKIVDIKKDSEQILKVTINAKIQKYKESINYDF
YFQPFLTPKQKEDKTILQQNLNIIKSAWDYDQKQKIGFFNLRIKPEYQKRSLVEIKTLGE
KAFNFGEDLIPQLKVDSKFKDINIKIIDINYFEPLDERQRELVVEIMISKGKNEQQAQLF
KKIKINLD
>UU029 conserved hypothetical hypothetical
MIDLIIKTLVQKLKIEAKYITNVLNLLADNNTIAFIARYRKHLTNNMDEFQIQAIAHEYE
YLTKLNKRKEVIIKNLEQKGLLTNDLLELINNCQRLVDLENLYEPYASNKKTKASIAIEK
GLEPLALLILKNNPNSNIKEVAKQYLNEQVLSVDEAIAGACDIIAQKVANDTTLREMLYE
TINKHAKLITRINKITNDPTKNFALYYEFSCPIKYLKAYQLMAIDRANELKIIAFKLDFK
KEFLIDFAVNKYTRKIKSNSYDYIKSAVNDGFDRLLIPSVSNAVYKEKLEEAHQQSAQIF
SNNLQQLLLQKPLKSHVVLGFDPGYVHGCKLAIVNKNNQLLHTDIIYPHKPQILITQAKN
TLISLINKYEVNTIAIGNGTASNESVIFISDLIKEFKLNLNYCVISEDGASIYSASSIAS
EEFPNLSVEKRSAISIARRIIDPLSELIKIDPKSIGVGQYQHDINKNILQQKVDFCIDYC
VNQVGVDVNTASIPLLSKVSGLNKRSAKKIFEYVKKHQFIENREQLKTIPYITDKVFEQA
AGFLRINNANNFLDRTSIHPEAYLVVNELCKYLQLPINKLINNYQVLNQLNPNELTTILK
TDIYTIENIINNLKNPLQDVRDDYDIPILRSQMVDINNLKIGMLVQGTIRNQTEFGSFID
IGLKNDALLHISNYCEEDNLHVNKNINVYIDKIDTITQKISLKLKL
>UU030 unique hypothetical unique hypothetical
MNLKTKFFLKVISVIAPIVIIPTILANCAHINSNELDNAKTNLKGSVEVVNINPYKTKQM
LASNINKEQINSYFIFIFNLIKTNQKIEEKILDKNDYEILNWAANDNDGTLGINIYIKTT
KQSYLINTKPVFLTDKQNNYLQELKYKTPAVYSIDEILKFSNNPYNLIHNNPYYREQLLR
AKIYFNQNEANVDDSKLYMNKIGYSEFGSDVQKRLENAFKIRYDEQNIYQINSPQILAKE
TKTLTSYIDKKTNNNYSINIELIKKLIQINPFGKLPKNFAQLINLIKKEEYPKFLTITKN
ESVDNIVVKDIYYRIIDRYAKLEFILEIYNKKTKQTVYLSANFNQKNSGLLKNEDYFQYI
FDRTISLDLLTTKDGKNVELNSGTGWIVDRIIDDSLPKNKIKLLIATNNHVMGWSNLAIS
KDNRMKSRWFNKQEYINYLENNAGFISSNIYEDKDRYQYLLWGTAPLKSPVSNKYNSLSG
ISFSNLAKVYNITNQNFINRAWYIPQLSANGIKINENLRTWYQINQEDIKSIKNGTLDFV
LVPMVFDIEDIKEKLPNYYKVLNTKDEANWYIGLGNSKKYLPQLQLFSGGYPGDVNPNSS
AIVSWRGSKSYGSLIQAFDREIKNESILDYYGPKQINNIDGYQKVGEGYLNKLFNVGTRV
ITSDEIGDLGSGSSGSMIIDSNFNLVGIHFASLNSRAYGAPNDSMIGNLFVAQSQDLSGD
IDVRAAVIKKLKAENIYTYKLNPKVSS
>UU031 unique hypothetical unique hypothetical membrane lipoprotein
MAIVAKINGNASEWYHAPIALAFFLRFSLINKIFAIILSCIFCVSIYRFRKKLVQYENFN
EIKSIKNNAILTVIFSVVAILSLTLFINLMIVFINQNYYYIKRIHNLLIPIRIDEIKILE
YSYIYLLRCGFYILLTVFIAKFIHDKRSMIKVLSLYLFVNFILMIIGTSFTFLEHTNFYN
GMLTYWTTFSCGLLYPEIINDNFQWISSFNYNLKNTIYENNFIAYLPYFCSFIVLIILIK
KVSWKSITISSNSY
>UU032 unique hypothetical unique hypothetical
MSKKINNNKTPRNKVKNNNVSKDNDDIVISLRYENWVKEERVNSLTTYTKDENQFLKNII
YILNTLFPYVYKNWKNKGINDHCHPIKQNNVFSKYIKLIKKLHPNLLKNDNEELELYQLG
LGRSVRVICSKIDNILFPLLIDHHHLGYESQSYNDKDTKKYDYCPLRKYNKNQDN
>UU033 conserved hypothetical hypothetical
MKEITPLIVANWFLTKESMTPKKVQKLVYYAYSWYLTLMNEKVDDLKNKLFDEKIKAWVH
EPAIPMLYNEFKEHKYNSIPKINDFNELEYFNLDTIDILNQVWDEYGHYSANQLESITHQ
EDPWIKARKGFGPLDSCNAVISDKEIFSYYIKQMKNN
>UU034 unique hypothetical unique hypothetical
MLISKHEERVKSILSARMENGNLRSRENTQVEFKQSFNKGNIAIYAKTMAAFSNNSGGYI
IFGIKDSPRSIIGLQNSNFENIQQEDLTDSINNLFSPSINWELGSFILKEKEINSNGDVI
IVQKIIGWIYTEESNIKPVIAQKNNSSEKIVNGDIFYRYRARTEKIKYAEMEQIINCRMK
QERDSLFKVFEFIRNNGATNLGIVDYNNGKLSTPYGVDVVLEKNLIAKLLKKAKFIKEGS
FSENEGIPVIKVTGNINLAEEVPVPLENLDETYPYIQKQLAEKLNITPQKLYALIWYFKM
KESKKYHLEITTSKTNKTHKFSKFALLFLKEKIIELDENKNELNNIISKFNNRKK
>UU035 unique hypothetical unique hypothetical
MRKFNKMLSNKKFLDLDIIKESFDNYLSVGTSRSTKKLKTLHGSIAKDLEELLGKEYNIK
SQGYRDDKEECIDGRYYNKKVDITIKNNGKSIAGLAIKFVMSNYSQNSNNYFENMLGETA
NLRSNSVPYFQIFIIFDKVPYYKSDGVLQKYDNISNHNLEKYLKLSDDDPKVYFHTPDKT
LFILLSLKEISEEIKNKKDYIRCYKEIMNDEDLLSYSNKIDDLFGNSIILNNYEDFIKRM
CALIIGYQKIKT
>UU036 conserved hypothetical hypothetical
MKINIYDSKMDFVIGNPPYVRIHNLIKEPNLIKNYLFSNKGMTDLYIIFYEIGIKMLNKN
GILCYITPSSFFTSLAGLNMRLFLSEYKLIESVCDLKHFQAFNATVYTTIICLNKSKKNE
CVEYYEFDEKKLKPCFIEKISHNDYFIKNNYYFGPKQKLIFLKKVLLSNKTTNILVKNGY
ATLSDKIFINDFDFESKFIIPVIKASKGELKKIFYPYDKENFLIDELVLKKDLKMYNYLK
FNKNNLLKKIMILVQKIVDMHLVEVKELKILIRIKLQ
>UU037 unique hypothetical unique hypothetical
MKELLRLTKVKRYGKVYTPDYLVNIILDKGHYINGNINKKHVIDNSCGDGQFLTYIVDRY
CKDYLINNNDLIELKKTIRNIYTWYRNW
>UU038 conserved hypothetical hypothetical
MLNLKQYLGETNFYDKKEKLEKKKIKSWLKSVCTFANGQGGKLIFGVNENNNVLGLENYL
NDSEFISETIKTKIDNIPEFDIEINEYENKIILILTIFPGRNPPYFLVDNGSKTPYKRVG
NQSVIASINDLLNWCLRSQNRTYDSLVSNKLLKDVSFLMLKNEYQKHTENLWEDKFLKSF
ELIDNNNYLTNAGALFADGYQVYQSGVFCTRWNGKTKTNGLIEALDDAEFEGNLLFLLNS
SINFIKRNSKNMWRKGVLYRIQYPEYPIKAVQEVIVNALIHRDYSIIGSEVHIDMYDDRL
EVYSPGGMFDGNFVQNIDLYNVWSIRRNPILADLFARMNLMERRGSGLKNILEIYASKEN
YREDLKPEFRSTESAFFVVLKNLNYQEQNISKNENQKISPSQRRKKIIEFIGQNPKTTAY
ELTKIFFVSINTIERDLAKLVHDGYVEFVGSSKNGEWKIKTNQ
>UU039 gidA glucose inhibited division protein
MKKYDVIVIGAGHAGLEAAFATSNLNLQTALITLDEKGIGMMPCNPSIGGPAKGIVTREI
DALGGIQGKAADATTMQMKILNSSKGPGVWAIRAQIDKIAYQRWFKQQIKQQKNLDLIIA
EVSDLLVENNIVKGVVLSDQKIIQADYVIITTGTYLKSITHRGSVCVDEGADGTKNAKFL
SDALVKLGFELIRLKTGTPARIKKDSIDFTNMILEPGTNQKIAFSHYHPVYKPYDEQLPC
HIIYTNEQTHQIIRENLNKSAMYGGMISGIGPRYCPSIEDKIVKFSEKPRHQIFVEPESY
ELDSMYLGGFSTSMPIDVQEKMIRSLPGLENCEILKYAYAIEYDAIDPTQLYPSLESKLV
NNLFFAGQINGTSGYEEAAAQGLMAAINVNQKYQNKEPVILGRDQAYIGVMIDDIVTKGV
VEPYRLLTSRAEHRLALRNDNADDRLMKIGFEIGLLKPEVYDQYLNNLKQIKEILNWLKT
TTVGQIDDLKFTTLKTNSYLIDYLKRPEIKLNDLLIYCPIKIEDEQIINKVQIQVKFEGY
IKNQEENLKQLKRLNNIKLHAIVDYKEVPNISLETIDKLNKIKPLDLEQASRISGVNLTD
IAMIKYYLERIKND
>UU040 gidB glucose inhibited division protein B
MSFEKYKTIIQKYNQIFNLTRLDSDDKIYQNFFLDSLAPYKELDFFTQNTNLKLIDIGSG
SGIPGVVLKIIFKNLNLTLLEANQKRCEFLKILTQELGLNDVLIWNMRAEDLTQSMRESF
DIATSRAVASLDKILEISAAFVKVNGYLIQPKSIKFYEEELKAKNIIKTLYLERIALKDF
WENDYHHLVGVYLKKQITPLQFPRPWNLILKKPL
>UU041 conserved hypothetical hypothetical
MSSLPVIILVIGIFGSIFLVIGYIPQVIKVIKTKRTDGISLTFLISLNIACFLFVIYSIL
VMIFNKHNGIPTALPLCLANTIVGILGLVILIYKVKNIKKAKLYLMDEKTYYEKYVLNNL
>UU042 unique hypothetical unique hypothetical
MSPISIELIIQISIGLSASLILLFAFLPQTLLTIKTKNTAALTISMFIICFIARLCFSLS
AILTIIVYIHNQNYGLSLYALTLPVLICHGINMLLNLIIAFIKINNVYKAKIHKMNENEY
IIFAYAQKLKEKVSIKNK
>UU043 conserved hypothetical hypothetical membrane lipoprotein
MKKLKLITLSLSPIPIVAIMATACSTTKKEKEVDHKQDELTTINNNLQLEYPQNKDIETS
AAIKEEIKPLNLPSGVVFSIKEISPKANDESTLIVKYTLKKGNITKEFKKEINGFKKIRK
DQNIANLKDMHDDFKTIFNNIKLKDTFDFKLKGLFNSNFGEYDKLLPSQIINNFAQGVET
RINTNQDRLGIEVIDVSYPNKNFGSANREGNLKMSLLVTDKKTKQVFIKSIIAYGFKTNA
MGLDENGSIPGGGADLVKPKVDENNYFNKTQLERYEIDNQAYLNGLKGQHMGKTWQQVRP
ELGDNEQKINEFDQKAKGVSQDAYASAAYKGFTLPVYDKNGDFKGLSINESSYGQARSWV
DTRGRDEWKTTGLPRTLPNEKYRDEALQTLGISSLTLKDGKKDTWDKSSGTTWILDYQKT
NDNKYPTKWYFATNLHVADTITDKTTSIDLMKLMDSVKTKTTLRLSNLDENIYRFGFASK
NNKFLLNHGLKKIYDGRNFLKTKPTEYLTEQQKEKYKDAGSFVDFAVFELDFEQLKLLNV
WNNQLNSNGGVITKYDHSSAQDLAKIITSDYANHSDKQIKFLSKSYLNDYSKIDVPLRST
SYKFEGKDELFALGWPNSTRDGFFERYVDDDQTKYRTTDNFSLWTNSDYRFFGKLTEQEG
GQPAFPTERTERGNYLSYAIGYRSFIDKPGVLDAFISAPHTGNDLYKSLDGKKYINMGLE
YMPRHYAPAGGASGSSVRNQNNEIVGIYHVSNEFASTGLATAFRSEGYDYKGLYGDKYKE
LPQYDLIYGGGKDQATGQSYREKMKEIYKNNNNIKTALFPNGFDQYDEKFKFNNNQSK
>UU044 unique hypothetical unique hypothetical
MKFIKRKTKLLTITIGAVAVSSILLGGIFYGTSQKSPSSFGIASIDQKENFINKDNLDYQ
KARPSIKDSNLKEIPKPKPQPKPKPQPTPFPDPIPTPPKKEELKKPDIKPEEPKKPEIKP
EPKPEPIPQPAPPIETKPKEELLPPNPPPPKEEPKPEPNPQPQPQQVPNNSNSRIIEING
VRVEAEVEVPPPRDIAEYDKQNNLVNPNPYINDSVGKIKNVKVTDELRKATGKLVQGNLG
RWDYKHLINDLLTLKPEEIEKYVKNDKSGYYAKVWYRFSRLFESENVVNFLTEQGKKEYP
EMKSKFVSKDHKYAWLYQHLDLTKFTQLSNESESYLKEGYTPDPDNAYVDENGKISSHAY
SPAKGYNSVTSRMENDNWNRRVFGYKSWYGRTPGNLVEGNYPGWKKTNVTQEFHQYGVSD
GDGITVNKLTREKTEDGRLNEGYVIDIDADNPQGYEKTKKLIQTLKEKNINITGYRIHNM
GKSDSSQKFVDILKTLPNQLPLLELFFSAGSHNTSSLIALKDKKIKELGLFTLGNSLLDE
WSINPNALRNVEWINSNDYNVSFNYKQGADIATRITFDTLAFDESDYNDNASDIKSKLKQ
INDGLRMVYWTRNNEPIFQGSFGPGLDPDHKESGNSYPQGLDFSRVPQIRSLRGLIFKDE
QKTSNNKDRKLRRINFYNNSTTYKMSIEDLNEAGFNEHIVSGEPGEKSKITFSNGSGTTK
IQIDGDQELSANGISNLSAMFNFAESLQRTIVVNNTNSPLANQLRNAGYSVESTTNAGLI
DI
>UU045 conserved hypothetical hypothetical membrane lipoprotein
MKKNKLTTLALILPITILTPIVIASCTNKTKVKKSSSLDKIASNLKLEYFNNKANTKASS
VQKDEIKKPLNLPNDVVFSVKDVFVSHKDQSVLIVKYTLKKGNEIQEYTYEIKGFKSVYE
KDKIVNDLSQANEDFKKIVNNIRLKDTFDFKLAAFPNQNYDQLLPSQIYKNYYQGIEIQQ
HKYQNELDIKIINFLYPDGDFGSANKNGTLKLSLMLTDKKNNQVYYKLLEVSGFKSNPYG
VDENGTIPGIGTERLKPKNQDDYFSKTQLQRYEIDNEGYLQILKRQNNDKNWKELRPDLN
ATVSDIKHFDEKAKNVGQDSYESAAYKGFTLPVYESDGKISGLALAGKDTPKGPSWVDAI
GRNQWQIGGLPRTLPNEKYRQEAMQTFSLGILNNDSHKNNTYNKTAGTTWILDYQKTSDN
KYPTKWYFATNLHVADAINENTLSINLMRLMDSAQIKTTFRLSNLDENIYNFGFRSKEHG
KNLLNHGLKKIFDGRDFLKTKPAEYLINSQKEKYKDVGNFTDFAVFELDFEKLELVNVWK
NFLGENNGLVTKYNNYNPQELAKVITSNYANNKNNQIKFLSKSYLSDYSKIDVPLKYRQE
DAKTWFKKYDELFALGWPNSTEDFFFKAYVDDDQLKYRTRDNFSLWTNSDYRFFNNLTQQ
EGGQPAFPPERTERGNYLSYAIGFRSFIQKPGIVDAFIAVPQIGNNLYTSSDNKKYINMG
LEYLPKHFAPAGGASGTSVRNQKNELVAIYHAKYDSSKTGLAAAFRSEGYDYQGLYGNYN
LPQYDLIYGGGKDQTEKKSYREAMKDIYQNNNIKTALFPDGFDKIPDEFKFNNN
>UU046 unique hypothetical unique hypothetical
MKFIKRKTKLLTITIGAVAVSSILLGGIFYGTSQKSPSSFGIASIDQKENFINKDNLDYQ
KARPSIKDNNLKEIPKPKPQPKPEPQPTPFPDPIPTPPKKEELKKPEIKPEEPKKPEIKP
EPIPKPKPQPIPQPTPPVETKPKEELLPPSPPPPKEEPKPEPDPQPQPQQIPNQSTVRKI
ELNGVLVDAEVEVPPPRQTFKYDQDNGLSNLNPYTNISVGKIKKVFVTDELRHKSADLVR
GNLKRGDYQSLVKDLLDPNIKPEEIDSYIAMVDKSGYHAKLWSKFKKLFDTDNVVNFLNE
QGKKEYPNMKTKFVSDAHKYAWLYAHLDFSKFTKLSANSEKYLQEGLTPDPDNSYVNENG
ELDSYAYSPAKEYNTVTSRLANDNANRRVFGYNEWYNRSPNGLANGDYPGWNKSDATAEF
KQYGIKDGDGIKVYKLERQKPQEGKLNTGYIVDIDADNPDGYQKTKELIQKLNNQNKKIT
GYRIRNMGKSDSGQKFSDILKALPNELPLLELFFSAGSHNTSALSALETKHIKELGLYTL
GNSLLDEWSINPNALRKVEWINSNDYNVSSEYKQGSDIATRITFDTLSFDKNDFNDNAND
LRTKLKRINDGLRMVYWTRNNEPFFQGGFGPGLDPDHKEVGNSYPQGLDFSRVPQIRSLR
GLIFKDEQKASNNRERKLRRVNFFNDKENYEMSINDLNEAGFSEHIVTNEPMPPKSKITF
SNGNATKRIYIKGNGSLTASGIQNLATLFNLAESLDSKSVVVDSNNSELKSQLEGLGYKV
SDASDANYIDI
>UU047 conserved hypothetical hypothetical ATP/GTP-binding protein
MKIKKLIASVSIITPIVFVSALAASCVNNKHEDKNIVHNSSDHGNNKKNNFTNDLNQNLT
THEFKSNLISTSQLDNIAKLINFTYENKANTYLKNILINQLKHSPIQNQDFKLEIIGLYP
KQNSLQDLIIYYKLTNQKTKEIKGYYFELNGFKKPDNTIFSNQLTPELKKIIDTIQFKKT
FDLVINNQQVLNYENVLPSQIKNQLLMGLKVIQKEYTDKIKLSVLDVLFINEGGQINANK
LGAFSLLLEVLDLKSKKTYQILIPVDKFKTNPYGADEYDLLPTQVNNGFAPTSLAQINQY
NNADQQTRYLYDNENYLKSLKAYQRNVNWYQIRQDLINNKQKINEFDQKAPQVFQDSYES
AARKGFTLPVYDEDGKYQGLSFNETEIGKSVSWVDAIGKDQWKINGLARTLPNDMYKQIA
LQTFGIQIQTPNGKPRESDVVAGTMWIMDYQKRNDNKYPTKWYFGTNLHVAEALKSTTTV
FGINKIMPTVKTKTTLGLANADDNIYRFSLVSKDNQPNMDKPISNGIKTIYDGRDFLKLN
PSDLLTSKLKNKYHNLQEFVDFAVFEIDFEKIKLGSITKNFYSGSDWSVDKYNNLDPSEL
AKLITNDYAQKPNEQIKFLSKSYLNDYARINVPLDSKYNQAFDTNKYDELYAVGWPSSAS
DYFLDPIKDQKQFESRRESYSLWINSNYQFYNKLNHNPPLFPLTQINRGDFLSYNIGYRS
FTNKPGLLDAFIASPITGKTVHKSTDNQNYIGFGLNYLPMHYSPIGGSSGTSLRNQKNEL
VGIWHVGNGFAQTGLAAAFRSEGYDYHGLYGSYNLPQYDLIYGGGKDQKTSYRQAMMALY
KNKNIATALFPNGFGEDQIPSAFKFKN
>UU048 unique hypothetical unique hypothetical
MMNTKTFTSVNRVIYDDNYSLKQQQKSSFINQFLKGLLSAITLLFFILLLIFAENTLFGL
GFGDENKSMMISKSLNAFFDLHSPKYLQLNFLIVFRFFILSFTLFYTLIKNFTNLYWHRA
TIKKYLPWFVLYLVIATISFLLFFTFFSVWPKEVFNLVFLLLVLFLLNLSYEIFNYFISK
KTNPLLYDNYKNLIIAMVFQALLLLFVIITPLVWINTGKSPNFLFVDNRFYTRIVDIFTV
QSGKNFIILIAFFFFLITFIVLANTNFFALVINKRYDRNYVKNNLWFILLLFSAIFIWLL
RVFAYKHENENLPVGNNHLLWVYILQSFFAIIILILYMVFTLKKRLSVKSSLNTLLNLVV
TQTILSLSLFLVTLFNSKSVVSLINVFITITVQMSVFGIYIFQNKNISTKLLVLLKVIMI
LIILTAAIVGFDYLLTSDHHNNYLFSNIQPKMNLVQIMLLLNFSLNFTLISYLTIKFAMV
IFKINKLNKELNNEKK
>UU049 unique hypothetical unique hypothetical
MKKNKSNLTPTTNYFDVFNTYKEKKASVDLITYEELMASVLFDNKLGFESEVYLDFVKKF
TLAFEKKLDIWFENFIINFNLNLKFSTTIMIPILVTKANSTTDAINFRNDQNPVYNNFLI
SYNQKIKKLLLQNHPVQILPHLILFKSNLNGSLVLVFSEKIIASIEQKSGN
>UU050 unique hypothetical unique hypothetical
MQLKDLINKKKNLNNINLKVSNERNIFLINIMKLNQRLTFFSKNAFEIKESILSLKRIYN
IKHDMLRHEERKIFKFLNKINDRVLWIYLTEEQKYSTDSYSRYEQKILKTIKSNRDDFIL
IGQGAIEFGKNHNLNVLQTFNDSNIKNLTTQLTKMIMILYTFDNYKKVNFVINSNKNYDG
HFTILPMNEFSFDKFINLQKCDSNIIDFQKVKIYPNLNEFINVQINVFLVNIINTLITES
SFYKTKNGLVATNNILKELDDNLSKIQRKITRVKTELQIEEINLLARQNMNEDDNDNDGG
VYES
>UU051 unique hypothetical unique hypothetical
MKMIMITMVVFMNHNYNIQITLLENKKFNIDNGLLYVNVNEENTWQKIENNTVLAYEIIL
LKIVDDDYKKTFYLFLKNTHISVLNNIVKIQALNDLHFFIKDGLNKKNNHKKELVDKYKN
ITNNILELEAKQQLGLTLSEFLDLDNLKQEQYITNMQIRLNLVEYKKDEK
>UU052 unique hypothetical unique hypothetical
MRNKLKIKLKFLASLATIPIVASPLIFSVAANEDGKQENNNGNNHDPNQQKKPKIPKNDP
NFNTFKTDADKTVKDSLEKGINAAIVYVKSRQEEILENKEIEFKKKIQQLIYLKNLQSYL
EKNKENILKNPNDYGFYLNTPQILGTLKNYDIKDIEFNGETYKQIKVGKTDPLNYQKAVA
PKGKISDVQSDQINDVEETKYKDTLKKYESEFLKEINKLIYDENDVPQINKDVELTRDEK
GQFNTTLPKGYNDWNAYFISKIKDRVTAFDLKQNQQTNEDKQEEQPNEQKDPDTPPPLPP
PLVEGDHNEIDLPPTQANAIISSLPLLLPYISPIYSNESLSGLKSKFDSLKPELKQTLFY
FNNPINTRYLYSVLDFGVNGSSMINIKVKIIDQVNPKLQRTYIINKYDPILDINFNSLKL
NEVNAIKQIFVNLYKHLGLDEKIDYKKLRNFYIRNALFTMIEAAQKLILRFNQIDKDNKI
IGQKTFATLQNEYLEKYKQKLVNNTDDKERLLNEFNNLTKENFFRYLNNTLINNDYYWYQ
LVGAYKQVSLQFSEVLRLNKDKIKANIASIKGDENTIANLYKLNNQLIYQLSAIVAQRSF
NSQQWYQSYLNVLQPIKENFDLMSILTNQTDIKTNKDKAKDFKNAYDSALKSLERQKQVN
KQIRRKIGIAFIVISLLVLIINLIIYGLIKKLKNKKVILIINSVIMVLTIIVLIMGIILI
I
>UU053 atpA ATP synthase alpha chain
MQNTKANPRIKSIFNYIVTVSGIYDYQHHQIFVLKNDPTVKLFVISAKEDLAYLLISNEH
ANINIGDEIIETNREENVVTDLNYFGKIIDINNNFIWPKPLNNLPSAKIAQTNPAFGLAH
NLMTVKTLNEQLNTGIVAIDLLIPIGKGQRELIIGDRQTGKTHIALNTIINQSRAGTKCI
YVAIGQKRESLTTVYETLKAHDALKNTIIIDAPLTAYEQYLAPYIGMAHAENLSYQDDVL
IVFDDLTKHANIIREMALLTNKPVGKEAMPSDVFFSHSSLLERAGSFKNRKTITALPILQ
TVDGDITSLISSNIISITDGQIVTSTDLFAAGKVPAINIDLSVSRTGSSVQSRMITKVAG
EINKIFRQYKRHLKLAMLDYEFNKETSLLLHKGKLIDKMFLQKGFSLFSYRFIVLSTKLI
AWGILKGVKDEQKAFMLLDYAINNYEDAQKAFNTISTTQNYDDKIMKNYFAFILKQYSDY
LNLNWEVELEHSFIPLQNEFLMNVAKFLGDK
>UU054 atpD ATP synthase beta chain
MNNGRVIKIWSDIVEIEFKNSLPALNHLLTTHDGNTFLLVKRLVDATHARAIVVYASKDL
AINDIVINTNKSFMVPVGNDSKNNIYNFWGHPLLETNKTPKYVEMNSTILNERYVDKSIE
IVETGIKAIDFFMPILKGYKLGIFGGAGVGKTVLMKEIIFNLNRHKQANSNIFIGSGERS
REAIELYNELTASNLMPNSVMFISKMNEAPGARTSIVPIGITAAEYLRDQNKENVLLFID
NIYRFIQAENEVSTALGKKPSVGGYQSTLESDVTHIQNRLFRNKNGSITSFQTIFLPMDD
LSDPSAVAVFNHLDGKLVLSRAQAAKNIFPAFDPLASSTNAIDPKIIGERHYNAIIETKK
VLKAYKDLEDVILILGFDELDAESKIIVKKALQLEMFFTQNFFMTEHFTKAPGQFVPLKE
TVESVIRILEGKYLKQSPDVFAYIGSNKDISQDH
>UU055 mnuA membrane nuclease A - hypothetical
MVCKKNKLKMFGFIAIGTVLTSAIIPFLVTCAKEKKIKQEVIKPKQISNLNLEAKNIDIV
LKNNVFNKETAKFTLDFDINKELNLQMVAVFDVFDKKNNWLKTIKTAKTNLVDKKFVFDS
LDENVKYLLKQIDFYDPKAPNQIIYTKNNQTFSFDTKMDDSIARTVELIIISGFNGFVDE
QIVPDYNKQTTYLKAPGLIRLLNEVNKIKKERGANNVAVVMGGNNYYENNISSLTRAQYT
TAALKFLNPVATSIANTDLNWGYDLIDEKTKHFKEYVKALYGNDGILSVNSYLKDGDKNI
QMTNNSKIINFGGFKLGLIGAMSNLINFESNLNLTKNIQWFSNEQTANLINDEADKLKDQ
GVKNIVLLSSFLADKAKENDTLTNDEKSFYKEASRMSKLIDNNVNLMSVINPYKALNVIA
NNKNNQPLNVVQSKPNSGFVRYMITLNPYNRILKTEIKLVDKLSTSGDNAGYHYITQQDL
LNPQKNPDFNQNLITLNNFLNNYKDHEYEQLREKILIKNDKKVNLYSSTYSLSSLGAFIS
DILAKYYQAPFYNKQTHTFEFKQTQAILLAPHAIRSLVSAKPIKLENLNQILPFNDTLVS
GEISVKNLKEFLINKNKSQNYNEPYQFSNTLKIEYENLQETKTKKKSRKKQSEQSYSDNE
KKDGLILSHQKRVIKVFLKNSDGTYTELNDNQKIIVSVMNSILKFNKKFSEALLNKTYAD
QTNIRDLLRTYLPKETQIDQKYDQSVFSKNDARFYKKKETDQNKSLIYNHINESINNKQA
DHLRIGHWNVLHQTGLNDPKNYALAKTILFNKYDIIGLTEIWPAENNNQEQNNLPLIGII
KYLNQLSGSDDYDFLISDNLKGSENDKLATNEHTSTERIGIIYNKKKVKPIPFANNKIGY
IYSNPLQPGKYEKAETDYSRPPFAIKFASIGQIKNDFTLVFGHLDSPGTYPSNTEYQKKE
HLLKRTELVNKKVISTNQMINKYEQGSREVDDAERLVKVMEEIKKIDNNKDDDYFFLGDT
NIRLHNQQWVFRTLIQNGYSSVFSDNDLFKSSLSVNPGEFSNPYDKIFSQVNGLTISNPS
IYNLWNVYEDQIVDQEWLKKVRSLYPNEYHDKLFYIRNDISDHAPTFFDLGLNKNDTK
>UU056 unique hypothetical unique hypothetical
MALTIVLILFSVLALIIGLLLSRTSPSGGLSSLNGQDLEIFKKTKDRGWIKGLQVFMFLL
TIVMILIIIFYRVS
>UU057 vacB virulence associated protein - Exoribonucleases
MSDFTKQTITEVISKEERPIPAAILAKKVLEKIPTLNKTDVYKLIDLLIQENTIKKLENN
RLVIGYLDYEFDHEIKQGIITINSKGDGFIKEDNTEIEYYVNKKYLNGALKKDSVKFVKL
KKEPKNNLQDAAVIEIVGHAKDHYVGQFITLPNGGYYIFVDDPLFYLNINLKDTTGLVNG
HKILFKIISQTTKDAIAELVHIIGHKNDVGSDVLSIVYDNGIDPTFDPQVVDLASKLEFY
VDEHQNKIRRSIIDREIISIDPVGSKDIDDAVYVKKLNDQRYFLGISIADVSFYVQPNTI
LDADAFKRGTSTYLVDRVIPMLPHNISNNICSLNEGEFRMCITCDMVIDKDGKICWKDVY
PAIMKNYRQMSYDEVNDFYEGKSRFESATLTMKEMLLEAKELHHILRNKKIKDGYVDFDI
KEPKIILDETGVPIDIKIYERKTAQMMVEDFMIAANEAVTMFAEEHMDKTLKEFNLEMPF
IYRVHDKPSIINLQKFEIEAKKLSFNISHDFENIQPNTISNWLKMNDNHVNLPLISKLLL
RSMAKASYEIINTGHFGLASDNYTHFTSPIRRYPDLIVHRLLWMFIFDSQSYTDKQRVEL
VNKLKLITEESNKNEIIAVKTERDVNAAKFAEYMNLHIGKEFIGVVTTVSSFGVFVELEN
TIEGLIRIKNLKDDFYDFIPENMTLVGQKRKKIITVGNKVRVRVIEANKLTRKIDFELVA
Q
>UU058 smpB small protein B
MIVSNKHARRNYELLDFFECGIVLKGTEVKSISRANCSINEAYVQIIKNQALILNMHVAN
FFEGNNFNQDPYRNRKLLLHKKEIIRLQHLVKTQHMTIVPTKIYWKNNKLKIEIALGKGK
QLHDKREDIKKRDLARETRLF
>UU059 msbA transport ATP-binding protein
MKRVYFNIKGGIIMKSVWKILLIKHKFLFFFILFLNLVQVLLVIGSPLLLSILNNGNYAS
TTADAFIYGGVLIAMAIGWAIFSIFTNYISTVFQIIVESRLQKKIFEKTMFLTYADKQKF
NQSILLTTSIKDVEELSKTIIFLTRPVIMGIFYFIGAIILLFIISGNLWQIPLTVVLMAL
STIIIFMIISKFNAKNWNKMRVANDELAKVSLENVSGVKVIRSFLLDAFFLTKLDFKWKD
NVSKSIIANRISKVSIAIVTFIIYVITPVILIIGICTNSMKATNILSIMQSTNLLVLGIA
LIGFGSEQYFRSIVSIKRINDLIFYKNQIVYNGTKEINNNNIEFKNVSFRYHNSKKWAVK
NISFSIKDTDRVGIIGTTGAGKTTLIKLLMHQLEPNSGEIFIDNIPLKDIKKTSLQAAFS
LNEQVPLLFYGTIRDNVLFGLEDIDENKINEVIEIAQAKDFIESKNEKLESLIAQRAQNL
SGGQKQRLAMARALLRDARTLVLDDSTSALDMITEKKFLTALKQQIKFKNSIIIAQRINI
ILDCDKIIVMDKGKIVGIGNNETLLKTCAVYKNIYQHQINKGAEYEPTTTNQ
>UU060 msbA transport ATP-binding protein
MSQQLQTNKPVSKLYLIYYYFKDFKKVFIGLSIAIIFWLSTTIAATFLLQETVDKYAIAN
GIVDTVVKMCAGLIGIYFFSFIFLLIINEFAIRISFKIESHLSMMVINRIRYLPMKYFDI
NKSGEIFTKTLSDPTSVQDGIVNFYIELNKAIFGAIGFGTALLITSPYIALIGIVIYVLV
MLFNILIFKKSHQLMRIKRQNFGEMNGYIEEMIYGQNVVANFNEQVFFIKKLDNMIKKLY
KNWIKAQYSSQIIFPWSIFSMRLMNAVLIVSYLLISIKGIHLPGLINNIDPTTNIISFGG
LVSISLFGNFFCDNFSQLSNTIPIFIVARTSLAKIDEIVKTPNEINWNEKLIIDASQGIE
VRFENVNFNYLKNTPTLKNINFVAKRNQRIAIIGPTGAGKTTITNLINKFYDINNGFIYF
NDVDITNKSRESVREHISIVLQDPFLFSESIYENIKKGKMNATKEEIIAAAKKAQVHDLI
LSFPKDYATVIDEKQNLSQGQKQLITIARAIISDAKIIILDEATSSVDTQTEHKLQLAIN
NLLKGRTSFIIAHRLSTIINSDLILVIKDGEIIAQGNHDYLIKNSPFYQELYYANFNE
>UU061 conserved hypothetical hypothetical
MTSLDITTLVISILSLIATLSISFNIYFIELRKQRERKIERLQQEAKQFIINNLDEKDFI
VLCQFIYKLYKHDKHTRKIHYEFVLLNEPVQKEVFKQLEILNIVDFKDNEWIANKFSILK
EIVNDYQLGNWDDYKFYENFNFAYTLFREEKCDAVFEEIKQNKFGGKNLSFHEYLNEYAH
RSKESDMLAPIDYFIDQNNLNNVFDRQKHAIYKLYLLDLILNELCRSMNNDHRINNEFKY
FDCEVIYVEDLYLKILYKLYFQLN
>UU062 lysS lysyl-tRNA synthetase
MERKFSDQELIRRTHLQELKNQNKNPFLITKVDRSMFLKDFAEKYKNFSKEELHNMDLEK
LTLAGRLIGIRQTFGIIQDFSAKLQIYINKKNVAPEVFSTFKSLDIGDIIELEGVAMKTN
SDEITLNVTNIRLVAKSLKVLPEKYHGLVDEEIKARQRYLDLIVNDETKNTFIKRSLIIR
EMRNWLDNKGFFEVETPVLQDILSGAAARPFITHHNTLNKEYYLRIATEIALKKCIIGGF
EKVYEIGRIFRNEGMDSTHNPEFTSVELYIAYVDLWYIMQLTEDLIRHIATKLNLLNPTF
RGFSIDLNKPFKKAHMVDLINEYVGVNFFEVKSDEQAIELAKKHHVKLLDHQKNFGHIVN
AFFETFVEEKLVEPTFVYGHPLQVSPLTKKNQSDPRFVDRFELFICQKEFANAYSEINDP
IDQYERFIAQLEEAKLGNDEASELDMEFIEALEYGMPPTGGLGIGVDRLVMLLTSNDSIR
NVLLFPHMKDKTK
>UU063 unique hypothetical unique hypothetical
MSKKIKIYLAGPLFTLAEINDRKQQASLIRKTFKDELPNYELDLFNPIEVNDELGANAHK
PNIFFYESDIKFIDQTDIAIIDIDNTDDGTMAEMGYFVALQKHVKPTLKIYILNTDWRVH
KHRNEVLNKFLDGMILSHCQYFTNFTDLLNHLLIELKK
>UU064 unique hypothetical unique hypothetical
MSDEQKTKLIELKQKVNDLEFELDKIKNEFMMKIIIAVILIFFLTIVGLFYLIINLSRII
SLNQKRKSLELKTKELNHEINKIEISLL
>UU065 pepF oligoendopeptidase F - zinc metalloprotease
MENKKYEWDLDDLLNNKSLDDLYAEFEEKKAKYIKAFPTFLDSKQNFAQWQILEEEFTIV
ANRFYNYVSNNLNTNVVDPKWNSWSQKLSASFYELETALSNYNSVVLANEAKIKEYLTDS
QLNVYTRKYNEIFRYQPHTLNNEQSKLFSTLIRADEGFSTIFSTYTNNDMKFSDAIDAKG
KKHPIKNEAEAFVHLKSKDRVLRKSAYLSMYRAYYDSRESITKMLYYNYLSLNQQAKAKN
FDDYIAKAAFDDVVDKSLITLIYDQVKLYKDTNEDYKKVRNTYLKKLIKVSKIEPWDNGL
PLISKKIDIPIEEAKQMAIDSLSILGDEYVSNIKRAFDEKWVSWLPQKGKRGGAYSIGGT
KGISKYYILMNYTNSLRDVQTIVHELGHSMHSLYSNRTQKIYSDYKIFYAEIASISNEVY
LNYYLLEKYKNDLEMKLMILDEMISGFFATTTRQVIFSNFEWIANELINSGAPFTADVVM
KEYQKLELEYTNKPIVEDLNSIYSLSSITPLRIPHFYVGNFYVYKYAVGQVAAIISGHRV
FTKVTGAKQKVFDFLSSGGSKDPLDTIKLLGVDLTKPQAWQEALEIVKLWIKDYKQTIAL
LNKKRSKK
>UU066 pta phosphotransacetylase
MLSSINKLKNKLKNLAKKPIKVLFIEQSLEIDKAKKMLSQDTLINIVDLSSFKTPEIINE
CEEIWYELRKLKGESRNDAQIAVNDNLNFAVCLSYLKKIDVLIVGANLSSKTCFSSILKI
LKNPNGSIAYSTMVMINKRELIFMSDCALNLNLNKQQMIDAAKYSCTISRNYFDVLNNHV
GYISYLSQNDVIYQNKNFDFIGPIQFDAVVDLKVRNKKVPNIHQYHINHYVFDNISIANT
VFKIYQTKLNYLTVGTYISNILTKVSVISRSASSDEIIATTYLLCVAFLTDLT
>UU067 unique hypothetical unique hypothetical
MDQYKINELIPSEYKLASYFNCGRITIHNAYEVLKVLGIVTTIKGSGYYVYSSIDHFTNK
AFANLYKTIDNIKYEQFLIDFEYHGNKFNSITKFSLIKNKKIIAVSYYITPNNMDLEQFD
TNNINISKQLILSGFDDFFNVKTQINYENINLLKSILEDENIKFNTPIILNKLTSSSLKV
ELLILTHISKEYFDYEETNKLIIN
>UU068 conserved hypothetical hypothetical
MNFKSTIVNKKPIDWKHTIVLEELNVDPKALEMHKERINTVFAKQTEEQRSQQLHNIIVR
ENLFNKAMTYLADFYEIDVNEEDIKDLAPRIKQAFGVEDEKLAYEIAQKIIAKALIFQDL
QKEFTIEIKDEELTKILESYYEETNLSIRDFKENKAQWEAAKSTLLEEKTTAFIVDKFDR
DLSILEANIRKKIAEQMELDKKIKEIQDNNKSKQNADK
>UU069 fecE iron(III) dicitrate transport ATP-binding protein
MFKIFAKYFCNHQLDRNQIINASKNDALIINNLSYRYHKKLPEVLKNLSFSIKKNSFTTI
LGPNGCGKSTTAKAIVKLLKLKKNIIKVFDRNINELSFKQLAQLISYIPQSIEIPQGTRV
IDFITFGRNPYLGFSGILGKEDKLIIDLVINEMQLHDLKEKFMQELSGGQRQKVILALCL
VQDTPIILLDEPTTYLDIKNQYELLESLKKLQILRQKTIIAILHDINQAIQYSDEVFVLK
NGQIYANGNPNEVITKELLKNVYNIDAQIDIVDNQKIVHKIKVKDYLSNSE
>UU070 hmuU hemin transport system permease
MKINQKTNLKQKHFYLIKNLNYKQSVIIKMAGLILIAICFVFLTLAIYFDTTNGFEASIN
QFNFNIRGPKTLMAFFSGGAIAVAGLLLQKVTRNHLADTSVLGIGSLNIILMTVYLILIK
DKTSSYLNPEMRILPLVMFLSSIFGTSIVYTLSKLGRANNEKFIIIGIALNFLFEAISVV
LINPANNSLFSNQDKNLMIAFENIKNYTLGIIPNSQYIDLSLVISCSVLIALTLIPIWFL
RKKIDLYETSAALASTTGINIERLKISIYLLVALLAGLEIVLVGYIALLGVIGASVARQL
FGNRTGITMFAAFLIGATLVCFALLISVNFNTQVPVGFLSTTIITPYFMYLIVRGK
>UU071 ABC sbp putative ABC substrate-binding protein - iron
MHKKTKKYLISMLATISIVIGTTTIISSCTKKTSANVQEQIKYDIMPTYTSQADNLLALG
ITPDYYPQQMYWKKNSPYDYLNPQKPNYQKWFYEKDDFANKFKEKLINLEKNIKQYGTTW
WSFSGNTYGEGVSEEYWNKNKGKLVYYDRYLIDNSHFERAKKTLVAHGGPISNQKTAIPV
DFKMSRDFYLTLNKNDILNFKNDPNSLLRKSLLLGLEYKDKEKGELNELYNYSYFADKLN
KNYFNAETFDGINFNNSAFKKRILEGNDIPIFYTETKWKDPKSLNSKIYEAFKTVVLTKK
VRESGLNKLNYDPFLSTTKQDSYVTSILQHHPIYEQNMRWDGGTQVYLGTMRDSLLYLYD
IAYATTKYAYSEEAKIDFKDNLAKLEPLKKALFNANQIANNLINRLNKMRLYFQAIGVVD
KNYNPNIKQFDNTNSKTLGLLTTSQNSGSSTLQTQSKYGFLYYDLGFKAPKPILKKDEWT
ELLEDVNGKQLLCHRHGNGQIHCFGGDNQDGTQIDKNIVGSLFNMDDNGWWWNLGEGSLS
ASNFAKFNSEFDYLIKISYQNLEDFHSNNLSRPQKELIMSLIKSDYDDPAKRIFDDNYEL
WNDGIKSPIGYNMILDSVIKIINKTIDPQLIQQNKQLLKEANDWGSYWKTFVNQK
>UU072 hlyC hemolysin
MIEDSQETISTQANFSVGILVILAIITLILICFSVFFSAAETAITSVTTVKWKTESNKIK
SKTITNVVYKMINNYTITLATILIGNTLVNTASSTIAGLFFAGIMKSFSTTSNAEAIGTG
IATGIITLIVLIFGEFIPKNFAKKNPIKVLKLVAYPLNCFYILFWPLTWSLNRIFNKKSQ
NIITATEEELKSLIEVIRHEGTLDSQEALIINKAILFDDILIKQKMVPWTQVVKINENKT
VLQSFEIFNSTGFSRLVVVNKNDEVVGIIYLKKIIKYLLNEPNKIIRTIMQTPLLINQKD
TLYDGLRTMQFQRIHLGIVVDNITEKNPIGIITLENITEELTGNVYDETDNENEIKEIQI
VNETTWRVDAKTNAKLFLHQYIDKDIEVNDDISMGKYISKINKNRAFKNRQLINTPNMYI
ETFKDVRTNQFAFLIEKKINQS
>UU073 conserved hypothetical hypothetical
MPKSTLQEIIDNDSNKFTFSEFVKEDIYTNTDYSSTDYKVILYSFFRNNLTIKIGQKLTW
IIKSQNLQIIEFILNGLDYFNNLNIEYEIMFEPDHLNKTRTNYSLLLWGDLDKLDEILKL
FDDANNENFHKDRYCSNFLIGAMLSGGSIAHPLENYHLEIRCDSNNYIPLLTKALARYGL
EYKIIYRNKKTIVYFKKSEIISDFLKAIRTQNSLFEFENIRIQRDFNNQQQRLNNLDISN
LSKSSKAGVLTKEMILEIKKNHDEFCKQSTKFLKYCELRVQNPDCSLNELSCLLKQMFNI
EISKSGLNHFNSRIKEMYEELKLKKLVFKN
>UU074 trxB thioredoxin reductase
MNQEVYDLVIIGAGPAGLAAAVYAKRSGLNVIIVEKQFPGGKIALTSNVENYLGINSIPG
PELAYKMYEQVLNLNVSIIYEAADEISLKEKYKKIKLTTQTLITKTVIIATGTENRRLNI
LGELEFENKGISYCAICDGPLYKNKAVSVIGSGNSAVEEAIYLATIAKEVHLIANKPQFK
AEQQLVQIANNTPNIKIYYNKQTFEFFGHQFLEGLKFRDLITNEVTTLNIEANFTFIGLL
PSRINTNNLCIFNEVNGFITTDKNMQTSVCGIFAAGDIVDKNVRQIATATNDGVIAALYA
KEYITRNNW
>UU075 lgt prolipoprotein diacylglyceryl transferase
MQLEIINPESTLVNDVVAHRVAFSIGSNFNIYWYGIIFVCGFLIAILTYSLRLKFHYKVP
YDPGFYYIFLAIPMTIIGARLWSLAIGDAKDFFDFRSGGLAIQGGVIAGVLSAAVYFPLI
LRMPKYHIRDIDADGNVVIRQPSMWIYADAIIPTILIGQALGRWGNFINGEIFGAESTVN
DLQWLKKAMPAVFEGMKHYFIEGNKTLFTIYQPLFLYESFFNVIVFVFIYFGLSYIKQLK
IGFISMSYFFFYGVTRFSTESARAPQFSFEGTYIINSLLLIFGVLGALYVQFIAPLLRKK
FLLDAIIEMFYKKKDQIHKFGELRKPEEFLFYCHK
>UU076 hprK hpr serine/threonine protein kinase
MEIRGKLFVSQVVRKFNLNVVANSDYIDREISTTGITRVGFELAGEILFKEIWNIVYFGS
KESNYFNKFSETIISKKLGKILDLNPPLIIFGKNFKHAGILLKLAERYKIPIVEVKYSFY
ELNFTINSYISQKLSHQSLVHGTLLSVFGIGVILMGESGVGKSELAIELVKKGHIFVGDD
AILVNRIGGNLYGRAEDSTKDFIEIRGLGIMNFSRSFGIERMIESTKIEIVIELIKPAKH
EKIKFERFGREIQHKEFLETKIAHYYIPVIEGRSISDIIETAITDYKLKTSGYNSAEEFI
LQINKKGI
>UU077 conserved hypothetical hypothetical
MKILIKLWTNLINRISNKKYLAAVSGGPDSMAMLNMYKRNIRVVCHVNYHKRESSDRDQQ
IVVDFCRKNNLIIEILDVDEKVYERYGHIDNFQTKARLIRYDFFKEIGKKYNIENLYIAH
NFDDFLETAYMQRARQSKALFYGIKESNVINGIIVKRPVLFVRKQTLQRYCDENKIKYGI
DETNELDIYERNRVRKIISSWSLNEVYDFKKFVIKYNKEHSSFANFIDLSYIEFKKNKYK
YDYFIRQDDMVQYYLIYYFLIDHKIINPSENKIISLIKFFGKQINKEKAYRVQENIYMHV
NDDELISLISYNKSDNISNSNVDIIDDHNVIEK
>UU078 pth peptidyl-tRNA hydrolase
MEKYLIVGLGNPGSNYAKTRHNVGFMVINEICNKLNLSLDSSKFNGIFTKTIYNNSIVFF
CQPTTYMNLSGEFVIKMLNFYNIPIKNLIVIYDDVDTKLGTIKLRKKGSSGGQNGIKNII
NILKTDEIKRIRIGIDKDPHIKLDQYVLSNFKIDELVIIKPAIIKGALATLAAIGEDFDK
VMNKFN
>UU079 dnaN DNA pol III beta chain
MEVFISIKKLIEAIKFSTTIANTNNANALLLGVLIEVSQNKISFKTTNNQVSGYKEITEG
FEYFNSGKVLVTAKIILGLISKLKDKSVLLKQIDTNILLIKTENFETQINTMNIEGFPNL
NFSLEDYVKISLPHQIMQEINTKVLPNVLNSQGIEKIQPISGILIDTQTLENKLIAIGTD
KIKASCLIREYMGEKFKFIVSYSTMKLIIEILKNVEYSNNQTVDFYVRSRSLIFKINDAI
LQTRMIDGVYPNIYSIFDETNEENTYVFDRRLLIEIIERGMNIVMQEQNPKISIRIDKNE
AEISLTTFEIGNMKEKMSIVNLNNKSAEFILNPSLLAHVLKNFDNNDVTFKVKDEILRPI
IFIDTKDVGFKQILSRIKN
>UU080 conserved hypothetical hypothetical
MKKIFISTEYVTLNQFLKIAGLINNGGQAKFWLLENKVMVDEKIENRRGRKLYDQMIIKI
KNQLYQIVKTNE
>UU081 gyrB DNA topoisomerase - DNA gyrase subunit B
MNDSNKEKKYTAESIKVLEGLEAVRKRPGMYIGSTQSEGLHHMIWEIVDNSIDEAMGGFA
TIVRVILKKDGSVRVEDDGRGIPIEIHEKTGLSGVETVLTVLHAGGKFDNDSYKVSGGLH
GVGASVVNALSKNFKVWVNKNHVQYYVEFINGGHAIEPLKPINNKDVKEKGTTIEFIPDF
EIMEENEWDELKIMARLKQLAYLNKGVNIEFESELTNRKEKWHYEGGLKEYITDLNAEKE
PLFDLIVYGEEEKEVRVPGHNEQTYNIKCEVAFQYNNSYNNSTHSFCNNINTTEGGTHEE
GFKLAITRLLNKYAVDKKYLKDTDDKITKEDVSEGLTAIISVKHPNPQYEGQTKKKLGNS
EVRPYVNEITSIIFEKFLNENPEESKKIVAKVMQAAEARRRSHEAREATRRKSPFESNSL
PGKLADCSNRDSSVTEIYIVEGDSAGGSAKTGREREFQAILPLRGKIINVEKAKIDKIFA
NEEIQNMITAFGAGIGPEFNIEKLRYSKIIIMTDADVDGSHIRILLLTFFYRYMLPLIQN
GNVYIAQPPLYKVSYAKTIKYAYSDQELERIKSTISNIKYNIQRYKGLGEMNPDQLWETT
MDPKNRLLLKVNIEDAAIADKTFSLLMGDDVAPRKEFIEKNAKYVKNIDA
>UU082 gyrA DNA topoisomerase chain A - DNA gyrase A subunit
MALKKPKKSRLTTEEIKQQLEGSTIKEQSITKEVETSFLDYSMSVIVARALPDVRDGFKP
VHRRALFAAFENGMTHDKPYKKSARWVGDVIGKYHPHGDQAVYQTIVRMAQDFSMRYLLV
DGHGNFGSIDGDSAAAMRYTEARLSKISYELLKYIDKETVDFVPNYDASEQEPSVLPSGF
PNLLTNGTTGIAVGMATNIPPHNLTEVCQAIKAYAKNHNVTISEIMEYLKGPDFPTGAEI
YGDSGIIKYFNTGRGSVTIRSKYEIEDIGQGRVAIVVTEIPYMVNKANLIEKIVELVTNK
QIEGISDLRDESSRDGIRIVIEVKRDVIPEVLLNKLFKTTPLQTNFSVNNLALVNGVPMV
LNIKEMIKYYFEHQIEILVRRTNFDLKKAKERIHIVEGLVIAVNNIDEVIKIIKASGDDD
IASKSLIQRFDLTELQTKAILEMRLRALTGLNIDKLKKEYEDLILVIKDLEDVLNNYNRQ
VNIICENLDYLIEKFGDERRTEIMYGVSSHIDDEDLIPVEDIVVTMSKRGYFKRLPIDTY
KNQRRGGVGVQGLKTYEDDDVEKILVANTHTDLLFFSDLGRVYRLRGHEVPLGSRQSKGI
PAINFLPIEKSESILTILPIDNYDQGSLFFTTSKGIIKRANLSDFESIRANGKIAITLKD
GDKLFSVMQTLGNDEVFIGASNGNVIRFNENDAREMGRIATGVKGINLENDEYVVGTGLS
SHGEYVLAVGSKGLGKLTDINDYRLTKRGAKGVNTLKVNDKTGNLVSIKVVNREEEALII
TTSGKVIRLSIKDISVIGRNTSGVKLISLENKEEVKSIAIFKKEEINDEQLLQENDYNLK
>UU083 conserved hypothetical hypothetical
MNVALELINLLKERRLRLSVCESASCGALSSSIGEVAGASSVFAGGFISYSNEVKIKLVG
VSEKTIFKYGAVSEQTAKEMCLQTNQKFNTDIAISITGNAGPQGSENKEVGLFYIGIAIK
DFAIVKKVTLNSNERTFNRFSIAWEAISYLIELIKK
>UU084 recA recombination protein
MKENNNLEKLDPIATLETKFAKSSYFIADEIKDEKINAISTGSIHIDQITGINGIPVGKI
TEIYGNESSGKTTIALQTIAECQKTGGTVVLLDLEGSFDINYAKSLKVDLTKLIITQPQT
GEQAFDMIETLIKTNSIDLIVIDSVAAMLPESEYQANMNEALMGAHARLMSKGLRKIQPL
INKSKTAIIFINQLREKINTFFGNPEMTTGGKALKFYASLRIETKKADLIKEGINKIGIK
TKVTTVKNKLAPPLQTCFIDIFFGSGFDYNNEIIDFAIQYGVLKKNGSWFYFNDNKIGQG
REQLKNTLSKNNELFIQISEKTLEFVNNEKSNWQ
>UU085 conserved hypothetical hypothetical
MGYLIAFIILLILFVLLITIVPVVMVVYLKKKQLKLTFVPKSQTSFKKIVQKTKDLEEEC
EDLNNKNNELKKAISDQNLQIDLLKKNNENFLLNATSLTAEQAKKELFNLLKIKFKKELA
QEYAKIKHEFNEAQEIYAQNILVETMEQIAEPLIVERSLFNIDIIDENLKGKIIGRDGRN
KAVFENEGGVDLIVDRQQPIVGISTPNPIRREIARIVMQKLIDSKNIDINRIELLFKEER
EKFEKKVFEIGKNVVEQTLGFFDLPEGIYSYIGRMKFRNSYGQNILSHSLEVAEYAERIA
KLINIDPIKAKKAAFFHDIGKTIDFESDLDHVEAGLLIAKKFNLDDYIYNAIESHHNKVI
PTTIYGALVKIVDTLSAARPGARVNSYDEYYSRVKELETICMRFEGVKSAYVIKSGRQLR
VIVDSNLVSDEQLELLGHEIKVAIEENDLLTNYKIKIVLIKEKRISIDTNIIG
>UU086 dgk deoxyguanosine kinase
MSDKKLDFLTPSFKKNRVSNSIAIGGMIAFGKSTLAQALHEKYQPSNVVYEMVEGDKLMD
LLLAKMYERENNVLFGSLFQLYFVLNRFANYKNNCNRKSLTIFDRSIFEDWLFAHANIDK
PSVFSYYDGLWQGVCKELIYEHGVPKLYVILDGDWELFKERIFKRNRKVEIDNFSINETY
FKRLLEMYKNYMVNVCKDFGINYVVLDANNSVEQNVDEVTKILQKLENEQDK
>UU087 dnaX DNA polymerase III gamma-tau subunits
MSESTLYRKYRPHKFKNVIGQDLIKQALMNACLNNKITHAYIFSGPRGIGKTSIARIFAS
SINCLNPNKGDCCGKCSVCESILKEQSVDLIELDAASNNGVDQIRIITDNINYLPTFFKY
KVYIIDEAHMLSTSAWNALLKTVEEPPQHVIFIFATTEYQKIPLTIISRCQRYDFKRLNN
SELQELIDSILTKEDIKIDNNAIDKLIQLADGSGRDCLSILDQLTTVKKNIDLDLINKTF
GLVDNFKVISLIELIQKNDILLLREFIYELYNQGVNLEAFCVQIINVLIDYLIYLKTNDI
NNLKKVSVDELKKMLLINFNGNYLLNNFISLFNNLKKSLNQVFEFEIYLYKIINANNDKL
ENKKIELSINPEENKINNSQIITTKKIDCFEEINKNTVDFDKLYKTKIFYHKKINNQNDK
ESGINQKEELSTELVNDNKLICNSNDILDNYELAKQAFFNKDIKLSKEMSQKFKDFKNEE
TIENSYIDIIKQADLVLWCSPNALVLGVEFLGLINRINKVTHSFEFIKEFVKKFDSIKLV
IAISKKQALNIINIKKQGLKTNIINDVLIDDIKMLLKQEEQRKQEQTALLNEIEDEE
>UU088 conserved hypothetical hypothetical
MDFQKLAQELKKMQNTLSKKQKEFEEKVFDFDYKGYVLVKIKGDLNIEAIEIKTEIVDPE
DKETLQDILRAAINEAISITCKERDAIMNATIPKGTGLF
>UU089 recR recombinational DNA repair protein
MSKPVEFEMLVDALKSLPGVGTKNANKWAFFLLQQDQKYIDDLIKRIKEAKTNILKCKYC
ANFTNKDECDICLNEYRDFTKLMIVTTNEDLERIESANIYNGLYHITNGEISLRKNVVIE
HTNIKTIKERVLNGSFKEIIIATSYTHDGEVTADYIIRMLEDIKDLQIYRIGFGIPLNSS
IDYADDETLKQSLINKRKIRN
>UU089.1 conserved hypothetical hypothetical
MYNYKEVKHMGYGKGYLAMFKNKKVRFKVVNSFPDLKVQFVTSFPDYKVKISNSSSFCEE
TIKIQVVTSFPDVKLQKVTSFGDFEAYID
>UU090 conserved hypothetical hypothetical
MLAHFFNIFNLRRGELIMANEYYNMCALDALKFVKNRNMLLPDIQREYVWDTTDIEKLFE
SIVDDYPVGSCIFWKTNKKVLNDEKPNLYYFISKYKQGVTKNEKAPEFVSDETDYYIVLD
GQQRITSLNIALFGSFTSKKKGKGYSVKNSKSWVERELYYNLSFYDSNELDDENPIKRFV
FLSEEEAKNGNYYKVKQIVKSDNLTDYVDTISNFNKNVKTDLMCLYRRIMEASATSVIHY
YCIAENTYDEALDIFVRVNSTGRKLSKSDLLFSTLIDGWKEGKENIDTLLSDLNSAGDGF
SFTRDYLMRLALVLVDANTNLKIDSLTSKTIKEIRDNWQKIKKALEKLSELLVSIGMCDE
NMTSYNATIPLAYYFYKGGKIDTAESKKEARKFLAVSMSKGLFGVASNDSLNQSRTALKS
VNEKTPFSLTLFSSITLTGNRTFTASKDDIEYWLTKFEKGKNTFIILSLLYPNLKLSQVE
FHQDHCHPYTSFDDKNIKKLGLTEDKIKEWQFKRNLIPNLQFLAGKENESKNKRPLSNWV
KDGNTFEYRPENVSLELSNFDKFFNERKSLIKNKLLDIFGLKAN
>UU091 ffh signal recognition particle
MFKAMIGSIVSKQMSKKLKNATIVEEDIKELLSEIRIALLDADVNLLVVKKFIKNIKEKT
IGLYVEANQKPADLVLKIIKDELVEILGKENKPVNTAKSQLKIMMVGLQGSGKTTTTGKL
ANYFKNKYNKKPLLVAADIYRPAAIDQLRTLAKQVRVDFWEEGTQRPDLIVKNALNKADE
NENNLIIVDTAGRLQTNEELMQELVNVKKTLNPDEVFLVVDAMAGQDIINVATEFNNWLK
LTGIIVTKLDSDARAGAVLSLTSLLNIPIKFTGTGEKIGSIDSFYPERMADRILGLGDIM
TLAEKAADVIDEKQVRGSMQRMMAGKMDLEDLMRQMSQISKLGSFSGIAKMIPGLNNISE
NQIGDAESKMKIWTILLSSMTLKERRDPRVFKKEPSRRIRVLKGSGRSPDELNKLLKQWE
VSRDKMAELGKMLQKGKNPFSKSGGLFS
>UU092 unique hypothetical unique hypothetical membrane lipoprotein
MNKKINLNSSLAYIGFLTRLIIVKKTTYLLPIITLLITLIIGIVVGCVVKQKTQFLIISY
VMIMFNLLMTTIFASLKALNIFKDFSEDGIDILVISKPISRKNIVWSKIFFFVLTGIVWS
LVSFLGLLIFYLISFNFAKNVNYYWILSYISPFICYLIFGLITSLLALKLNAKISILIPF
VSFIPLLTIGIIANLVSQVQSQAFLRLLKQKSTNNIEAFYLNNNLDQYYLINTGFFNHKF
NENQNLEIMNAYLKTRSLATFWQVSSWILPVYQLADVFNKSDYEPFSDFIKNQVDQILYA
NNLASKQFNYQLEKNSNSLINFSINNDKSFLIPSLLKNDSQNLINNNLNQEVIYAIDNWK
DQTIEYQKNSYTQLSSDDIVGSLKWMIIKEVLNVRSFNTYANNLFKTLDQKANQKQILDL
ISNSVQKFDFNKWNDENADLFKKDFNKLLIKSKTEQQIYLAVSLIYYLYFNPHYTNLLKI
LLVDHQNNLQYKTQLKINLNNKNYLIGGFKSYLLHQILPQENDDGIDELKKDKKIRYRYS
LEQGGNYLFDYVQQNYSFKRKQQIVYKEAYCVIWLILIFSLLIGTYYGYKRKDYR
>UU093 bcrA ABC transporter
MNNEFILEVKNLTKIYKKSNQGVFDLSFNVKRGEIHAFIGENGSGKTTTIKSIINAYTNY
KGSILIDGFDNKTPKSHEKIGYVPEIALFPSELTTFQYLYSFARLSNLNKKQAIERIHNF
LEKFRISDLKNKKPINFSSGQKKKVILIQALLHDPELIILDEPTANLDPSARHEFNNILK
ELHEQNKTIFICSHILKEMDTYVDSLTLIHKGKLVYSGHKYDALEKIYYDSVLKNK
>UU094 unique hypothetical unique hypothetical membrane lipoprotein
MFKKRSSSRKWFIICTSLSISSIAVVSLSACANTNNKIVNAGFIYNGSTTNDAITGFDVN
DYIIKAPENDTNLNQQILRNNNYEQKPILWNDYLKEYDSVKKQHDQQIKNFYEYIWINEA
SKYKNLNKVIDINDPYFINWFLKLTPNTLKNDLYNFINNIRKDNTKPSLVFSSSEPQIKV
WKDLGNNQKQVLNPNQAIFEPLTEQDIKNNINLLEKNKALRVSISFWYALTNQSSANILI
NDPFYKKPSGIASNTSEKYFIRIEASPIALDFSQTDRLERDKYSAQTTSIKNTYKMRYYF
NNIRVEKQVTKVKNNAKRGDQNAEENFPKEFYFGANSNEKFSFGTHSYTLNNEITQASYE
QDIFSLDHKIKNELKKLNEQQILKDIEYAFTSGYDVAIDSIGSIFNILKGVANDLNLKEL
FLQSSQDFRNLTYNITQQNNLTNLITLITSNQSLGMVIDGFKPILKEIIYNNPSIDQSVK
NTIWSKIDSMDFKNNLIAEIGQIRTLLDSISLTEIKTYKPIINKLLELISLIEARSKKDP
KNYGFIDGLDELFSFFLNLKQNDLPSSINFKIGDQNYTLYDLITEVKKIANNLIPHENQY
DPKDQQIISTNYFLTKIKILDLISLNKNDQLDYHKGVEMIFSLLKKFQIAIPEFIYKIID
ELLIQNTNWNKENIKKLLDAILYPKITSNDPSINDLKSYFKYGISKPEITSKELEYDQNN
LLIKKLNIKYRYKVLANAEFDIKPLFDLLPQKPLSFIDLGGLWEQIKKEFPYKIVLAKND
YVDHTISISQPQELTTLIFKDRSDHDKYKIGYVFYPTHTVQTHMPNSMKAIIENISLRND
RLLPNKYVAQLLNWLFYKKWVFINPLAIYETFEGDKKIPNDKNVKYLIKDNLNKYLKNYD
SNTYCEGFDFKHFSNNLENKVGNQTIRNLILAKIKTIKTDGQELYQDALGRKIIATSAYD
QINLTLQELIDYKLLGFGKKVDLKKDVYLSAVAFNFGLNTNDSDQTNVLNNNDEIKYNLN
ILKKVVITLHFTKPMLDLSDPNRTKLVNSYTFVV
>UU095 hsdR type I restriction enzyme R protein
MENKVLLAEHENSTVVAEFKSIKVHSNKFESEAELEETFIKLLIAQGYEYLPIKNNNDLK
NNLRKQIEKLNNYQFTNNEWESFLSTYLLNPNDGIEARSKKIHEDYSYPLKKDKDSITKN
IKIIDKNNIHNNSIQVINQYQNNNLDNQQKTRYDVSILINGLPLVHIELKRRGTNLKEAF
NQIKRYANHSFTDLYLYTQIYVISNGTQTKYYSNTTRETSIKERNNTNSKKTSNSFEFTS
YWADSKNNQILDLIDFCQTFFAKHTILNILTKYCVFTSDNTLMVLRPYQIVATERIINRI
KISLNDKKLLGTTGAGGYIWHTTGSGKTLTSFKTAALAKEIEGVDKVLFVVDRKDLDYQT
TKEYEKYSKGCVSANTNVNELAKQIGNQENKIIITTIQKLGIFISKNPKHPIYSKNVVLV
FDECHRSQFGDLHKKITKKSFKKYMIFGFTGTPILEENSNVKNKNIFFTTEHLFGACLHK
YTIDKAIRDGNVLGFRTEYYKTLSEKDDIDDETSSTGIDKKEALENPIRISEIVDFILKN
YNRLTKRNEEFFEHNKIANINEVITSRNKLSENKVLTTLNGFNSILACSSINAAKIYYSE
FKKQQQKFPQEEKLKIGLIYSYLPSEQESNDNELSNFELLDENNENTNQLDLDSRNFLDE
AIKDYNEMFGTSYSTDNANFNNYYKDFSLRLKDRSLDIAIVVNMFLTGFDATTLNTLWLD
KKLKYHSLIQAMSRTNRILNGVKSNGNIVFFINLEDEVNEALRLFSSESNINSSIAILRS
FKEYYEGYYNEDNQYIQGYRNLVEELKSNFKIPFNGTKEEERIFIKLFGDILKYKNLLSQ
FSEFEQNDDLIGTEMQDYQSIYIGLRDKYQDKKRMETDSIVSDLDFKIELISQQDIGVDY
ILKLMNEKLKKDLKEVKYHDLERDILSSLKARKKKDLIIEFVNEINKLPNKDEIDIFNEW
SKFIKNKKESELIKIINENKLDNKKTFEFMKKAFENNEFNENGVDIVNLMPPTSFFKKSN
QNSNRSKIKENATEKLLEYFEKFRG
>UU096 hsdS type I restriction enzyme S protein (fragment)
MSFKHISANELKRYEKCNFGNVKLLSTGLYDGYIKYNENDNNINYGEIIALPSGGSPIIK
YYNGYFIDSLNIIFSQKNKKECNLKFIYYFLIANKMLIEENYRGASVKHPNMIEIIELLI
PIPHISIQNKIVEILDKLEAYTKDIGVGLPFEIKQRKKQYEYYRNKLLDFKKY
>UU097 hsdS type I restriction enzyme S protein (fragment)
MSNVMQEIIIPIPPISIQNKIVEILDKLETYTKDINTGLPLEIEQRKKQYEYYRNKLLDF
DNIARERES
>UU098 hsdM type I restriction enzyme M protein (fragment)
MFGDAYEYLMSMYAANAGKSGGEFFTPQEVSELLVELTLIDFNNENKDVRRKIGKVYDPC
CGSGSLLLKYAKLNEGVKFYGQEINLTTYNLARINMFLHNIGYDKFDIKLGDTLLDPKHN
DDKPFDAIVSNPPYSTKWEGKSNPLLANDERFHVTQLAPKGKADFAFVLHILHNLSSSGT
AAIVMFPGTLYRDHAEQDIRKYLVDNVNVVDSVIQLPDNLFFGTSISTCIIVLRKNKNNN
DNANGILFVDASKEFVKSGIKNKLTNANIKKIVDTIRFKKEVTYFSKLVSREEVKNKNYN
LSVNTYVEKEDTSEKIDIKLLNMQIKEIVAKIEKLRKEIDEIVLELEE
>UU099 hsdS type I restriction enzyme S protein (fragment)
MNKIEKLINEFCPNGVEFKKLKNIITVAPKSPFGVTKLLKMEKGNYLTITSGKKSFYVDN
FLVDGEYIFVNDGGQADIKYNFGKTMYSDHIFAFKVNEYNTKYLYFYLLNISNFINKKLF
IGSTLKNLNKKEFLNLAIPIPPISIQNKIVEILDKYTELETELETELETELELRNKQYIY
YRNELLNFNKNQTLLKKIMDSDDIKSIDHKIEFKKIEYVCEIKRGQVYSKEFINSNKGNY
PVYSSQSLNDGVLGNINKYDFDGEYVTWTTDGAYAGTVFYRKGKFSITNVCGILKVFDNS
N
>UU100 hsdM type I restriction enzyme M protein (fragment)
MDNKKEIERNNLHATIWKIADELRGAIDGWDFKQYVLGILFYRYISENLTKYINDNEHKI
GDHDFNYETCNDDDVDEEMKITLIKEKGFYIKPSFLFANIVKNAEKNENLNETLETVFNN
IEGSSSGYDSEKNLKGLFNDIDVNNSRLGSTTQERNKRLARILIRIIYKNMDLLILKPYI
NKKEIPN
>UU101 unique hypothetical unique hypothetical
MAKYIKTGVSYINLDNARTINILPEDIDSYLELGGDEAYKTSDLGSELYINYADFESTNI
LFDLKKEELQAKIDAFLISNDTVLDLSEVFLDIHFSEDDDYEEDCCCEDECCSDEENEAC
CNSEVKVEEECCGGAKDDCCGGHEHEHEVCCDSETKTSETQEECCGGTKDDCCGGHEHEH
HHHHSHQH
>UU102 uvrA excinuclease ABC sununit A
MDKIIIKGARENNLKNIDLEIPKNKLVVITGVSGSGKSSLAFDTIFAEGKRRYFESLSSY
ARQFLGGNDKADVESIEGLSPTIAVDQKSTNQNPRSIVGTITEIYDYLRVLFARVGTPFC
PNGHGQIKSQTPKQIADFLFSLSPKSKIQILAPIEIKKGYKINDVLNNLRNQGYLRVLVN
NEVYQLDENLPQFLDNKKTDVAIIVDRLILNIDHQTKTRALDAIEFALNYSGGEIAFKVN
DDIHYFTQNDVCQVCGFKIKEIEPTLFSFNSPIGACEQCKGLGYNYVPDERKMIPNPNLS
INEGGLDYFKNTVNTTNLDWQRFNSIIKHYKIDKTKPLKELDRKEIDLLLYGSDEAIEID
ITSANNKKYSSIDYVEGVLELVNRRYQETSSELAREHYNKYMSEKVCKSCKGKKLSSQAL
SVLINKINIIDFIEKNIDEAIDFLLHLDLNEAQTKIANPILKEVLDRLGFLKNVGLEYLT
LARPASSLSGGEAQRIRLATQIGSKLTGILYVLDEPSIGLHQRDNDKLINTLKEMRDLGN
TVIVVEHDEETMLAADYLIDIGPQAGVNGGYVIAAGTPQEVMQNPNSLTGQYLSKQKDIL
VPKTRRSGNGHKVILKGAKHNNLKNVDLTIPLGKFICVTGVSGSGKSSLILETLVKAIEY
TNFNPFVIPGEYKDLIGASNVDKIVVVNQDAIGRTTRSNPATYVGVFDDIRTVFENTIEA
KARGYSKSRFSFNIKGGRCERCWGDGTIRIEMHFLPDVYISCEECHGKRYNDETLQVKFK
GKSIYDVLKMPIDEALVFFENYPGIHRKLQLLVDVGLGYLELGASSTSLSGGEAQRIKLA
KFLQRKPTGKTLFVLDEPTTGLHIDDVAKLIKILDKIVDGGDTVLVIEHNLDLIKVADYI
IDIGPEGGNKGGKIIATGTPEQLLSKKDISYTAQYLEKYLKKN
>UU103 unique hypothetical unique hypothetical membrane lipoprotein
MKHKTKKITLLIAGITLTSLCTIFAITACSKQKSQPNPKIKPNKIIEKIDQAFFNEFKTK
IEQKRTLPNIKITSTFKIPFEKNENTLKSPLFKIGEKSVFDLKQNEIPITWVQDLKDYFL
SQKTILTYYSLANLKLTGNDAKDAYFLEFIQYIQNMQQKGIISEDFYQQLWYLISEISDY
DMQNGILRSVYRIANPKLAIKDFYLDGSLYGFKKEKSKYMNFTSLFQWPNAEEKATFDVV
FKNKNSAQSYTKKIELIYSKEKKFILDSLINYSEFTPGEYELVSIKKHDDMNAKNLINPN
NPNIAKIFKIKVFKENEKFKPITLTSINQQEADEYDRQRNQIIHKNNSEIGILDDSNKIK
ELGTFLYFKKPLSEITINDFDRYFRTYFICPEQDFNDFSRQYKITKIDKQKQIIELSILH
INNKTNEIYSSPINFKFYYKKIYDINKNTDARLDLSFDESKKEQKQKLQELVNKLNFDKL
TYNDLSELAVVMFEDVDLENTKIYVEMIKNKDRSITLKAFVDKAFKNGKLKVSNKPDILI
KEFKINYFMPNYFK
>UU104 hpt hypoxanthine-guanine phosphoribosyltransferase
MIKNQKTRNDGIKMKDIDPRIKEVLITEEQIDQKITEAANWINKEYEGKEPIIIGILKGC
IPFIGKLLPKIKIDMKLDFLAISSFKGATSAQTEPEIITDLKFEVKDRDLILVEDIVDTG
RTIKKVYDLLKIRGARSIKLVTLVDKKDGRLVDLQADFVCCDIPLVFIVGFGLDYKEIMR
NLPYIGVLKEEVYQNDLNNKNEGDGE
>UU105 ftsH ATP-dependent zinc metallopeptidase - cell division protein
MYFLKKIVNLFSSKIESEDNNVKKDDLTQPRKQSPEARKRRNRRIIFWLIILLIIGTIIG
VIIYFSVRKEYDNVIVKSAQTEVVNNKKVLYLNTIRPNSTQITRYTIDEDQLLTARVNIL
NNTNFQIISNASSLGLSRISFNIVREGVEKFKLGETNIYAPISGNTNNQWNWLTSIITQN
AGIPSSGFNPQVIISPLISIIFFIIFLYIILRVSKAQSDSLLGTNKANAKLTKSGVRFSD
VAGIAEVKEELIEIVDFLKEPKKYVAAGARIPKGVMLYGPPGTGKTLIAKAVAGEANVPF
FQTTGSSFEDTFVGVGARRVRELFEKARKSAPAIIFIDEIDSVAKKRGNSLTAVQDQTIN
QLLSELDGFDTSSGVIVMAATNRLDTLDDAILRPGRFDRQISVNLPDILEREQILRIHSR
NKNLSAKVSLEDIARRTAGFSGAQLENVLNEAALLSVRDKATSIHMNHLDEAIDRVIAGP
SRPNKVISEREREQVSYHEAGHALIGLYSPGADVVQKITIVARGRAAGYTLQTPERNENI
LQNKTELISRVRTALGGRAAEELIYGPNEITTGAANDFYKITNIVRAMVASFGMTDVGLT
QYIATEGVDNPYRNSYSEQTALAIDIEIEKIIQREYKIVKEMINEHREELELIVQTLLEL
ETILKPQIDYIHQYKQLPPEVIANKNKREASQKQANSSVEEAKVVDDEESIKDKEKDQKS
N
>UU106 serS seryl-tRNA synthetase
MFDINLIRKDIATTKEKMLNKKVPSNLFDQIFDLDVLVRSLMQQEQNLNAKKNQLSKEIG
ILAKNKDPKLQQTLDLVNNIKNELQDISLTLSNKQDELNKLLLVIPNMPDDSVPIGNDEN
DNVEIKKVFKPKKFDFLPLAHWDLAVKNKLIDFDKSTKITGSRFIIYTNFGARLYRALQQ
FCLDMNVKAGFSEIWAPVIVNQESLIGSGNLPKFADDLFKLENSNYYLSPTAEVQLTNLH
RNEILKASDLPLYYTALTPCFRSEAGSAGRDVRGVIRQHQFHKVELVKLCKPEDSFKELE
SMTRQAESILEALELPYRRIVLCTGDLGFSSAKTYDLEVWLPSYNAYKEISSCSNCTNFQ
ARRAKIRYKETIDATTELVHTLNGSSLAIDRLWAAIVENYQQEDGSINIPKVLKKYIY
>UU107 potA spermidine/putrescine transport ATP-binding protein
MEKTLLHLRDITKIYDDGFAAVNKFDLKIKKGEFVTLLGPSGCGKTTMLKIIAGFEQPTN
GKILYNGIDIKDMPIRLRPTSTVFQDYALFPNMTVKQNIKYGLKLMRKPKDNVDQSIYLQ
ADKVYNSASKKANEKIKELKKQRRGLLAEIKKMDLKYQKNKNIFEIKEMRKNQYLGTLDE
LYQKQGINKNGKPGFLNYFKSWFSHEKLNLNDPIDREIFNLKKAYKEKSGLDKRYDKITY
KYNDLDYWESYWATYPQLKKEQFENKNITRLLTKEEVEKEANRVINLVGLSARKDSYPSD
LSGGMQQRVALARSLVIQPEIILLDEPLSALDAKVRKQLQDELKKLHKNLGITFILVTHD
QEEALSLSDKVVVMSNGQIEQVGKPSDIYDSPNSLWVANFIGKTNIFEGHYIAKGEVEFD
GITSKTDVINGFSENEACYIMIRPEDFDVVKKDEGSINARVESVLYKGLMWDIKCKYNDM
IISVEGVNKVNEGDEIGLDWDDIDVHVIKKDYLNNEQAI
>UU108 potB spermidine/putrescine transport system permease
MNKQFNFNFAPSKLSDINKKNETVFFLKEVKVIKKNNRKHYKQTLFDKLKMNKALILTIP
YFLVTIFLLIIPLVSIIVKTFINNTDSTGVTTNIIDNWSVITPTIGMKIFNSLWIAAVAT
IFCLIIGYPFAYFLSIGKSKFLKAIAIALITSPIWMSMLVKLIGIKTFFDVVNGEINSTH
GHIFTILGLVYINLPLMILPIYTSLSTMPKNLVNASYDLGRGFFYTFFHIVIPYTKNALI
SGVWIVYLAAFTSVVVSGFLNNDNAGGLIGGEIFAQGQDGISSGVQLSRSSTITLVISLI
LLGIYLIIVIIPKIVQLIYYKRKNLKKGVKNNEAD
>UU109 potC spermidine/putrescine transport system permease
MKQINWLSWLRNFYIWIILAIIYIPLIIIVLLSFTTPSIKGNITSAFNWNDGSNYLTLTT
NQFTDALINTIIISVIAVPISTIIATITCFGVWHAKIFYKKLMTASSQTNIMIPDVISGI
SLSLLFAATFIPIGFSFGFGTIILAHISSCTPYAIMIIYPRMLKMKKNLILASYDLGYTK
IATFFRIILPYLLPSIISATIIVFAMSFDDFIITKLVGGKVNTIGTEMYSMAKGIKAWAV
CFGALMVLLTILIAALISANKIIKLKLINKQTNKRKLKIWNRQV
>UU110 conserved hypothetical hypothetical membrane lipoprotein
MKINKKLLKIFAGITSLLVFIPIITACSQKSKLVVGNFDSYMDPDVANEQAKRFRKNNLS
YSFYDNNEILSSLIKAKISDVQVASAYEVAKLAKNGLIKKINWAKFNLKDENNQTITSIE
GLKKIFTKQVWAISNAYSSYLGDLDKDGKNDQLLEYMIPYFYQDLIFAYRGKKIPNLDDN
KKDVYWSDVFKELTRNDGTPNRFLYEQKANLGFGVDKRTPITIAKNKTKIIAIDDARTIY
DIAKIMQLEGDNKNNIIKIINHEILGIDNSISQILHILKNPNIKEDIKEENIKKLKRLQK
QLEDRQKELKTNVFLPDSSSVSYIEDKLNNISNMFKNLHPNSMYLKANSNDVLNDLAMAN
VAGAIAYSGDIAFAANGGEYTTEADSNYANMKPTSDNFHVVRPKDTMSVLDGFTISNSIN
KQNEQAAYEYLNELCFAGLNEKNTDGESKILDYGLKIHRNKTPKEIADYENSLDDQNEVG
DVLEDSGYLYTPMRNFDYVQYSPTLNTIADYVLDENNGFYGKTGFESDLLRQKMVEIFEI
DTKYKTKKERQRKHKYISLLNEIINHIYNTYQKDKKFIFNPTLINDIYEQKPIKNLIYEC
LNNLNIKIESHVFNNYLLLKLEAIFNNINEEVEEHAALNATLRKIFNVRLNINTLEFPTN
DLSISNLKLAYLAFREKI
>UU111 unique hypothetical unique hypothetical
MNYKYSAEEKQIIYNYILREYGQVDHIIFLSNEHIRVPIEYDILVIKKQNLQILMTFGLG
AFKSHNHEENTQERAEIFLELPVDWDFNKHENMWPVHFLINIVKYSYSNHLTLKWLQTFI
NPSYFNKSNKIAGFLDLSWYGENSLECKINNDFFVSFYQILIIDDEELFYAKTNGIRALS
KFFDDGKSRIVDLNRKSFVK
>UU112 unique hypothetical unique hypothetical
MKICDNISEINDDQDLVFIDIEATDSKGEQRIIQFSGYRLNIKKNKIFNFNKKFNPEQEI
NSRIKTLLNFNKNFNNIEQMPKLDKQAAREIYCFVKNAIVITFTDFDIKKMHELFTYYNF
DFEKIVYFDVYKFFEKKLQTKSVPSLFSLGILSGIKINFFKLHNALYDAFILKEIFMCIR
HKTNEELYEMYRYYEFLPKIISSSYFVTNEQEKNRGIIKKEIKYVMYIKEFDFSNKFNLD
FVVYKKDHHFYSKPIYDSSLELQTISSLTSKSNFMKVKLANIFFNYLSKSAVFSIKKLSI
KQSEKFLKFYKTQTNKRKVIKVLNLNLKKEIKPENFVIKAQIICEILFKNPIIHHFVHEY
LKIFQNIFSQEEKDN
>UU113 sfhB pseudouridine synthase (uracil hydrolase)
MNLKEIKIKINDANQRLDRFLLKNFPNLSRIAVYKIIRTKDVKVNHKKVDHNYLLKENDV
VSIYAKENFLEKKVDLSFANAKDELDIIYEDKNILVVHKPIGLIVHEDNRYKNDTLQNRI
KKYLVKKDEYHPFDESAFVPSLCHRLDLNTSGLIVAAKTANALRVITEMFKNNDVIRIYK
CLTYNQLPKNNDVIYNFMYKADDNTMIVQNFKTKFNKTAITKYTYIDKYKKYFIYDIELL
TGRTHQIRAVLNFLHAPIVGEQKYITKDIDKNQNYMYQCLVSYKIKFINLKKYQCEELNY
LENKEFRIKNIWFLK
>UU114 folA dihyrofolate reductase
MLKLIWCQTLNGGISKNNKLPWYIKEELDHFYKTTKNHKIIMGKNTFDSLDQKPLNNRTN
IIFSSIMQTPEDESYFVTNDFQQVLNDAKKEDIFIIGGKELFDIFLAYADVLIVSVLKDY
YDCDLYMKVDYNNFNLDKQDVYDNFIVNYYSNKKEK
>UU115 gph phosphoglycolate phosphatase
MFMIILLLIIIQIRRKNKRFMTKKLIVFDFDGTIMHTHTTMSLSIIGVLEFYNHHIPSLK
EMNDLLGNLSMVNIFKKYAKHDLLNIEIEMMISKYYEIYESSLFMIHSYFFDGILDLIKK
LKSLNNNVKLAILSNKRSSLLATMVDYYNLRPYFDYIFGAEDVEQMKPDPSGLLKIMNNC
NVDHKNTLLIGDSIADLKAAINANCHFILVNWEPQYQKHMETIINLKPLIVKTIDELETQ
INHFLY
>UU116 upp uracil phosphoribosyltransferase
MHKIINHPLIKDKLTRMRKVSTVSTVFRTNLEELTQLMVYEATKDLELNEIEIETPVVKV
AKGYKLKNKICLIPILRAGIGMVDGVKSLIPTATIGHIGLYRNEQTLKPVEYFKKFPKNI
SESDVIILDPMLATGGSVVEAVNIIKKYNPKSIKFVCIVAAPEGLKYVQEVHPEVDVYIA
ALDDKLNENGYITPGLGDAGDRIFGTK
>UU117 tyrS tyrosyl tRNA synthetase
MHSLIKDLKARNLINNITNEEKLIKALEKNKGIYVGFDPSADSLHLGNYIMIMLLKRFRL
YNIKTLALVGGATGMIGDPSGKSAERNLLDKTILEKNIAKIKFQLEKFTNSQVINNYVFY
ENMTFLDFLRDVGKLININYLLEKEIINSRLSVGISYTEFSYNLLQGYDFLQLYKNDNIA
IQAGGSDQWGNITTGIEMIRKNLGDDNIACGLTINLLTNSEGKKFGKSEKGAIYLDENKS
TVYEMYQFLINQSDADVEKLLNFLTLIDVEEIKKIMQAHKNNPALRVAQKALAKAVVVDI
HGQQKYEQALHISEVLFNGSISTLNQEELEIAIKSLPATKLDKDEIKIIDLLNLANISSS
NRIARDFLNTGSILINDIKINDENFLVKKQDAINQKFSIIRKGKRNYFLILWNKD
>UU118 ABC ABC Transporter
MRNKKENDNVINPLSNPDENKKINIKDLSKDERKELKKRIKEVEKLNRNHKGDIDMPSRD
PNNIIELRDVKKIFTNGYLINETLKGVNLDIRKGEFVIILGPSGSGKTTLMNIMSGLDRA
TDGDVRVCDKQLINMNQNKLTDFRKEYIGFVFQQYGLLPTLSVEENVEIGADLQVDKKRR
IKPQDALKAVGMLDYAKKFPHELSGGQQQRVSIARALAKNPIILFGDEPTGAVDETMSKI
ILKEFVKVNQELKTTVIIVTHNPIFAELGTLVIKVKDGNINELIRNDHPKSVDELKWDEQ
>UU119 secA preprotein translocase
MNLISKISPQNRILNRARLIAEEVLKKEEEYEHFSDQELINKSDDIIEYLANNNPLDDKL
VEALCIIREVIYRVHNKRAFKVQIIGAIIVYFGDFAEMMTGEGKTLTLVLVAYLNALYKK
GVHMVTVNEYLVKVGAEFATPVLNFLNMSVGQITANMNEYEKRNNYNCDITYTTNSELGF
DYLRDNMVTNYANKVQRGLWFAIVDEGDSVLIDEARTPLIISGEPQEEIGNYVKADRFVK
TLYPQDFTLDPESQSVALTESGVEKAQKFFNTKNYYNFENSDIIHKVTNALRANFTFFNG
REYIVKKDDDGEDIIALVDQSTGRIMEGRSYSAGLQQAIQAKEQIKIEPENLTVATITYQ
SLFRLYKKLAAVSGTAITEAEEFLNIYNMVVVTIPTNKPIKRIDHPDYVFDNKRTKWKYV
IADVIRRHENGQPILIGTASVEDSEILHQLLERVNIPHEVLNAKNHAREAEIIACAGEYK
AVTIATNMAGRGTDIKLSPESLEAGGLCVIGTERSDSRRIDNQLRGRAGRQGDIGESRFF
ISMEDTLFSRFATDNLAKADDKLSEDVISTKFFTRLLNNTQKKVESLNYDTRKNLIDYDH
VLSNQRELIYKQRDKILISSDNKDILYRMLDSVIDDLIYQSHNKPNEDIIDIKKLIDLAT
QNIFYDNYLNQDEYYGLKFEQIKTKLKKDCINFFEQKEQLMTPTIFNQILSEIMISNIDE
EWTKHLDITSKIREGVNLRAYEQKAPLNIYVEDSDKLFEKLKHNVAWKTVCSIGKINYVH
QDYSDLNSEFIVNDNEINENNNSIDFENFNESIPTDQTIQESFDDNQSDNEDDKNNN
>UU120 uvrB excinuclease ABC subunit B
MDDFKKFELISDYKPAGDQQKAIDEMVNNINQGIQRQVLLGATGTGKTFSVANVIAKTQL
KTLVLAHNKTLAAQLFAELKEMFPHNKVEYFVSYFDYYQPEAYKPITDTYIEKDSVTNAE
IEMMRLSTINSLATRNDVIVVASVACIYASVSPIEFTKKNLYLHVGELIEFEQIKYKLVQ
LGYERKDYDLVPGTFRIRGDLIEIMSGYSDKFKIRISMFGNEVESIDLCDPITNNIISKE
QRFILRSASEYIFDDSRLAIAIENIKNELDERVKFFLKNNQLIEAQRIEQRTKQDLESIV
EFGFCSGVENYYRHLEHREPFQTPWTIFDFFSYNNQDWLLIVDESHISLPQVKGMHNTDR
SRKQTLVEYGFRLPSALDNRPLNYDEFNKKLSKTIYVSATPNDEEIALSDNHIVSQIVRP
TGLLDPIIEIRKTEHQIDDLINELMLLKNKNQRAFITVMTIRMAEDLTNYLNNTKIKAAY
LHNELKTLERSVIINKLRKGIYDCVVGINLLREGLDVPEVAGVFIFDADKPGFFRSDKSL
IQIIGRAARNADGKVIMYADVITQAMQTAINETKRRREIQLAFNLKHNIIPKTIIKPIHE
DLSGHDYKQNAELYAAKASKNEYNQKIKELKKKMEEAAKKREYEVAAQYRDMIVELEAIK
QSVKSK
>UU121 lig DNA ligase
MDKIKAKIDELKQKLDQWNYEYYVLDDPSVPDHVYDQTMRELIELENNYPQFKTNNSPSV
KVGGFVSEKFNKVKHKRPMLSLSNAFNDDDLKKFDQDNQNASVDLKGYVVEPKIDGLSIS
IIYKNAKLHQAITRGDGINGEDVTSNILTIKDIPHYIDQKYKDYEIEVRGEVYMAFHDFY
EMNDNLEESDKKFANPRNAAAGTLRSLDNSIVAERKLSAFMYYLVNAQELGIKTHYESIQ
FLRDNKFKVSDLIVKVDTINEVINQIDCYTKVRDKLSYMIDGIVIKINNLEVYDEIGYTS
KFPKWAIAYKFPANVVSSQLLEIINDVGRTGKISYVAKIKPILLDGSMVEYATLHNFDFI
KEKDIRINDEIKIYKAGDVIPYVDGVDLSKRLANSVPYEPIINCPSCQSVLVRENDEVDQ
RCLNIYGCKKINIEKIVYFVSRNCMNIEGMSDAIINKFYDANLIKNIADLYYLQKHKEFI
LTSDFKIKEKSFSNLINSINNSKKCSLEFLLTAFGIRHVGPNLAKKIAKQFKTMTALMHA
NFDELTNVDACGEKAALSLINWFNDEHNVSLVNQLQQVGVNMEYIDDFIYDDNINIIDEY
KNKTFVITGSFSISRDEIKTILEKYYHAKVKNSVSKKTDYVLVGTEAGTKLEKAKLLGVK
IIENEFWKKDNNF
>UU122 conserved hypothetical hypothetical
MLGLGILVAYLSHFIRFNFLAFDFSLFTLVYLIYKVKYRFVYLVTILLSLANLLHGSPSW
IGTMVLSLNNLFFVTMVILFKKLFIPKRPKFYLNLWVLVLSSFLTTVFNVIMNGILYTPL
YWYTFKITPTLNFLEVQKIYEKHPTLFLLNIKSYWLGIIALYTSFNLIKNIIISFISLTI
LKIFADKKTIITY
>UU123 cysS cysteinyl-tRNA synthetase
MKLYDSYSNQLVEINDELISIYNCGPTVYNHIHIGNARPLITMDVLYRFLKKHNIKTKYV
LNITDIDDKIINYALANNLKELEVSEYYFNEYLKIKKALNTLEMINPKVSTHMDKIIDYI
QKLIDKQAGYFIGDDVYFDTKKALNYGQLSKRDLENDIVGMRIESAANKHNPNDFILWKK
TNKGIMWNTPWGIGRPGWHSECSCLINTYIGEQVSIHGGGIDLKFPHHENENAQNQVLYN
KNLAKVWMHFGLVNINNEKMSKSLNNFILVKDLLAEYDYQVVRWFFYQADYKQPIKFSHE
IMKQNEKEILKIKNAIYNAKNYLYFNNQLKSLTQIDHFELFDERINDDLDFVGIVDLIHI
SVKKINILIKENKDMNELKLNLTQLLYMLDILGINFVDLHNDENLALLNTWKNYVDKKDY
VKADELRKQLINIGIL
>UU124 spoU rRNA methylase
MNYNFGKKALLDAIGNKQSISKVYLLSKNYELINLINKNKITYEIVNEAWFKQFDHSLNH
QNIAFKLVKKNFQKTSLESFLKLIKDKKNALVLILDEIEDPRNFGAIIRTANGFGVDAII
YKKHHQASINDLVIKTSMGAINYIYMIEVNNLSNTIKNLQDEGFWVYATSLLKSQPYEKV
DYANKTVFIVGNENKGVSPLILKNADQSIRIDMFGDVQSLNVGVATGIILAHYRTKIKP
>UU125 conserved hypothetical hypothetical membrane lipoprotein
MKKNKYKLLIKSLVITSFLVTTSSVIVACTNKEKEQHLTELKKLSQHAKQIYNEIKTNEL
FKKEASVLNDQINKVLKINEQNNLDVITKNYNDLKKLLDEIQEKISKEKEKEKQQNAYLN
KEINIKLENLNQIVNHNLLKGNKESFFNQIINFTPITTEIQTIINQNQNLLDFKNEELEL
KLKNLDLFIKELDHKFKNIIDQLFNIEDSYINKFLKFINNQDFIKDQKYQEREKFNPQEY
LELTKSIQSSFNKLKNVTINSNLDQYLNSLNLVLLSLTNETKAFFTKFEDQIKKYFKWIV
YGRDDTLTKAFNRIVEEQKRNEFIEQTEKALLTFPMEINQKFKMFVDFFTLKNDKNETEY
QKIWKSKHNEVNKVWFGIAECFATGKCTDKNKPS
>UU126 unique hypothetical unique hypothetical
MQKKILKNLSIGVVSTIILGSITISLSNCSYNKKTFSSSTITNQDTKNLDIIAKNIKFKY
DIFENEDEQIIKINKIKVVGDLGQAKIIIKKVIIEQKSNNFFVQYQLSLHNQTKEYTQNL
EINKKQSVIETKYINDELINNDYRPFALKQLLSSPQNIKKTSDLSLITMQKNNQEFNNYF
NFIQNEDNFKQLPFNQATLLTKQNQLTDHHTNFKFEKIEIDKQNQIATVSFSHDSDSQTI
QKILNATNKRLLIKNFDWTNPFSKIISYEKINNNQLRFSLKDFPKSLTKFIITHIQYDDV
VESLGRDLKNLFLYNQIEEELTLKKLNFYLQENEVYGSAFFDFNEQTLKLYKNKIFLFEF
TLDENYSEAKKNQSLIAKYTPPIQYVRVPFKSLWKFKIPHLYNGYLYKLNRISVRDNNSL
TPFAFVKVKELNTSTFFVKNIIYNDRKIIDLYYNNNQFFSTKYQTLKNKNLTLNDLYKLW
ASNQNNLYLDYSLRNFISLVQYENTYLFYQNKTNEGFYDFITKKADFILVNNNEIKNLHK
TTLKDNPDLIFKKDKDNYFQLTKKINKIKNLNLVNEKNLVFNITFGLDPNLIKETNLWKN
LMLRSQISLAVPYKTLKNKKVIEDAEFVLNYGIGNQEYEYELYKKIKQDFRFQISYINDE
LKIKIISKNNISVFDNIWEHNSSIDSSYFLTKANFNIYYLNNTTIDIMEDDKSNNQYTTR
IYKNNEQNFLPIKNARDRVISLSLIQDGTWNVLGKVKPNDDDDYRYYLISCAHVLNSTQA
FKSINKTGNKDLFESSNSSNGDFDPLVPQIIHENETLNDKKNPYYNALEKNGKLEANQNQ
FQFLNFPEKISIESIINFDHQVKNKLSPHVNALGFFNPNASLDFSLITINLKPFFQKYGQ
LENSPAFNDLTKEQQSVIRHIINFKDLKPLKLSNQTKYFDDNQNVKWYLSTFPRTETINE
FNAGKLPRYREYEINKYDKIQENIITTNNYLSTVGTTKISNQYFDVGSGSSGSVVYDENG
DLVGMISFGAHENAKFTAGGMIVFDSLISGFFGDKNNFANRTSLIQQIKQLAYLYPEKYE
DIYK
>UU127 unique hypothetical unique hypothetical
MKIIGSAFLGIVFCILLAFAIIFGIEIDYYHQGDYLKYLNFLDKLHQYNKIDNSFEYSNH
YESALIGVIVLTIICFLIFITPIIIIVITKIKEKKVINKKI
>UU128 atpC ATP synthase epsilon chain
MANLTKLKIVTPYAQILEKDVYSVELKTSEGRITVLPDHNPLMSTIENHVAYIRELPNTP
RKPLLLLDGIVYIEQHQVRVFSDYFKFLDEIQIDEINSSLNQLKHDLNNEEDDKKKLQLK
SKIKLNESILIAYKDR
>UU129 atpD ATP synthase beta chain
MTEVKKGKINQILGPVVDVRFPSEWLPEINTALELNNHGSKLVLEVSQLVGDNIARCIAM
DTTDGLVRGQEVINTQKPITMPVGKQVLGRMFNVTGDPIDEQPAPTGKRMPIHRPAPSFA
EQAESIEILETGIKVVDLLVPFAKGGKIGLFGGAGVGKTVLMQELIHNIAKNHGGLSVFA
GVGERTREGNDLYYEMAESDVLDKTALVFGQMNEPPGARMRVALSGLTMAEEFRDAFGQD
VLLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLAFEMGQLQERITSTKKGSITSVQAV
YVPADDLTDPAPATTFSHLDAKVVLDRAIASLGLYPAISPLQSTSRLLDPLVVGVKHYSV
ARRVIEILQRFMELQDIIAILGMDELSEEDRQLVMRARKVRNYLSQPSHVAEKFSGQPGL
SVKLEDTIEGFRKILDGECDDIHEQHFLYVGKIDDVFEKAAKNK
>UU130 atpG ATP synthase gamma chain
MSLDAMKRKINSVQTTAKITNAMKLVATAKLKRQRDRLAAIKEYCHDYYDVIGLLLSVVD
DVEFLKIPNAKDRTLYITINSTMGLAGSYNYNVNKLISKIVNETDITFTIGKKGHDFMRL
SGRVDQVNTYLNLNDNDLTFDMSLQIAREALELYSQGEVNKICIIYTKFINAITFEVSVI
DVLPFDKTALIKDHLAETIELAKDNIIFKPNKFELVKKILPTYIATVLYGSLIESKISEN
ASRRNAMDAATKNAKALAENYKLIYNTLRQGKITREITEIVAGSDD
>UU131 unique hypothetical unique hypothetical
MNQIKMNKSFAEFSKLPKIKQVFTPWFIAALVIFIVGLTIAFTMVGLLNEGFENARALVN
DQGQIIGKVADVSGDNHSLMSWLGYDQHANYQELYKTIHDQLINGKTMESLINNTNKNND
PKLYEALHYHAHSKFINHNGTWGFVTKVLSDWENSWFYKYNQLFSQLANSQNPVLAAQGI
KSLAKLSTIIQYQNPNYIAYNWVFIVFMMPQMITFIIIVVKLATVFSPKKSAEEKQAYKL
AKLEVKNQKKAKKLNNSLQQINLNLEAN
>UU132 atpA ATP synthase alpha chain
MTDNKNHSLISDIKSQIKKFSEKALTLEVGNVISLGDGIVLVDGLDNVMLNEIVRFENGV
EGMALNLEEDAVGVVLLGDYSNIKEGDRVYRTKRIVEVPVGDVMLGRVVDALGKAVDNKG
NIVANKFSVIEKIAPGVMDRKSVHQPLETGILSIDAMFPIGKGQRELIIGDRQTGKTTIA
IDAIINQKGRNVNCVYVAIGQKNSTIANVVRELEAHGAMEYTTVVTANASELPALQYIAP
FTGVTIAEEWMHQGKDVLIVYDDLSKHAIAYRTLSLLLRRPPGREAYPGDVFYLHSRLLE
RACKLKDELGAGSITALPIIETQAGDISAYIPTNVISITDGQIFMMTSLFNAGQRPAIDA
GQSVSRVGSAAQIKSVKQTGASLKLELANYRELEAFSQFGSDLDDETKRILKLGKAVMAV
IKQAPNKPYNQTDEAIILFTVKEKLIPQVPVERIQDFKEYLLNYFKGTKLRADLEDKKAF
DKENTPAFRCAIQKAINSFLNNSQDFKPCEEAEQTAFDKFFNENESIVVDGENDFNFINE
EVSLKPTTETSEAVQIEEKVQDFVEPQEILETNKMEENHIFEEVEPEKIICEHHEFEIAE
NQEKIEGQQVLEDTNHEYSIYETVEQSGEVDNDESKDDDLEVLVPVAEIEHDEAILDERE
NRNWVFSDSAVSEVEKQTIMISISSNEAEQLFDNAKSVVFFKVTPKYPVEKVLVYVTSPV
QKVVGEFDLLKIDVNSVNTSWNKYRSSSVISSRKEYLEYFNSHKEAHALLASKVYKYRKP
KDLASFNMNKGPSGFTYLK
>UU133 atpH ATP synthase delta chain C-term
MQSNTKLAKYSKIIANRLKAYSNQTRFIEIKTAFELNDEQKQRIKKTVISRFGDERPIKF
IVDPSLIGGISLKINLEIIDSSLKTKLNQIINTKEKEGA
>UU134 atpH ATP synthase delta chain N-term
MKSSLKPVEKYAYSIFEIAKEEKKLDLYKHNLETINSIIEEVPAFFEAVGDPARDRNERK
QIVIKNLEGEIDIYLISLIDLLIDVKSVKLLKKIVLKALDFVNEALSVKKVLITTAYELT
KNQIDRLLQSLKKKYVCEKIEPIVVVDKSIIGGLSINFESQVLDNSLKTKLFNIVKKVN
>UU135 atpF ATP synthase B chain
MKLNKKHLVAILSVLSLSIIVVPLLTSCTGDIPELNPAEIINTLFPNVWVFIAQVIAMCV
VFSLVLWLVWKPTNKMLDKRREYIAKEITDAENAKQEALQYLENAKSEHLAAQAQTLEII
AKAKSESLTLRESLEKEAREAADKIISSAKISIANERRENLERLQSEAREAAYIAAEALM
KKELSREDNDKLVDQFIKELENNEK
>UU136 atpE ATP synthase C chain
MSSFIDITNVISSHIEANLPAIASENVGSLANGAGIAYLGKYIGTGITMLAAGAVGLMQG
FSTANAVQAVARNPEAQPKILSTMIVGLALAEAVAIYALIVSILIIFVA
>UU137 atpB ATP synthase A chain
MENYSPLDIMIALPHIAAIIMVTLIIGTVSLIYFSMVKKLTVHDVPNRFVIIIGMIVDYF
RGLVVDTMGAKHVKLAPYVLFTFCYIFTANLVSLFGFKEATTASAVPLAMALGTVIGGQI
VALKYQKASFFLKFAFKIKGFPIMINPLEIVSKLTPIISLTFRLWGNISAAAILLNITYW
AFAGFTNVVPWVGVSLIAAVVILPILIGYFTCFAGTIQAFVFTLLTSINWGLEIKEGEEH
HAHLAHKKAEKLAAKKLAELDTQNQIQNNEAQVVL
>UU138 conserved hypothetical hypothetical - cytochrome b
MNLKRMINSYLIIFLPFLSVSFVVFVFLGILLEASWSFFYSYLLVIPFGFGITLLRIFII
SKLLNKRLKMNNLGVNPKKYRRLPANFFAFGTIYILFNFLILVPLIIGNLVNLYQSIFET
ISLFVLTFFMFFIQMGMQIYLGIKKDKGEKK
>UU139 unique hypothetical unique hypothetical
MDEQIFIQLLENNLTNSKSYVTQPIILEFKTDVFLIINQILKQYKKGKIIKNNTNEIILE
IDNKLISITNLDINKFHSYQIVNINENKNIYNERNSLILFDLVNYIIEKNQNSIRHINFW
TIQMSVVNWIYFITYNFNNSYLIDPNWKKYVFKIKKDESKGVISTNLLHNYGFVDFVVQS
KSQNFLKAYRVQDEILKSVLNLGDNLNNEFLEEIMRKYDTYKIIDRDHKYLVINIE
>UU140 p115 p115 protein
MIFLKKIEAHGFKSFGEPVVIEFKHPMTGIIGANGTGKSNIIDALKWVIGDQSLKSMRAH
KNDLLFSGGRYAPKAHIARVNLYFNNVNNVLYTQHKEIKISRVLNIKTNENTYYINDEVA
LLKDITDMFLDSGLSKGSLGIISQGAVSWFAEAKPNERRKMFEEASGIGRYSKRKQEALN
SLSRANENLARLNDIVANLKKELAKLQKQAMRFNEYKQIKDELTKLDLVIIVRDIIHWQK
QLNDIQENLKEYKKEYNKQKPLIQSKKNEIESLRVISDRYAKEYTNLEFEYKKLEDTIND
LNLKLSLTKNTLETTAFNATNTQERIDAFATLIKTTEIELNNNKKNINEKKDQLKDIQKQ
KLELESLKTKQKNNLDTIIWEIASKNLKKEMLEEQFKRQTENERGVKTIIDSQKALVGVY
GTVAQNISTKTEHELAISTALAKGINNIIVKNNQAAENCINFLKKNNAGVATFLPIENLQ
AKSIKPEFYDVLKELEGFVGVANELVKINVNYKISIDYLLGNTIIANNLKNAIILSEYTY
KNYKVVSLEGDIVFGGGAISGGSNSKKNIILNLEEKIKELDLKIKKLNEEQIELNNLHNQ
TKKQWQEYYNSEQIINGILNNLITTNNSLSDNLNNYKSQYEALSATKLSKEEIESKISDN
WNEYNKKKNELINLKQKIQTLKANLNTANLNKNELEITYNKELEDFYNLDKNITSCESNI
DNLNYSIQNVQTRLVDNYKLSVENAIETYQNQEIDMSESAARLRIESLKIDLEKYNDINL
NALEEYEEKQAEYDSNFLEYENCKQAVDQISSSIQELDKKAKADFMRVIRETNKLMPEIF
EYLFGGGSCAISLNDPNNILESGVEIIANPPGKRDVPLSALSGGEKTMVVLAVLFALLKI
AKFPLVILDEAEAALDASNVAKFGAIIAKYSDETQFLVITHREGTMKSCGYLLGTTMMNN
GVTTLLEVDLNDTKIKYESEL
>UU141 ftsY SRP family of GTP-binding proteins - cell division protein
MGFFKKIFNKILGKKDTEQISQEISQKNEENRILKLEDNSINKFNEGLRKSSSALTDAIN
ELAVKYIDIDERWYEHLEEVLISYDVGYVATNKIIESIRNEMIYQKVNDPDLIKSIIIDK
IFIYYIQDTEINTAINLKENQTNVVLVVGVNGVGKTTSIAKITKKFIDENKKVLLVAGDT
FRAGAVEQLKVWAQRLGVDIELPNKEGQDPASVIYAGVKKGYEQKYDLVICDTSGRLQNK
INLMNELKKIHDVIHKFDEYAPHETLLVLDATQGQSGINQAKAFNEVTKISGIILTKMDS
TSRGGIVLAIKDAFNIPVKLIGLGEKLEDLSVFDLEMYVDSIVLGMKLDVK
>UU142 conserved hypothetical hypothetical
MLNKNKRWYLIALYDIYQGLLTTKQCEYFNLHYFKDLSFSEIAELKEISKSAISDCLNKV
CDQLLKYEQALLIYEKNKKRNDLYTLINDSELVKKLKDI
>UU143 conserved hypothetical hypothetical
MKRIKNRKWWKFGGVLFLLPLASFLIMCKNQEAPKTNQEAPKTNKENVLDDFDANIINIE
NISKPKFINQNKTIINLKLKKFNFKSPNTTITLTYKDNNGHKFTSDPLSINDEQNYDFIF
SNLTPNRKYQIQNLTFNNQKRTDIYLKTNLNNAIFSIKPIPIKTNNFKIKVFNQNALISF
SIPKNSDVRVNEKIALEFENLSSNLVPNNEIISRIDKNFNVEFKLDNLKLNNKYRIVNLR
FLDTNPPNVSPNIFEKLSNYESSFIIPGIKTNMHNHKDLNSNDKKYIDSPYNTKIELNDK
NNFNDKVLPDAFEQQNINIQEVENLNQDILNQNELELQKYFSFISDQANLKDKDFQNYSF
NDINKNSKQEIKFKIKHINIDSSNKKAIIELDSSSSNDNTKLLEANNKQLLIKSYDYNNP
WSKIVSYEKKDNNKMIFDLHDFPKDLKTFIITHIRFDDNITSLGKIKENSFEYYQNDKEY
LLKSLKYYFDIKENQLYGSACFNFNNDDFKILKNKTFVFKYEIDTKNNILNKYIPLNKYI
NVDFKNLAQFKIVNVFDGLNYKLESIKIVNKNSLLPYNDHVNIQNANNTNFSVWHKVYPK
QNIINEFFDDSLIKDEFNLSKIDFNHLWKNNTDQKNIPYSLRNLISLTLHEREYAIYKHN
ATNGFYLYNTITSNKDFNLIKNNKESYHLNSLIAHLAIKDEGLKKDESAGFFLEKDLNDF
DNLNNFKDEDIVFNVDLELDPNLIYESQLVDKNMRRSHVIIPISYKVIKKQHILEDVEFS
LNYALGSEAYENHIYQQIKSQLKFNVFLNGSKIKVEVKPRNDNIKLYDYVWKHNNSNQPS
YFIGRYDFIVNWLTNNNEVIIDKKLEEFKKKSYTARILKDNENEMSKAAIKQVRERTITF
SLTSDGTWNFLGKVKPNDPNDYRYYMLTDHHVIGSGGSWYNPQINWAGKMEYESINLNKK
TIYDDDGNEKYTYSNFADYTVVIPQTISQNDLNKDKYQPYYNYSSVNNQDTPGKNQLQYF
AFPFKLKFEKVMDFCLQKNNIYKHYNALGRYDDKISELDWSVVSIDLKPIFEAFKNQDLN
KPFIYNNKTLSPEETSVIKYFLSLKNIKPLEVSPQTRYVRSNQDVDWYIGTFPRYTNTNQ
NSMGVGELRYREYNIQKIDSVNTNFVTGGKGVLYKSDIPYTTISTDYIDAAGGSSGTSLY
DEQGRFVGSIATGRTPSKNGHPTWETIGWSLIDSQISGFFGDRENRANNSSIIQQIKQLA
YLYPEKYEDIYK
>UU144 unique hypothetical unique hypothetical
MSLHKTIYIKFNNRDYDVKLTNVKIANIALNNDNVNNIEQNHISFRHLSTNDIKNSNDKV
EAKFSIGLGFDISEKLKNIAFKKLDTNTNKLIDISDPTILRLTFYEYNKDQKVENNLAAP
TDKTKISVVEIKKSQLMNSSIVSFVKKLNKNAKYHMANIAFNQQLLPYLNKQFNVNADFP
IDLEQNPIDFNDNKQANDEKIKKTKESAIKVATAIAKQIVGIDYKGRDIIKNFIELDNVV
NKK
>UU145 ripX integrase-recombinase protein
MERQSMINKFLQSIKKRNLSKNTYLTYESHLRKFKVQEQSFKQIIKQLLNNNYKPKSLKL
AKSILSEYWKFSKQYQYVQELEQIKLSKEQKSYKKVFSLDDIKKCLKINKQDTKQIKFYK
TILLFYATTGIRAMEIYQLKQINNDLFVISGKGNKNRQICYIEHLWNNIKNKKLPSTKTL
RKYLKVFFDNKNVSLHTLRRSFITNFLTSNENYKRGDMLKIVQDLVGHENIQTTLQYVQI
TKEQVDDVYKEFFKEFENDK
>UU146 unique hypothetical unique hypothetical
MINNIFNKKLLVYNEKDQRWYNKFDRTKPLFSPSRLLSFKNYIFEKIPAKNLEYPIEFGT
SLMQIIQYYFENQSKLDVILNSINEEKLKEVFLLFLDYLKTNDYSLIAVELHLFSPKLNH
YWHGFADVVVKTKDDKYKVLEIKTHNEIQSVPSWKFQAGVYDYIISQELSNYEPSAILAF
SRKQAKLSVYENDSLDLSFINKINELYS
>UU147 unique hypothetical unique hypothetical
MNYILNKNKKVSLTELMNQQPHWYLEELQEHLIKYLDTNGLNDTKKLIKQTIKEWKK
>UU148 unique hypothetical unique hypothetical
MDKIKNYLEKLQAFYKLYSLNLTQGTEILIIQIIDKGNLIFDSIEKGKTFNESKIIEPLL
FIFKKINTILAILKLTFTKDDLIGILQSLEEHISEFIIANYKYDFEIEEDDED
>UU149 unique hypothetical unique hypothetical
MEKIVGFIVNIINVQKQMIKDLKELKNHKDIMVKDHEKLNDMLNSMIDEAVKNYKIALKN
ITEILNVHLNCVLYNHNLKCGVKDEKLLLPLFKRKKAS
>UU150 unique hypothetical unique hypothetical
MAMLCMCDECQAIINYYVVQIEQLCNEIVKTRKRVEPYKKLGKLFFEIIQNDLFEAIAEE
VFRIDEKPKRKTNKRVCK
>UU151 unique hypothetical unique hypothetical
MKNQNEKQIKEYVNKFKDLRNQLTKNNDVKKVCDLINDLFFEVYKNNLIDEVIKEINKHD
>UU152 unique hypothetical unique hypothetical
MKLSRRLTNMTNWDKEHALSEELRQLKDEFEDLMDDLARINKDLDFNIWERKDLEYRKAS
YETDIESIRLRINQKQNEMMEIIKNDK
>UU153 unique hypothetical unique hypothetical
MTNSIKREILSALNDETKKVISKLQQTNNLIKQLSDEKKTLEQYLKDNVNNHEIVDLDSD
LKIKIYDLTSKDSIVLDYDKIITDYKVDTKKYETIKKGTTSTRITWSGADK
>UU154 unique hypothetical unique hypothetical
MVKDDKLVPSIRLLTPNELSEQWANPNSEINQITRAVLTIQGIDLKAIDLNQAAQIIYFC
QANNLNPLNKEVYLIQMGNRLAPIVGIHTMTERAYRTERLVGIVQSYNDVNKSAKTILTI
RSPGLKGLGTVEAEVFLSEYSTNKNLWLTKPITMLKKVSLAHALRLSGLLAFKGDTPYIY
EEMQQGEAVPNKKMFTPPVAEVIEPAVENIKKVDFNEF
>UU155 unique hypothetical unique hypothetical
MSSNNFDNNMPRIEFKKMPLTFIRLNTKKSNNAPFVSGSFWLADKVNANVYFSEYLMERI
VPFENNKTNIVILENVSCYINFNWEEKRIIMRVVSFDNIFYKHQLSEQQTIDFVSAEKEY
NYQTQTVNSYSNSDDEIEIINWLESDEQKAYFDSQLMFIDYKNQGFFKNKTMPDKLKNNA
NALELYKQIIKLDLEAFSGLYNGLKPFEAANKLIEKGYITLNDFFKYAI
>UU156 unique hypothetical unique hypothetical
MRSKQWHLSTQDANLANKKYDYIYFRGVNQLYLKRLKKSSNKFFVYKKCKIVPRMISKHL
NNDHLINVNDYVPLTKEFIKKSVEKEVKHYLRFISYENKTKQMPELINFLEKSLEDKLFI
VAKDYDPLFSVFLRYYIQSLIEKYINELWINEW
>UU157 unique hypothetical unique hypothetical
MNKWVIGIDLSTTITGVAILRNEQIIKTFAVAFDNFNEKNLYNNVIRLIKEINLNVWLLA
DDDYYIGIEVANFSNPKLTQRFSIYAGMIIALMSQVLRDFNAEFKMFNANAWQLKIPQIQ
YNTLRKDRKLITKNLMIKTFNIKSNLNEDEYDALAIAYFYDSINSTLEQEEITKAKKIVK
MNKVKQQLSISKKINKLLEKKSKLKKATAISKVDEQIEELKKLNK
>UU158 unique hypothetical unique hypothetical
MTKQEFKAITKELFFFNKKRLMLWIAILIFVIAFAMIIVFVPFFNFNDKIKSLFDKLKHI
NWQDPTALFGLVFSVLGYLITALSIPLKVFELMLMLRFRLMLAKLIKDGILDPKAFIDDI
RHSYLSRRKQRKLEEEIEYLKRIKSDY
>UU159 unique hypothetical unique hypothetical
MMNNKNKFKNKEWKFSKKQVQLIYLTSSIISGLFLGLALLSTYLIAGLPNDNAFVLFVKE
QKFYFPFFMTIGFINLIISMLTLLPTLKTLWRTVAKMHQYGDLSKEEFEALDILVEQIRN
RYISVENIKAVISSNNYKTLDEELKKLEQQEKQLKIQEQEQKVKRLEQEIIKDDKTRVQS
DY
>UU160 unique hypothetical unique hypothetical membrane lipoprotein
MKEYINRRILWLWILTTLWTIFLICSFFIKIGETSFVFFGKESEYTDKATLWDWMISKFP
KLGSTKKWQLFLVVLFAYIICGCVDFFAISPFFWRFTTEGKNWHLKTRIEQDKLKSEWKA
INEQKRSIKKAQNDLYKQNKESILNDEQ
>UU161 unique hypothetical unique hypothetical
MANHEVIFKWYLSLNFNNSSVDWSDKDYSLTFSFDRNTDRNNMLSDSGETQQQILLWNQY
QPQFLVVRVNAEKSGVNVDLWLIDIVNKTFATNFEVGLNYEWSVRTIYVGE
>UU162 unique hypothetical unique hypothetical
MNNRLLLSVEEYLSLFPLIVRNENLEDNQLQLERKKQALTTFILRAQSMIDDCVASNGGA
GFIYSWFDDLKTTDYQKTKFKEAIATLTNYLWLQGHFIDKDYTSAIGDGLSLSFKSENAD
FEKKRLDIINKLRVCGLYKKSKFANFNDDGIYVNYDELKINAINNVHEELRDHYISKNNP
VVNNNFDLNHHNINNVSSINASGNLATLNGFILNDCTLPNDLTTDKSNKVYDNAIANYVD
IHDVKNLAWYGQNNNNAITRQELYEYCNKINSKMYWDAIYDYKAGELVYDLDEKTNTIKV
YKALVNNGVSTHNIVDPSKQINENVWELINIQQIDLNKIKEGVQDAVDNKVNEVKKAIDT
KENTFTKNLENKVNEAKQAVLSSYEQDKASGVFKGEKGEPGIQGPIGPKGETGPKGEKGD
SANVDALTSNLESFKNTALNRNVRFPWKIMDNLNKII
>UU163 unique hypothetical unique hypothetical ATP/GTP-binding protein
MGILILILRFVGRLLLSKIKSLISTLINLFSRMLKMFKFDFFKMFKNKTGAFMKKGKTVF
HDFNLKPDDILKKFFDNSSLEKIFNSKELKIIQDNKDLAKKLKDAINEAIKDIAKQTSKY
TTKQKDSIIKHLTDTLDNASKTEKKNFEKVRKENQFKDVDNVDIDFNKHWIDYGTWYASD
GVGKIGYLTLKLMKPSKRNPLARYTWRNIPKRIATMLKFAPTGTTFWNIFYHANRKNLIH
LQKESIYWFDASRKYFEGVK
>UU164 unique hypothetical unique hypothetical
MADNQNTWKRPDPNAKYTITQYLDVVNANNERVVAGGFEKYMLENQFNAEFLGSATMTPT
KIMDDMRTAIYEVGVIGQVEEYRDDFTQKQVPAIDRLTLHLSNDYQKEVSISVFDKKTGA
QWNDFLAKTLANLEVVKQDQINLINIDAIYQSCLATGNYIIIPELSPDRVESLTDDERLK
IVEKIYRKAKQVTKSRTKFNLGADPNKLRFVLSDDAALVVLTAKTYKIRDGQAYSDYSTK
GLGSSSQYMGDYLGMPIYSSAYLGEDYLKSTDQKYTSNLIRDYKFSKLSGIITMPETTIC
LKQELMLTTFQSPTSKSHQLIHNSWSMNSAVFPQFAHLNFVILNDKPTKDEINKARSNLY
SQFPSLYAEFKTPISEDSKITEVNKANWRGLSTYK
>UU165 unique hypothetical unique hypothetical
MVDELEKNQVQPQETEENKENALYDEIDKRIQKQFENYLKTNEQLDNANKLVEAKLKEIK
DLENTFKQREQELLNKIATLEQNQQFVNIHQEKPVVEDANSHFLKFFN
>UU165.2 unique hypothetical unique hypothetical
MNKIIKFHNERIKWLWILTAILAISFFVICFNNVKWIYTENTAKYELLTSSLEKIVKFYS
FSLVDKPFARGVPNSIDVFSRAIIGVAFGLGFVGTMLIDYFIISKVAYIVKQKIKQSKKV
GM
>UU166 unique hypothetical unique hypothetical
MESLKMSNIYLDELEGYSQKNIEDSIDSLIEPNQKPIHLCPFRILKGFIKITNTGEQSLL
VNDKDFSTVWNIKASNEPIIAYWDKSFTYNFKGSLNYISKDYARIDPSNTTLKNNFKPYY
FQAWVQNYSQANNVSTIVFNDKEHTVIKTITTVTLIVKYPSVYEDEIYQNEQGNLVSHKA
KFKQWTTDMLKEYLFIIPDEHAQANQWLMVNEVIPFYSTTSKRYEGAQITLTNVNDLLTS
SGNDILATIQPCQPGDGYLWPVIQNGKLTYDERKEKPLGVKSIQLLTNGPYALNSMLITG
RTYNNDTRELSANKRLLLYKAKIPVASKFFNVSAPTSNYVYLYNAFFEIEKIYKDQYEKQ
KDFTFDHNANIKLNGGLLLNHKWDASNNALSYEDNRYPFKLWDEGFKIHASFFNFKLGGT
GAQKGGSLTENAEQKKPLADAVVTGQVAGEVVSTVFESIGRNVSQGFNLNNLGLWSFNMG
FAKTKAEQIKEATKIGLNNITMPPGTNLHTFLNHNAFMYDLIKYLPYSYKETIRQNLGEL
IDNTPLSLGKVRRGIVDILYPGWTKVEDATGYNMSNIWLNTRGFNFIAPCLPLELEVSNK
LKADLINLDIFTNKPAKTFSPLGIPAIACCYHFDITDRFAKFVDDELKVFDTELIGQTTY
RDGTYIRKDKKPLYWDSFCEALPPNTPLSYEPAVINIASGKREDVNRVKYPYVIDTIDIK
GLGKCDIKLTAFSGFYSPDARLKDEFKNVYEAIFESNGKYTDDMSQWSNYINFSTLDEIN
SVGTKLSYPKPPVETDFLKNTKTNSDDGVNASLQTINETLYKVGDNSLLSATQYRKPRFY
FYEPDSSKLANLFGYGSYTNKLNYLFGGSNLSDVIVANKVIAYSFVFKWDFNYREWLNLG
SVNKTKRNLKLTFEIESNWIQKGWTNQFNVDNSFNQLITLLVLN
>UU167 unique hypothetical unique hypothetical
MKVELYTNDWIDFFKNIAIAWFKTKRYGNKRLSSIEQKQVNKLIRQEFDQYVEFKIISNL
IKDYNDNMEKVISLYGANLMPLNLAVQKLYPELTPTEQDELVKELEHKQKLENGEFENE
>UU168 unique hypothetical unique hypothetical
MALKTNTIIKSKWNPSNFDINIDIKEMIARTAQESTVNDVILKTKDNVPLEWMEFIDNIN
ENNEILKLIKGDCRIKSLYGINYVGFEIYNNDILIFNADINNAMNKSIRINQQQEYSSTI
YRKIALMKDSEYLSLKELHTPYEIKRLIYNSTGVYKIIFNEFEVSTPMYFKDIFKNKNVV
HNYGVLCTKEFLNRSFIDFENKINEKLPDWYPVNDLINDTNALLNFIKKERELNKTRIVG
SIINHNDAQTYRNQWIDEIQYMSSDLILNTNTPDKNAFEIMQSTFNESIHLQAITEKLNL
IFKGCGYVWNMGDSLSYQNSETATNLNKATFETQKWK
>UU169 unique hypothetical unique hypothetical ATP/GTP-binding protein
MRIKLDFIECFGFYSDLVEFVAKKLPIPFNEINLLGGRSSGKTFATLDFLSSLVAIKQQN
AIYVFRQNISDAKKIFSDYLNFLDQKQLLKFAKINHSERTVIINGWTVMFEALNETRNNI
NKGAKVGFRLWTQARYVFAFFEEASQLDFNLVKNSQQSLRGTKDTQVVSIFASNPWTSEH
WYIENFNNHLAENEFSIQQKPYYEYSVVDKKLFLRSTYRANKFTSQQEIEQFEWWKDIDY
SKYRVISLGLSGSVEGAIYARSLSVMHEPYGEYDNYAMQFFGGMDWGDGTSSSSSDTACL
FGSISKENGIEILDEMVYNNNVNPLTSEQQIELVVRWFIKKQQEVNVKIVIYIDNAHLRY
FYETFNATFKRIAFQYNMYGSELVFAPAIKHAIWDRVVLVNYMLASGKLRFSKNACPKLY
KDLKNCYVVLPKTIKEDTKKERSHEHTHTINALEYLMCAFHLYFYAQAPAINEKGAIRYG
T
>UU170 unique hypothetical unique hypothetical
MMKRNELKQLQELQLKINDFYTLVMTTKNLDLCNLSALLEFLGINWGVWVNLSTQRDEFN
KKRYEYITKANYGLRMALNELLGRNASYDKEINNQGLRKFRTQEYFKRLDFELANEQKST
DIEDTTITFEKVDDNNKLTIKKLINVI
>UU171 unique hypothetical unique hypothetical
MIANKITINKIQNGTATIEVTFSKFKLADANKKDFVLEVKDSANDDASAISATELVFDAN
KKILTGKLNGLASNINYKISKFTLNNNEIKFDFKQEDQQELLNQYIQQAELNTIIDKANK
KINIKLQNFSILNSFQDNQPVLTFDIEINKKDGITQVVHKSLTKNQLLNPNGLEIDLKDK
MKNNIDYWTLAYVVWFLAI
>UU172 MBA paralog MBA N-terminal paralog
MKLLKNKKFWAMSLSAIAISTSIVAFAASCSNTNIKSKLSKQLAQTKDQKNHFAVYEIEN
YTKLTDEEKKSLENLEFGVSILDKDGKNPINIKVKGVQKEGKIYVKLPRKPEVNEKLLVV
PTKNILKTEALVLNNDNLNYQTVTFEQVPDQKLEPKEEKQTKAVDYEKAIKDEDYVKQIT
LSNLEKYISNEYQYLNPNNKTLDYKNHSFVQKFLDEIDLLAQKLESNDLNLEDKQIYEKI
ILGLRWLLAEDNNETKNKALELFKDYFTTIMKATKVNDKVHYDPSFINEFYGSISNLFEE
HDLEPSVEIESNKIRIVKEDKDVIKDKTVTATFNLYNGFDWSTLLKDVVFKEYKKDSNGK
PVIDEKTKMPIETDKIVEDPVVMRLEIAEYPKDWNTSKENPKNFSYINFKKSEVLKSPKL
VFTKVFNLDKEQKYHINNVMFSHKLIPNLLKALDIKNNTTNAELIKKIKENMTAIDEKTQ
TNLNTNYIPLSLTETNNKK
>UU173 conserved hypothetical hypothetical
MRTGKYITKYDYIGYYTKQKAMWFFTNAEIKAKIDLLLKNVSSYDFEDLDDEEEHDYEID
AYEIYKEQTDFLSQLEINKNIDVDNPKIAEGILLDKASQEDIKKTYHYIKKIINFETDPL
FKNKSLEELANLTLELIDKNDKIIFFQPVFINDKLITKPDCFIKKNDEFIVIETKGTSSI
KKHHILDVFYQAQVISKHPYFINKCISYQMCIVDYVKLKKNQVNFTISPYYNYQKSVVLS
LPPSAANQFNKFEINELKRKRKRGEAIYLKKDENKKYYEDIDAYDHCKGILIDDLIDGTY
SSINDYKEAKKIYDYKTEDLKDDVRFNKTMDELIKGIEKLHNDFDEVISELLVHKQNLLA
LPIEQRIPNYFIPSYNDKGDYKDNDFWLELRNLYAYSGYDVIKYSGKILTIKKFGLDNVT
KDILGIDILKTYANQTFFNLYKNNQIKIYQAAVDLFAKLKSKKVYFDFESINSAIRAVDN
SFPFTQTVTQNSIIIDDGSCDIKNLKCTNMIIDPREINNEWFKAIIDKIHQGLEYSYIVY
NKSFEASRLKEMAEFINEEIYELKVSEIIKNMYDLADFFIVSMGKQLIVIPELKGFYSIK
KVLPIIEKEFPQIYHDVNCLNYKELSVGNGLVCQTKTTKRFFNTITDLEWEQFVHDARIY
CENDVRAMIAVEYFIKKLIDEAKMKNLILS
>UU174 conserved hypothetical hypothetical
MGKNNKYLIACDLDGTLLNNDSDISEKTIEGIKKIINQGHIFCIVTGRPLRGSIHIYEKL
GLTTLMANYNGSYISNPSDKKFAPINMTFSKDIVSAILKNRFIAKNIVNAVVEADNVATI
LNSNMDLNIWKSFIDIFHVPIRDMNEKNKLTKENDINNLIRDANALLLNVNDKALFDSMV
YHIKQIAPTLAVRSWSARVDDQFEVIEINSSFADKAMAMRYLSSYYGIPLDRCIAFGDGE
NDLTMLNHAGYGFAMKNGTRPAKLLARHITKHTNVENGVVWELEYVLNENK
>UU175 trpS tryptophanyl-tRNA synthetase
MKRLISGIQPTNNLTLGNYLGAIKNFVDLQDDYEVFLFVADLHSLTPNIFDNTDFSTTKR
QIIATYLAAGIDPKKTCLFYQSDILSIPLLAHILLCSTSIGELTRMTQFKDKSIKATKMA
NNTEMIPSGLLTYPTLMAADILTFNADVVPVGQDQKQHLELTRTLADRFNKRYGNTFKLP
QVYIPKIGAKIMDLLDPNIKMSKSSKNLKGVIFLNDSKDIIFKKIKGALTDNLNKVKYDL
TLQPGVSNLMTIYACLTNLSFKEIELKYQQQNYGVFKNDLANIVADFLEKLQQKISYWLN
SPELDIMIDNSCERANDIAYQNVQLVLKHMQLK
>UU176 conserved hypothetical hypothetical
MIYVLYSPNCAVCKKVVRFFRNNQIEITKIIIGEDKIERSMLLDILSLCEDGFGTIISFK
TESSKRLNITSKTFLDLSTKELLNLIQNDLNLIRRPLIYQTKNNRPYRLQIGYDSEEIEI
FKRAVHEK
>UU177 conserved hypothetical hypothetical
MKNNKPICFYDIYCFKPQECFKRNDINLLEDKLKRYSKITFLRNKENPEIIFLLGGDGSF
INFINQQWKKNVKIVGINYGQLGFYSSYDSIKTINLDEIIDENMYYNPLLLKVSINNQNF
FYCLNELSLFSNELVSFDISINDYPYEKFRGSGLLFVTPSGSTGKNKTAFGPIIFNNHEN
FIMTEIFPVNHLKYSSLNAPVVFRKDYKISLTNIKFKKSFSVAIDGNIINFSDKINDIKV
ETIQASSKIHGLNNFKKYIDKLNKSFIKGE
>UU178 conserved hypothetical hypothetical
MQNLNNKQKTLIIFLGIITFGIFIIYFFTKAKKVSQIRNTHLIVSSNIPFSLNDFYNCIG
SKNNLVNVDATINTLKIELKEINALNNEKLKVLGAKGIMCNQTKISIIFGDFCLELKELI
KKDLFS
>UU179 unique hypothetical unique hypothetical
MLIKPAKRSEKIYTIIAIKDSVVTLKNDYQDEKNIQIYEFDLQNIIPEVGKFINLIKYDQ
QGCSVFEEYDKNI
>UU180 conserved hypothetical hypothetical
MMIKIISVGKLKQKAFVDLINDYLKRINHYLKCQEIVVSDEPEPVQISNKSLEQIKSKEA
SKIFKNINQNDFVIALIIESNIISSETLAKKIQQWLNTFSHDICFIIGGSNGLHESIYER
ANYHLSMSKMTFAHGLAKVMLCEQIYRALSILNNGKYHK
>UU181 tpiA triosephosphate isomerase
MKYIIANFKMNATQELINHFLNNLTLFDEQKIIIGLAPGDLYLKTFVNLAEIKKVNLYAQ
NPSLHNKGPYTGQISCLQLLDINIKNALVGHSEIRIDFSQSIIDQKIKISMDLLEQVIIC
VGETFDAYKQNKSLNFVLNQLANIINYKGLKKIIIAYEPIWAIGTDLELDFKHINYMIEG
IKTYLYNCTGINIPILYGGSVNDNNINELCNQKLIDGFLIGNASLDVNVFNKIIDKCK
>UU182 pgm phosphoglycerate mutase
MKLNKKIGLIIIDGLGIGKEDNTNAVHLANPPTLNYLINNFPTLQISAAQQNIGLLENQA
GNSEIGHLTIGAGRIILNDNANINNYMKSVDYESAVLSNIKNEIVHIVGMYSNGLVHSNY
EHIHWIIKQIIKNNNQVVLHLISDGRDDYPYGFAQFIEQINALKKQYNIIVKSLSGRYFA
MDRDQRWERTQKAFNAMFVKQDKICEKTFLEVAQSIANSYKSDEFVQPVVFNDDEKYNLK
PHQKVILANYRSDRMRQLAHLLKPNKKFHYNNPFLVQDVNLITLVPFPDVDAIALFEKQN
LNNTLGDVFNKHQIKEARIAETEKYAHISFFFDGGVNKYYSTKTQYLIPSQKVATYDLCP
QMSAHLITKTIIDHYFDHDVFIVNYANPDMVGHSGNMQQTIEAILSVDHEIRKLYDFFEK
NNGVLMITGDHGNAEMMLDDQKQVITSHSVNDVWFIITDNKVILNSTQKFSLANIAPTIL
EYLNIAQPIQMTATSMIKKICE
>UU183 unique hypothetical unique hypothetical
MDKKAKIYTWSHIILIVFSLVCLHWFFILSITIPNQTGFLINRVGQWINSSSTYAYKIDP
RSLFYLNYTLNFNIALNASGIASIVLFICYILTFIFNLIMIGIIRSWRPSLLHLIIAILI
WLAILYLFIIIMIKPNFNQIINNSYYTWLKNVIFNDQTLTLNKKNVILNTYINHYHLPII
NDPQVALLDISKHQINNENLTFNPSYNYNANLYFTKAKLIYCTYTIIGIIFIISFIYYLS
EIIKRCLLVNDNWKIKQHERKDGLNIKKRKNKQEIVAPDPILEEIFKELDL
>UU184 eno enolase
MKIINLLAYQILDSRGQPTVAVKLFLENDQSVIAMVPSGASTGAKEALELRDGDVNYFFN
KSVKLAIQNINNIIRPHLINKNVLNFFELDNLLINLDGTENKSKLGANALLGVSIAIVKA
GAIAASKPLYQYIKEDLMHNYDVNYYAPIPLMNFINGGAHADNDLDIQEFMIVPLNAISF
SQAIQIGSEIFHQLDKLLKSNHLSTTKGDEGGFAPMLKNNYVTLELLVHAIKKAHYLPSK
TQGVCLALDVAASELYENGKYFFKKSSSHNITLEQTSFSSDEWIKYWSKLVSMFPIISIE
DCFEENDWNSFALFLKNNPHIQVVGDDLYCTNLKYLQKGIDFKATNAILIKPNQIGTISE
TLDVIKFAQKNNINTIISHRSGETEDTFIADLAIGVGAGQIKTGSLSRSERIAKYNRILE
IEQELKDKLIYEPSKFFKFR
>UU185 pfkA 6-phosphofructokinase
MNQVNFLNLDKNILIITSGGDAPGMNASLISLIHRLMNNNFNVFIGIEGLLGLYNNLIEP
IKDKRVFDVYFNEQGTVIKTSRFIKLDINDKKTQIIKDNLLSHNIQKIIILGGQGSMQAG
LVLTKMGFEVFGILHTIDNDFSETQMCIGALSAASFNQKLLKCLNYTAKAHCAFNLVELM
GRECSWLVNNSVGKLKPILMLTNQDNKYTVDEVIDLIKDKINSIKEYDPLIIVQELIYDQ
KWYELLVKTFEQKLHKSLRITILNYLQRGAPVSDFDLQLAKDSANVLVDFIVNQNDIKNT
NNMYVVINKFDNKLEVIKFNK
>UU186 pyk pyruvate kinase
MFSKTRIIATVGPATTKLFSNWLEFNDLNNINDAQQVCINIKDLILSGVNIFRMNLSHGD
QKIHLFRTQLIKKIADELKIKVEILFDTKGPEIRVCEMSDNNFIIKNSEVIIHCKEKVLG
SFNEFSVTDATGQYNMISDVKINHRILIDDGKLILIVKKIDFLKNIIYTTAKNSYSLKTN
KRLNLPDANYSLPFLSKKDIDDINLAVKLKIPYLALSFISNIKQINEVKQLLKKSSFIPK
LIAKIETQEAIDNLEEIIKNTDGIMVARGDLGLEVPFYKIPIYQNKIVELCHKYNKYCII
ATQMLDSLERNIIPTRAEVTDVYYAVKQKVNATMLSGETAAGIDPINAVQVMKSIILETE
NNNIENEITFKKNELLIPKEVKLKILSFHKLKINKHKLLVVNLISKNSKHLVYDILKYDF
NFNILFVIDKNQEHDLLLKNANFIISENKMLKQEELLKSFNIDFNNHEFLFISI
>UU187 rpoB DNA-directed RNA polymerase beta subunit
MQNNKNYTEKFITDKVMRRDYSKIKSNFEGPNLLEIQVESFKRFMEKDLKEVISSIFPLK
SPQGKYTLAFKGLKIKQPTKDESACRDEGKTFETPIYIDLELTDNYTGEVKRAQRNTKTG
EDGIYLGAIPKMTEKGTFVINGIEKFVISQIVRSPGIYVLGKSSIKLNGSRKRLFEGKIC
EIYPSKGTLMLGYIPKDRHNIQIVARDSSGDNAQTFSVTTLLKAFGLTSAEILKIFNNEK
EIRESLEIEKYAPEYIFENSQENEIIFKIYSDAHDIHEKADRRESNNKLKEEYIEQGSPL
LSKLKQLIFNYVEKNDEIDALLHENKDVEDASFIKNNKKLYDEREEIINCIISEKAAKDI
VELLGINIKNIETLRHLGKASYQIALQQHFFNKRLYDISSAGRYKFEKKLLLSERLYQKV
IANDIIDKKNNILIPKDTLITKEHIELIKKESRDKNIKWTKKINLLPTALESEIEQFLEY
ESIAVYKDNDLRDETTEIVGLASGCKLQTLTVADLVATTSYIYNLNYEIGEFDDIDHLGN
KRLKLIHELLRARIATSMARIEKFINEKLAISDGSSNNITNVNDKGIDTELDREIEESDM
SDEEKKKAISVKSIINTKQFQSLVKDFFNSHQLIQFIDQQNPLAELTNKRRISAMGPGGI
SREDPNLDIRDVHHSHSSRICPIETPEGMNIGLIMSLASLAKVDENGFIVAPYYVVEDGV
VKEDYKYLTAHEDDNYIIAESSVQLDENKRILDEQVVARYRGSTGLFSPNEVDFIDIVPK
QVVSIAASAIPFIENDDGARALMGSNMQRQATPLIKPYAPIVGTGTEFKIAHDSGMAVVA
KNDGVVEFVDSQKIIIRNDNDKLDDYKLIKYRKSNQDTCNNQIPIVKVGQRVHKSETIGD
GPAMQNGELALGRNILVGYTTWRGYNFEDAIIISERLVDQDVFTSIHIDEHTIQCMKTKN
GDEEITRDMPNVSDTAKRFLDNQGIVLVGAEVHEGDVLVGKTTPRGNVETAPEDRLLQTI
FGDKSKTVKDSSLKVKHGQEGIVAAVKRIKSSDENGSELPDDVIEIIKVYIVQKRKIQVG
DKMAGRHGNKGIVSKVVPIQDMPFLKDGTPLDIMLNPLGVPSRMNIGQILELHLGYAAAE
IGKKQLIQIAIDQLGYEKYISLFGINEIIAKKLYENISNLIKHKQAKQAKDIDLIDVTII
LKELGLSYDDIGIKISTPVFDGANHDDIVSIMNEANIDIENNKGKQVLYDGRTGEPFDGL
ISVGLTYMLKLDHMVDDKIHSRSVGPYSKITQQPLGGKSQNGGQRFGEMEVWALEAYGAA
YNLLEILTIKSDDVQGRNQAYNAIIKGHDVVADGMPESFKLLTKQMQGLGLCITVETKDD
RMVDINEYTLNQNRLNNDDDEVILDENLKEINDSNEEIFNTNFNNNDYDDEENF
>UU188 rpoC DNA-directed RNA polymerase beta' chain
MSQKGIKSLTISIASPEQILNWSKGEITKPETINYKSLKPEPNGLFDESIFGPSKDYECY
CGKYRKVKHKGKICERCHVEITESIVRRERMGHIELAAPVAHIWFTKELPSPSKISLLLD
ITYKEVDQVVYFVNYIVLDEGNNVYDGKSIFNKKEVLDLTSPKNSIRSRNKLRRTLRNIQ
ERIEDELNHEREALIQDFDYRLAVTYDQMLKDSNIPFSVKDVMAFIEKHTGVRFGIGAEA
IRELLEKLNLEEEHEKIKQAIQNSPNAYDQKTKRLLRRLECVRWIKDSGSKPEWMVMTRI
PVTPSETRPIISLDGGRFTTSDTNNFYRKIIIRNERLKQMQATDAPEILLDNEKRLLQEA
VDSLFDNNSRKKPVVGKDKRPLKSLSNHLKGKQGLFRQNLLGKRVDYSGRSVIVVGPELK
MYEVGIPALMILKLFRPYIISELIRKRDELGNEIQPICANIKLAEQKILAQDNEIWPVVE
KVIKQRPVILNRAPTLHRLGIQAFEPKMVDGKAIRLHPLVTTAFNADFDGDQMAVHIPLS
KEAVAEARSILLASWHILGPKDGKPIITPTQDMILGIYYLTKEKFPQVIEEMMAKDPTQA
RVEFINNFHIFSTQDEAIRAYKLKTIRINDVIGITTKAFNNKTFSKEGILVTTVGKIIFN
QAFPVNFPYINDVKNLYGENQFEIIGMHESILDYLKAYNLKEPLTKKTLSTVIDYLYKVS
EIEVVPQTMDKIKALGFKYSMISATSISAFDIPSYDQKYEYFKETDELVSKLREFYLDGK
LTDDERYTKVVQAWSQTKDKVTHDIEKLINSNEYKDNPIVIMAKSGARGNTSNFTQLAGM
RGLMSKSYNYDQKNNNGVIKDTIEIPIKHSFIEGLSVSEYFNSSFGARKGMTDTAMKTAK
SGYMTRKLVDSTQAVVIKDHDCGTKEGIIVREIRNTKDNTSIESLKDRIVGRYSINTIYD
TKNKLIIESDKLITSEIANIIQNSGIREVEVRSPLHCASLYGVCQKCFGLDLSTNKLIET
GTAIGVIAAQSIGEPGTQLTMRTFHTGGVAGDTNITQGFERIKQLFDCIQPQENEKAVIS
QVKGTVERIEKDSNTNGYNVVIKYNKDNYVNYPTRSNAVLRVKTGDEIIAGQKITEGSID
VNDLLKYAGIENVRHYIIKEVQKVYRMQGIEISDKYIEVIISQLTNKITITNPGDSGLFV
GETISINEFTEVAQNMLVNKKKPPSAINQVFGLDHAPSKSGSFLSAASFQDTKKILTDAA
ARSQKDMLIGLKENVILGNLIPAGTGLKDVEEVIAYGEEMYKKQY
>UU189 MBA paralog MBA N-terminal paralog
MKLLKNKKIWVLTISSVLIGVSVITSIASCSSSNIESKLSDKLVEDEDNNYYVAYQISNY
EKLKDFEKKQLEKVTFSTSITPTDKTKNSQVFNAKVNEGILFNQQAKTFYIKLVRKPEVG
ESIIILPNNSILKTHGFVVTNENLNFIKINKKGELQRSNTAITKKNNLTNEYK
>UU190 conserved hypothetical hypothetical
MLWKNLDELFLKYDRVVILTLSSGLSSYFESLSIIKEDYKDKHLVCIDSRSVSIGILWLV
DEINLLLKNNPSDEELISLVKQRSQKIIGGVIVNNLDQLIAGGRVKKTKGIIAKALRLKL
IVRWNGQLDFMDKTPNLSTAIDKLLDIIDNQNHWRTNGIKNIAILTDLENESQINSLKTS
LQEKIRQTIEIKISYLPGCIYAHVGLNNFAILIEAK
>UU191 unique hypothetical unique hypothetical
MKTAILIDTGANVLDIKDDNVYFVPIQLIIREQQIWKRIKRCYWR
>UU192 conserved hypothetical hypothetical
MYIYYNKTSLNDTLIFLKNNQQYDHQVFLNDDLLLFYHGDELIGLNLFNASEYLKNLNEG
YLYPTTQLIQKLSDLIKIKLSLDNAFKGFVVGKILEVNLIPNTHLHICLVDIGDQQIQII
CGAQNVRIGLKTVVATPNLLMPNGNEIKKSKLMNYDSFGMLCSQKELNINNFNSQGIVEL
NDEYQVGQLFTKVYSNL
>UU193 prsA phosphoribosylpyrophosphate synthetase
MSKNDDILLFSLSNSHQLANKIANLLKIELSPIRIDKFADGELIVAPQVPVRGRRVIIIQ
STSKPVNDSLMELLIAIDSIKRASAKAISVVIPYYGYARQDRKAKPREPITARLVAKMIE
SAGATSVLTWDIHSLQTQGFFDIPFDSLEAVWVLMKHYFSAYKDSSNITIVSPDYGGVKR
AREISIATGATLAIVDKRRSGKNQVEINNVLGDVKDRDCVIVDDMIDTGGTILGAAKIVR
EKGAKSITIIATHGLFNNNARQHFQQAIKDRIINKICIADTIENEPFDGLEIVSIAPAIA
KCIEIYSEGTGSMSFVHDENSKVLFAKKIY
>UU194 conserved hypothetical hypothetical
MNKPIIKEVIIVEGKTDAQKIDQLVNAQIITTNGSEINKKTLALIKQAQLSKGIILFLDP
DYQGERIRKIITNYLKDGIIKQCFISKDNMKNNSKKIGIAEANNDALLKALKSQGTFVIN
SIESITWLEYLSLNLNNKKIRLMLCDYLNISYCNHKQLFKRLNMMQKTFKEIKIIIEGF
>UU195 conserved hypothetical hypothetical
MKLCDKEYILSVIATPIGNLEEVSERVIKCLNEAYVILCEDTRVTAKLLHLLNIYDYKKL
ISYHNFNEIQKLNEAINYIKKYPTALVSDAGYPTISDPGYKLINECHQQNIGIQVINGPS
SLMHALVASGMCSQDFMFLGFLGKTQKQRVEKLKLYKNLQTTFVIYEAVHRIEKTLMDIY
EIWGDILIFIGRELTKKNESHYYGYLSQLPPITEKGEFVIVIDNKINQDVIKNNNINECL
IKIRDLMKQNFKLKDACKEVSKSSNFDSKELYKLIINQK
>UU196 conserved hypothetical hypothetical ATP/GTP-binding protein
MLDKLIKTLKNPHSIDDIVGQKYLLDEIGIIRRMVNHHQVFNLIFYGPPGVGKSSLAKVL
AQDLKVPFAFFNPVVDSKKQLMQIIEQALDLNNFIIIIDEIHRLNKDKQDILLPIIEANK
IKLFATTTENPFFVINPALRSRCQLLSLKPLTSSQISERIKTLINVEEVFEPQAFNLLIN
KTNGDLRAVINTLEIIYLLYKEHKVDYVLLKRIMQESYALGSSDGDEIHDLKSAFHKSMR
GSDCDAALYYLARLIIIGDFEAIYRRVSVCVHEDIGLANPNLCLRVDQGINSCRFLGYPE
NQVILANLVLQICLSNKSNSVYLAYQKAFEDAANGKQYSIPNHVRDAHYASAIKLGVHGY
KYPHDFKNNYVNQQYLPRELTNKKYYVPQNNEQEFKLNQNQQKFKNNN
>UU197 metS methionyl-tRNA synthetase
MLKQKKFFISTPIYYSSGNPHIGHAYTTIIADVLARYKRLFGYDVFFLTGMDEHGQKIQQ
KAFEENISPKALVDRNSIIFLNLWKRLNISFSKFIRTTQMDHEESVQKVFSYLYKQGKIY
LGQWTGYYCVSCEENYNPAEIIKSQDNIMLCRMGHKLETKSEESYFYKMSDQAPFLKTYY
QNHPNFIIPNERANEMVNNFLNNLEDLSISRTTFDWGIPIAENPKHVIYVWLDALMNYLT
ATGYLSNNEELFQKYWCDNETEIVHLLSKEIARFHCIYWPIFLNDLQIRFPSTILSHGWI
ITKEGKMSKSLGNVIDPNVLIDTYGVDALRYYLMADLSLFRDAIFSEDNLIETYNTQLAN
SYGNMISRTLGMLKKYRNNIVPKYVGCVLKNDEKLENLINKNIELVQENINKYSIDKALN
CIQEILVEANKYIEDNKPWELAKNQQEQELDSLLVHLVKVIQVTTTLLSPILIEGSKKAV
EQLNFDESFLTLASLASYDIFNYHKVNDSKPIFARIIVEKQ
>UU198 conserved hypothetical hypothetical
MRLRYKILCASLGVVGVVGVIAAISIDYKQIPIVYANGSSSVLPLIQALSEKHHKQDIIS
NAGGSSLGIIEAVEQRTNIGVSSRSPNIDFEQQSVEKSHVVYDKWKQNQLKTYTIAWDGI
GIIYKLNKTNHELVLTKDNIIKLFKAFTGNEQVSYYDLDPQLPKTPILAYSRTGGANASG
TAEAFLTSNPLISKKEFKKKYHDIYKVIEAGTYGKLIRSTEESNTQAWTNISKDNVDGSI
TYLSTGFILKNYDQIIAKGYKIAYLQNKDLKNYLPFEINENKQEIVNVAKTYGWYRPFNL
VFSLNMQGIKNTKEFVWWLLTNKKVEKIIQESGFIPLTFEQKNSMFLKPYKDEQSFQEAI
NNQSAKNNFFVSDFELIESNRINILGAKSA
>UU199 pstA phosphate transport system permease
MSILNLNSQQTKKIIFNKKIKDKLAKTLVISFAWLFSICFIGLVVFIIIRSIPGFEAYGL
KNIFWSKNFNLADYAAGSSVWFPLAITLLVSFGAIIIAAPIGIKTATFIKFRIKNKRLQK
FFRVTILALAGIPSVIFGLFAIQSLGPAISFVFHIDTVQNITTSMFMLAFIIIPTIISLT
LSTYDGIDMRLIENGIGMGSSYTRSIYKIFKKEARGGIIIAIIIALGRAIGETMAISMIL
SDQGYQNIFGTGFLQIMHSALRPLGAVISANMFAENGGEGLRGLLYIYGIVLFVAIMILN
GLVTYLTRKRSKKTYAWFIKLEKSLAYIVCFIPDQLKILYEKITHRSQYKLHVNNLDNLN
NYITDRIQNRKLKRLYTVHKLFFESLAFMVAFAFLAWISLDILVNGIKAINLPTSTVVAY
TKNTTGQATINTLIIIIVAILIGLPFSLFVAIYINEYAKNKWPKKVLLFFIDSFGSTPSI
IFGMFGLVIFIEIFGFTSMGNIGKSLLAGALTITLVVLPTFTRSIQQSLKAVPMSIRENA
YGLGCSKWETIVKLVLPQAKKGIISAIVLTIGRIVAETAPLYLTAGLSSAQSITILNPGQ
TLTTRIYAQLYENNTNIAHNVMYESAFITLWLVIALIIIAHVIVPYFEFIKHDIKKWFKI
LKNYLRAPYMRDIKVFKPQIYQKHLYLTHNQAKIMGYNESVNKVAKIGLKLYEIRYVDDE
QIQKELLKVRG
>UU200 pstB phosphate transport ATP-binding protein B
MNDQKDNKEIQTIVPLNQKTNLNELDAKAIYDEFQKLNKYQRAFAWLKLPKQKKAELKQF
LNKKKTQVDLLKEDFNHANVFEIRNFNFWYMNRTKHVLHDLNLDIKRNKVTAFIGPSGCG
KSTFLRNLNQLNDLIEGTSHEGEIYFLGTNTRSKKISSLELRTRIGMVFQKPTPFEMSIF
DNVAYGPRNNGINDRKILEKIVEKSLKSAALWDEVKDDLDKAGNALSGGQQQRLCIARAI
ALEPEVLLMDEPTSALDPIATAKIEELILELKKKYSIIIVTHSMAQAQRISDETVFFYQG
WIEEAGETKTIFIHPKNKRTKDYISGKIG
>UU201 conserved hypothetical hypothetical
MATNYFLMKESQCDLLNDFKNFFQMVIDNQKLICDLLKNDQSSYKETYEKACFLEKKVNT
TYADMLEEIMWIIQRDQPRASYLRFFIAGINSIKDLERISDHSEIICEYFLETEFDEEQK
NFFLTSFEISNQILSDLYDFFDKNEFSVNTIEHIKDLRSKSIMKINKNLIQSLHDQSKLL
DENSNYIKLILMYRHIERNIEHGINIVQNFGNVHITSR
>UU202 unique hypothetical unique hypothetical
MTYMLLTSSDLHCGSCSSNLYNVLEKIGAQNISVNILNSEFAFEFEENKIADQDVIKEIN
KNGFKTNILEKYIY
>UU203 copA copper-transporting P-type ATPase
MLKNNLIKKFQLLPINKRRYLISLMKTSIALLISIPLMVFEMLFMFKSNLILSIDGYFIY
GWIVFVLSIFIVFGLGFSFFKGAFFEVFKWKKPGMSLLVVISTCVAFIYSTYSLISNTII
YEPKLHGFFETACMIIATMSVGQLVSDRIKLKANQDLQSLNNLQVKKYNSYDLNTKQVSE
KVVFQAKINEYALVKKGEIVPLDGVLYSQIAEVDESSLTGEARPILKTINNDIIAGSINV
GDNFIFKITKLYNDSTIKKIINGVNQIASSKPKIQVVADKISLWFTPFILLMAILAFLLQ
AFVPSIQELPIAFLNLHGSNNDSNLYEKAAYVAVSVLVISCPCAFGIAVPLAVLIGAGHG
AKSGITFNNSNIFEKIKKVNAIAFDKTGTLTYGKLQLKQVIGNDQFLDLIYQMELISLHP
LAKSFVTYAIINNIVMSTKLIDIKEVAGVGIIAKDVDGNIYELTSEHYANENQFDFSLIN
QKSSTSTNLLASNIIFSINKKVQSILVFEDEIRADAYETIKVLHENNIETYMITGDSFNV
AQKIAKELGIKHFYAQVKPEEKANIIKKIQNDQKTVMYVGDGINDLLALKQANVSISIGE
TNKATNAVADISLIKPDILNIYKVIKLTKITKMFIVSSLLWAFGYNLIFIPLALIGIIPP
FISVLIMTTSDIAVVLNSLIFRLLKMRLVNKKQIHKLNLKIINEAMLHK
>UU204 rps15 ribosomal protein S15
MAVSKQQKHDLTVKFGGSASNTGKTEVQVAILSAEIDSLTTHMIENKKDKASKRGLYKKV
AQRKKLLSYLQRVDIERYRALIKELNLRG
>UU205 rnc ribonuclease III
MDNKKFLDFLKQNRIEPKNLSIYLEALTHKSYANEHKLTKNYQRLEFLGDACVEWVISNF
IFNYKIKDNEKMRSLDEGEMTRARSNMVRSEILSYAAKDLGLTDFLMIGVGLEQDQSARM
EKIYEDIFEAFIGAVAQDQGIKKVSLILEKTLIKYFREGQINYQKDYKTIFQEQAQRINK
KPIMYKLVRNEGDKKEVHLVWNDLIYGIGIASTRKEAEILAAKNAILKLDDYTKKA
>UU206 plsX fatty acid/phospholipid synthesis protein
MEKIKILLDTMGYENDLEHVIKAAKDFYYQHEDDLEIILVGNEQLIKPLLDNDWRLFPIV
HTEVSIEQNDTILSARKKQNSSMHLALRYLKDKQADGMLTAGNSAVFVYNAYATIGLLEH
IKKPAFMPFVPTIDGGVTNLLDVGASIDVDGTDLFNFAIMANTIAKMRTPNPRVGVLNIG
TEDHKGLPYHQEANELLKTSNLNYVGFVEPKTILEREVDVLVADGFSGNIALKTMEGVGK
TISNFLKNEYKKPKNLFAALLSKPIFKKIKKAFDYKEHAGAFVLGLDGILVKTHGSADYQ
QFMSALKILYETIKADVLNEIKKDLNNYYGQ
>UU207 conserved hypothetical hypothetical
MKTIKLDLFQKMLYAGAKILEIECEYINDLNVFPVPDGDTGSNMKTTTAGAIIAIKEIEI
SNFSQLAKIFSRGLLMNARGNSGVILSQIFRGFMDALNNDAYEVSIEQLKQAFNGAKEKA
YASVSTPIEGTILTVIRVINERISERQNFDSVEDLFAFVTKEAQIILERTPEMLPSLKEA
NVVDSGGYGLVSFLKGMYQSLTNTFDEKLIIKNEEENIKSKTKPLDLEIIHKEKEEGFGY
CSEIILSLRKKIIPNSPSKSFFEFEKYKSELAKIGDSIVAIQDEDLVKVHLHTLTPYKFL
QLSQKYGEFDKIKIENMTNQFYESLERKGLTTKKENKLTLSMEQKIIATVPSEKFKKMFI
EEHGIDNVIVTETEGAPSIQRFVDEINSTNSSQIFIVTDDSNIVLAAEQASKIVAENNIL
VSVIGAYNVFETLLAISHFEQQNDYRTNFKTMNKIVKKARSGMITTSIKNVKYPHITVNK
DDYIGIINKKIIASEKNAYDVLLKTIEMLIESLKKPEICYIYYGINASQTDVHQIEKYIS
EKYGIICDLRYTGQSLYHYYIGIQ
>UU208 unique hypothetical unique hypothetical
MLKKTKFDTQLVKSLITSSILKVPGIFSVDINDKLSDFNRNYFVIKIDLHEDVVNVLSVA
NEARNLVYYELSKQLNDDNVVINIIINC
>UU209 unique hypothetical unique hypothetical
MNINWKSMYKEILIRNSDLNYIVSDPFENMIGGFPIILFENDNYIYYLSGQNAYLPSKMR
RWKNWDEILINKNDLLKENFIYKDIYINLFQIYVTKKNNLSRYLSNQFNFTLTKNDFKDE
LWNKLIYNTIKKLINNSNPQILLFEISRNKKQKYHSLLLFADKNVLKKFYLNSATKDNYE
DIIDLAFNKFENLQNLLKTTKVKNHLKNLKKY
>UU209.1 rpL28 ribosomal protein L28
MAKRDQLTGKGPLSGNTRSHAMNHSKRRWNVNLQKATIKTENGSQRVLVSAKTLKTLKKH
NLLA
>UU210 rpL27 ribosomal protein L27
MNKLYWLTDLQLFASKKGVGSSKNGRDSNPKYLGAKLGDGQSTKAGQIIYRQRGNKIYPG
LNVGQGKDHTLFAKTAGVVKYTKFMGDKTKVSVLPKEDNN
>UU211 conserved hypothetical hypothetical
MIKINHYPNALLVKGHANFDEHGKDIVCAGVSAIIMGALNWFDQQKTTIKVEQGFILIII
DNNNQLYRQYLELIIIQLKAIYFKYQSYIELHEYKQQYKRGL
>UU212 rpL21 ribosomal protein L21
MFAIFQTGGKQYKVQQGEKIYVEKLDLEVGSKISFDQVIMVEGSVGTPFVKNAVVNATVI
KQGKQKKINIIKFKSKKHHLKRQGHRQPYTQLVIDSISVK
>UU213 gmk guanylate kinase
MKRGKLIVFSGPSGVGKHTILSKIINRKDLNLAYSISMTTRKKREGEVNGVDYYFVNDEE
FKKAILNNELIEWAEFVGNKYGTPRTIVEKLRDEGKNVILEIEVVGALKVLDLYKNDDLI
SIFLLPPSIDELKKRLLKRNTETLETIKKRIQKATHEITIKDYYQYNIINDNPDHAANQL
AEIILNEIKQS
>UU214 conserved hypothetical hypothetical
MKLNNHNLKEIYSLSLNELKEELFKLGLKSFISKQIYSWIYQKRIFNFDKFSNIAKNNVI
ILKENFSNNLLKINSYQSNSDGSIKFEFLTDKNLIINCMIIKFKNGFLIKINPFGINFKK
EIINLSTNELVLQILLIQQFLDQRKLGNITNVIIKGLQDSLLNMDVVSNFINIINNENGL
NIGKRKIAVWTSGINVDLIKWGQLQNQIELIISMNASNSLIYQKIMLKKLNQNWSFLKLI
EQIKAYTKITNNRVVLEYLLIDKINDDLNYANELVELLKNILCYVLLIPYNLNNYRTSAN
LDDFFNILSVNKIRISKRIRKSNDLDISFKQLKIKE
>UU215 ptc1 protein phosphatase
MNFGFISDIGSQRKHNDDCALVIQNQYQQTLLIVCDGLGGYKGGAAASHITLETIKDNFL
TTDFSEYDKQQIQKWYIKVIKLAQVEIDRTVLLDKDVYNMGTTVVASIVVNDFSYTLNIG
DSRAYLLSNEQFLQISRDHNLLQVLQERKANPEVYKKHEKNLFSLTQFVGRTSNIFLSYD
LFVNKLNPNEIIVLTSDGFHNYFELNTLYEKLIKSTQETKNELLQQLIRQAIINGSNDNL
SLAFLIF
>UU216 pkn serine/threonine kinase
MREEIKTNSILNYKYKVVKHLADGGFSKVYLCCFLSDETKFIVIKVLDINDEKQQMVVYD
ELRISNLIKNSDSDKKNYIMEYYEYFETGSLENNDKRIYIVFEYIEGLTLREYLDEFKTI
TYVKAVEIIRQVALGVSFFHSCNPQIIHRDLKPENCMINKTLTKIKIIDYGAASVFYNRE
DLTKDQEIKCTIIYASPKLLSLGQKVKEQANKGLNKRALSLINDALGVSYDIHSLGVMLY
ELITGTNPFSEHTITDDRDYLEKWITYDVEPLSLINKTIPKGIDNILMRCFAWKKEDNKL
LYKDIYTLIDDLSNVMDPESNLNQEYIKPLNKLRIYRKNLAGLYEIKEKDRKWYLQKWFI
ILISCLSVILIILLIIILFFKKSGAI
>UU217 conserved hypothetical hypothetical ATP/GTP-binding protein
MVGDDVEVELIGNTYLITKIYERYNQLIRPKVANIDIVLIVVSIVQPDLNTLSLNKYLAF
YEARNIKNVLIGLSKYDLANNHLKQKINKLILDYKKNNYAVFILTKENDILLLKEKIKSK
TLCLAGNSGVGKSTLINKLDPSIQQRTQEISHFLNRGKHTTTSTKLISFANGFLVDTPGF
GNLEVNLTKNEMANAFNDFANYARFCKFSNCLHIEEPECAIKKAVDEKLIVNWRYDDYLK
IIKELPNDVLKIKTRAQNRKCK
>UU218 amt ammonium transporter
MRIVSTIITTSWGVDPNIYFSKHELTWVPATADANTLALTNFNPTSTLLVALAIAFVLLM
TPGLALFYGGLTRRKSTLTIINQCVASLGITTLIWIFGGFSLAFGPSVGKGIIGDISTYF
AFRNLLFADGWSGDVGIVFANFTNGVPLILFFAYQLAFAIITPPLMVGAFADRMKFKNYL
VFLVLWQYLIYIPFAHWIWGQGFLAAAGVIDFAGGIVIHTTAGFGALAASLVLGKRVLLK
NDKSRPHNIPMTIIGATLLFFGWFGFNVGGSGFVAGGNAATWSAATSAWINTIIALAIGM
VGWAVLETIFNKNHKATGVGLVTGAIAGLATITPAAGYVPIWASVPIGVAAVLVCYTSAK
TLHHFHKIDDTLEVWGVHGMGGVTGSLLIGAFASKSVNPSIMYEAIGPTTTGVLFGVQLG
AVLLAAVYGFVFTILLVYITRPRLSARQQLGHIDYINHGEDAYSFDIEIPSEKEMEQYEL
ADSTWHSSTGVKYSLLNNKNQQNHKVANDH
>UU219 amt ammonium transporter
MKIVSTWGLNKDIYFSTHELTWVPADASQSTLNAIGFNPTNTLLVALAIAFVLLMTPGLA
LFYGGLVRRKSALTIINQCVASLGITTLIWIFGGFSLAFGPSVGKGIIGDISTYFAFRNL
LFADGWSGGAVLVFANFTNGVPLILFFAYQLAFAIITPPLMVGAFADRMKFKNYLVFLVL
WQYLIYIPFAHWIWGQGFLAAAGVIDFAGGIVIHTTAGFGALAASFMLGKRTTLITDKKR
ANNLPMVVLGAALLFFGWFGFNVGGAGFVKENTNHISQAISSWLNTIIALAIGMIGWVTL
ETIVNKNHKPTTVGLVTGAVAGLATITPAAGFVPVWASVPIAIMGVLVCYSVSRLLDYFR
FDDSLEVLPVHGMGGVIGSLLIGAFATNTVAHGIKYDAVGLDNNGNPIYGILFGLQLGAV
LLAATWAFAFTCLIVYITKPRLSVRQQLGHIDYINHGEDAYKFDFIIPSESEMFEYESFD
QTWECKASGCKKSNLAAKKNPVFIENENDCTWQSKSRECTK
>UU220 unique hypothetical unique hypothetical membrane lipoprotein
MPRINTQVFNENNDKNRIKSNNNKICDDIEYTRLLETKEYNAGFSPNNDSQDILIKKQDN
ILKLKPTLNFDDSDQLISIVPTKNYENLRLKEIEIDKKNTVDYQLKKEIIDQDLTDDNHL
SISQKSNGFALKTKQFIPQNISEFIYHNEDDPKTYGSENNLTFSQLEEKVNQKNTPDFYL
KEIHAVRNKIIIWTILLAIGVGLIFYLIYEVIINHFNPWIFLPISIYCVLMIFFLALSCS
NFINFKKEMDYQKNHFDCTKATNFIVGIYRKLIVVHINVNWITAYIYLTSLFMIFGVFVV
SYFMNLYYNAAIGSRFGDLIIKIPVVINNHLSQKISFNKNPLWAMIGLGAILGLTFIIHL
WLVFNAHHRINRIHSYYVNEIITSEEIISLKKQANRRGLVIFLVLTVILGLIFYLMYTIL
KRKYTIKK
>UU221 fthS formate-tetrahydrofolate ligase
MAKIIEEMINKKGLLIDDYELYGNEIAKIKSIKKLNKKDSKLIVITSMNPNPAGEGKTTT
AIGLVDALNKHGYKAIGALREPSMGPVFGMKGTGSGGGLSFLKPFDKINLHFSGDFHAIT
AANNLIVAVIENEIHNRSSMQIDSQKILIKRCLDVNDRSLRNIEYDINHQQTKSGFNITA
ASDLMALFCLAHDHKDFEDKLAQTIVAYNIVNQPIRICDLELTKAIMAILEDALYANLVR
TNEDNPVFVHGGPFANIAHGCNSIIATKNALALGDYVVTECGFGSDLGLEKFMNIKMASL
NLKPDLIGLVISLKSIAYHAQTNEKDYVKQGFANVLCHINHIKKYNVSFIVYINVNTNTD
SEEDLLTLEKLLDEHQIEHARSYAYSYGSKKSEEITKKTITLTNQINDHELKLIYDIKDH
LSYKLKKICENVYGADGYELSYEAKEQLNRYEHLDFYLCIAKTPYSISDDAKLLNNPKNF
KIHIERFEINYAAKLIIAITTTIYRMPGLNKEPAAKNFVMK
>UU222 xerC integrase-recombinase protein
MKDFIRYTKKRNLSLNTIRTYESVLKHYEPVLDSWIKIRNKIINSNFKPRTIHLHKNVLL
SFFEFKKLKRYLQNLKLLKLPQIEMKYFDVISKNNLYKKTDILDDDSLEIKKYKTIIRFL
FETGIRAHELFFLESINNRLYVLGKGNKKRQIFFVKQTFEQLQKFYENLKGFETTKTLRL
YIKKIIGKNFTPHSLRRSFATFMLIKGANPKTVMLQMGHANIQTTFSYLNLNEQTNRRIY
NKIMYQNDAE
>UU223 xasA amino acid antiporter
MGFVLLTASAIIAFYTFPSLSTAGWIAIIFAFITAMCWFIPIGIAAAEMATIKGWAEGGI
FTWVRNLLGPRNGFIVTWLQFQVTFGFVAMILFVLSSFSFAFAGADGYNYFNTLKLGTTL
NQATSVNFSKNFSNGALYGIGIVVVAGLIFMSLLGQKRTHQFGQVALIIGILLPFFIILG
FQIYTVATMPDPLYFIGKHFQKEPHLDPSVTGTSYELNKTFMSSVVMASFMAFSFSLHGV
EVSAIAANRMDNPSKKYPQAMMIVVISALVCIIIGSIMISMTVPTSTLSFNGGLVQTIMF
NLSVGGIDVKLPDGTVAHYKTLAHAYSVIETQYGTAAANQVMYQFVYGHPINTGSDLARS
DLLTLTSEVNDPLKNPSLFISVMNIETNKMAMQGLQAITFFIGIGVFVEVSVWMSNLSTG
LNYAMRKAHFPAWVTYRLKNGSALTVAILWIVLLMCIFAIYMFGYNSLMQYKGQTISDIL
ANEIRINQDQKEPMALLSNQNLDEIKLMARSIYEHSHAPGAQANVLHFDFNKHANSEVKA
IYDKIKDYIGINAVASGTPASITNISFISNVVSQISMYYIGYNIFLIGYLRYVFKANWLR
REFRVKWSWLQISLALLAMGVNTFAVVATYLPAAPELYPGQEAYYVFISIALPMFICTLL
LGLFIYLINYAWNKKRGINLSEHSNLTNVDQNVLDVINNWHLYKDQKEFAKFERHVQLLQ
QKQVIVRTTKDKAQRELVANEMQYLAAEIATRFAPEEEH
>UU224 unique hypothetical unique hypothetical membrane lipoprotein
MKKNHKKWLLMTTPILLIGGLSTLALTSCKDGKKSNPKPDKPSTIEEYKLSLSSVETGFN
EAKLIFDNNDSFKTLDNFKVILKNTQNTNEVIEASNLSATIENQKLVLKLNNLQDGQTYK
INKILYQTNKEVILSNNQVFTTKTKPKIEYEVQEKILKLDDKTYYVVLKVKDPQNLNEPT
KEILKSVTFTSKISNVANLKNAILENQRPYVKEDYSEIQIKLPRVPVISEKIEITANNSL
FKSFTITVGEKHIKNVEKIIDITKKVFGNQELKSISITKQNSSSANITLSLKLNGNSIIV
GANKLINKKDKAIKFSFFVKNKATNTVKEFNFNEKSKPIGSYQFTLNGLDANSDFVIEDI
RYDDKSIKITEELLASLSFSTK
>UU225 unique hypothetical unique hypothetical membrane lipoprotein
MKKWQKILTIALPTSLLVAIPIVVASCSTKSEAQKEFEKTYKEYLSWLDKLASKMPALKE
AFSTLKEEINKQINKSEKLSDEAYKALTASLKVSIDGMKKTLGQN
>UU225.1 unique hypothetical unique hypothetical membrane lipoprotein
MHLGIYYMVYSYYGSPYLTQDIATTNVVNAWAMYNAGVAFLVIFALIEIASFALFVTTTV
NVGLNLKRQENFVLPFVFGILGCLGIIPIIGSIIIYVQLNKFYKQQNESSLI
>UU226 conserved hypothetical hypothetical membrane lipoprotein
MRICLEKIMRKIKLNKKIILASVIGIMGVALVPIALVACSQNKTKSDSRNLTLNNFYGRP
SSDGDDAYQAIYASKIQDGARMLGLISFRHKNPISKYFNSPKDNQQVSAVLIDEIYDLQT
GKDRIASITYRADQAAFLAGIAAAYYLNSNQNVFGKDNKLTWGGFVGIHLPSTTRFIQGF
KFGIQWANEKLKNKKVKQTENNEEKEWINVEQVFATNYQSGDFSPTSDKAKAIVNQLVSN
NVDLILPVAGPQIDYATTAAAESSKPIVVVGVDTEQELDDNTNKARISENNKSLANGKTI
IFSIVKRLDLAFKGALLKASEGAQLTNDINKDAYKLGTHTEASFNKNTYVDNTALVELSK
AGHQYLIDAIKLSGLKEVNDYKTIVEIIQEDPLFKLLSQIGTKKLDEVATKSQQGDWVLK
SEYQDLPFIQLQKMLGGLVYVDQKNELYPYELSNSFYLEKDPNKRQASRAFYNYWNAKDA
NQINLVKIFLGQSVDVLKDKSFSESIYKGLEEFYKSKNIIIPKLY
>UU227 infC translation initiation factor IF3
MSSNNDARKNQPLINDQIRFRTMVVIDDHGNNLGEMNRIDALNLAASKNLDLVVIAKKGN
IPVTKILDYGKYKYEQKRRQKESRKNQTIIKVKEIKIKPMIGEHDLKVRAENAKRWLEDK
DNVKFVIEARGRMCTKDEFIVQAYEKFIDLIKDYGTVVQANKKVSNYRYETIIEPIKK
>UU228 rpL35 ribosomal protein L35
MAKIRQKTKRAVAKRFSITKNGKLKRKHAYRSHLALGRSTKAKRHLRKDAIMSTSDTKRY
TQCL
>UU229 rpL20 ribosomal protein L20
MRVKGGSVTRQRRKRWLEKAEGSWGTRNTSYRIARQTVIRAAEYAYRDRRNKKRDFRKLW
ISRINAAVRELGYTYSQFMNALVKANVVTKDGQGLNRKMLSELAINNPEAFNQLVDKVMK
>UU230 rpS10 ribosomal protein S10
MNQELRIRLESYDHRLLDDTVKTIVNISNSTGSKLRGPIPLPTKKEIFTILRSPHVNKSS
REQFERRTHKRLIILENPQPKTMEALKRLSVPFGVEVTFKI
>UU231 rpL3 ribosomal protein L3
MKSLLGTKVGMTQVFTETGKAVAATVIYVEPNKVLAVKTNEKDGYSAIQIGYETVKEKAL
NKPLLGQFKKANSDPKRHIKEFRDVVAEVGAELTVSEFEPGQLVNAQAYTKGHGFTGSIK
RHNFSMGPMGHGAGYPHRYVGSIAKGRGGSQAQRVFKGTKLPGHYGHELVTTKNLLVLDV
KANENLILIKGAIPGPKGSIVLLKSAKKVGHIVSDPQVVNYLANKASSSEANE
>UU232 rpL4 ribosomal protein L4
MAKIKLLSIDGNFAKELEVTSDLFVEVPHKQAMFDSVLAENAAERQGTHSTLTKGEVRGG
GKKPWRQKHTGKARTGSTRNPHWTGGGVVFGPKPNRNYNLKVNAKVRLLAFKSALTIKLN
EGKMLGLVANSDLETPSTKKMVNFINNANLENQKVLLVIVDNFSNIKKSTNNLQKVTTKL
WYQVSVRDLMHANVVVVAEEAFTNYARKVSK
>UU233 rpL23 ribosomal protein L23
MELTRVILHPYTTEKTYSIRNKSEHETLTFIVDKNANKYQIREAFIAIFGLKPLKIRTTN
RRPAKIRTSTARPGYTKAKKIAYVVMPVGVKVAVSKEEVEAANAK
>UU234 rpL2 ribosomal protein L2
MAVKRIKNHSSGKRQTVVVDYKSILTTSKPEKSLLVTLPKKAGRNNQGKITIRHHGGGHK
RKYRIIDFKRNKDNIYGTIKSIEYDPNRTSFISLVVYADGEKRYIIAPKGIKVGDKIISG
NENIDILLGNSLPLEFIPEGTLVHNIELSPNAGGQITRSAGASAQILGFDETKKYILVKL
NSGEVRKFRKECRATIGTVSNDEHILENLGKAGKSRHLGVRPTVRGSAMNPNDHPHGGGE
GRSPVGMDAPRTPWGKRHMGVKTRNNKKSSTSMIVRRRK
>UU235 rpS19 ribosomal protein S19
MSRSLKKGAYADPSLLKKVEAANASVSKKPIKTWSRRSQIFPNFVGLTFEVHNGKTFLKV
YVTEDMIGHKLGEFAPTRNFKNHTEAKR
>UU236 rpL22 ribosomal protein L22
MTNKVIQRNIHISHRKASLVIDLVRNKPVHEAIRILSNTPKKFAPIVLKLLNSAISNVQH
NSKDMDPSKLYIYKIVANQGPTMKRTLPRAKGSADQLFKRTTHLEIVLSDDVNEREKELA
AIKAKKSKKPLAVEPIAKVETKKVAKPSKVEIKPVEKDENVDPELLKREQQVLKVVEKTA
SQKEEETTETIMISTSPKNAQVLFDDLEKNVIFYKTTPINKVLRVLVYVTSPTKKVVGEF
DLESVEIGAISSIWRKYSKQSVISKKEYDAYYEGKDKAHALVSKKAYKYRNPKDLSEYNM
TKGPSGFQYLK
>UU237 rpS3 ribosomal protein S3
MGQKVNPNGLRFGINKQWLSRWVPTDQLQMAKWLVEDDKIRKYLSTKYKNAGIDHVEIER
DQQRVNVYVYAVQSGLLIGTEASEKKLIELAINKIVGRKQLVSLKVVEVQIPELQASLMA
REIADAIENRVSFRIAQKMVIKKVLKAGARGIKTHVSGRLGGVEMAREEGYTQGVMTLHT
LRADIDYSMQEAHTTYGIIGVKVWINRGELFGNKLVNSVAHAANKEFSRSSKPKKGSFNR
SSRSKNTKPAPKQAVSE
>UU238 rpL16 ribosomal protein L16
MLQPKRTKFRKPHKVSYEGKAKGNKQVDFGEFGLMALEGAWIDARQIESARIAISKRLLK
TGKMWIRIFPHMSLTKKPLEVRMGSGKGSPEKWVAVVKAGTVMFEIANVSEELMCEALRA
AGNKLPIKVKIVKKGEAN
>UU239 rpL29 ribosomal protein L29
MSSIAQDLRKKDSLELEKIVIELKAKLLELRFAAANGEAEKLHTAKEIRKTIARALTILN
ERELAEKLNNKEANK
>UU240 rpS17 ribosomal protein S17
MERSRRKVLEGLVVSDKMQKTVVVSVETKSKHPIYRKLVISHKKYHAHNDNDDAKVGDLV
EITETRPLSATKNWRVSKILERAR
>UU241 rpL14 ribosomal protein L14
MIQHMTRLKVADNTGAKEVGVIKVLGGSKKRYASVGDIVVVSVKKATPAGLIAKGQMAKA
VIVRTKKSIRRESGLLIRFDENACVLIKEDKTPRGSRIFGPVAREIRDRGYTKIASLAPE
VL
>UU242 rpL24 ribosomal protein L24
MNRIKKGDTVVVISGKNKNKSGVVIQVNPKEQTALVEGVNKIKRHQKKDQTHEQSGIIEK
EAPIRLCKLALVDPKGKDKGKATKVKYLLKDNKKVRVARKSGSELDVNKK
>UU243 rpL5 ribosomal protein L5
MAFLKDLYKNKVAKDLQKEFAYSSVMQIPKIEKVVINAGIGNAVADKKHLEAAISELTLI
TGQRPVETKAKKSIATFKLRAGQSIGAKVTLRGDRMWAFIETLFNIALPRVRDFKGISNN
SFDNQGNYTLGIKEQIIFPQVVYDDVKSVRGFDVTFVTTAKTAQEAKALLVGLGAPFQKV
RGDK
>UU244 rpS14 ribosomal protein S14
MAKKSLIAKQKKHQKFAVREYTRCVRCGRPHAVNRKFGVCRLCFRDLAYAGAIPGIKKAS
W
>UU245 rpS8 ribosomal protein S8
MYLDPIAELITKINNGRKAHKAEVSFATSKLKTAILELLVKEGYIKSYDIRPTENNKSET
VVKLKYKNQTTSSINGFKQISKPGLRIYSTHLNLPKVLNGLGIAIITTSKGVMSDKQARK
ENVGGEVIAYVW
>UU246 rpL6 ribosomal protein L6
MSRIGNRKLTIPANVNVSVESGKVHIVSQTAKLSVDFPVNLISVDVVDNTVKVSRANDEK
QTKMFHGTVNANIANALVGVTTGWKKELEVKGVGFRAKVEGSKLNLGLGFSHPLLIQIPT
GLKVETPSATEISINGADKAAVGAFAAVVRAYRKPEPYKGKGVMYKGERIVRKAGKTADK
KK
>UU247 rpL18 ribosomal protein L18
MKRINFSRAKQRALRAKRLHVKIRNLQLAANKPVLVITKTNAHIWAQLICYNKNITLASS
SSVQLDLQNGNKDNARLVGVDIAKKALAQGFKQVIFNKNGAKYHGRIKALADAAREAGLE
F
>UU248 rpS5 ribosomal protein S5
MENNVKKETIVDSEKVEKQQLVTAPVVNKKENTEPKAKTFKRETTTSNFEERVVKIKRIS
KTTKGGRMMRFSALVVIGDKNGTVGFGMGKSIEVPDAIKKAIKNANNNLIKVKQTKKGSI
YHDVNGRHGAAKVMLLPAPEGTGIIAGGPVRAVVELAGFTDIYTKSRGANAPMNVIRATI
NGLLQQLTPKEIARLRDKSLREI
>UU249 rpL15 ribosomal protein L15
MQLHNLEYKKGSRNHKEKRVGRGHGSGLGKTSGRGQDGQKARKSGMVRLAFEGGQTPLYR
RVPKVGFNNDRFANKYNVVTLISLVKYETKELTVEFMYANKIAKNEDLPIKVIGNAVLPS
GTVVSAHKFSKGALESISNSKAKAQILE
>UU250 secY preprotein translocase
MTNKQKKKNAFRQLLMIFKNKKVLVALIVTLSILILFRIGSVIPMPYIKLNGNFGNQGSF
FSIINLLGGGGLSQFSLFAIGIGPYITAQIIMQLLSSELVPPLAKLSKSGERGRKKIEVI
TRIITLPLAVMQAVIIINLMTRANGFISIVSNAPFAIGSPLFYVTYIFLMVGGTYISLFL
ADLISKKGVGNGITLLILTGIVASLFNHFIAIFSNLGSLTSSKVSQIIGFILYILFYIMI
LIGVVFVNNSTRKIPVQQTGQALILDHEKLPFLPIKIMTAGVMPVIFASSVLAIPAQVAE
FLDKQSMGYYVIHNYFIVDSWTGLAIYVVLILLFTFFFSYVQLNPPKMAEDIKKAGRFIP
GVQVGMDTEKHITKVIYRVNWIGAPILAFLACLPHLVALVAKTINHGIPVIQPSTIFGGT
SIIIMVTATLELWNAIKSTSTSTSYAYQRKELETSITVSAESDKSSKSQIW
>UU251 adk adenylate kinase
MKILLIGPPGSGKGSVSELLTKNNTLKHVSTGNLFRAILKEDSELARKIKEINVSGGKLV
PDEITNQVAKSAIDELIKNEQSFILDGYPRTINQALALEQYCNLDYIFYLDIDHQELMKR
LTGRWMCPKCAGIYNIHFKKPQVHGLCDNDQATLYQRADDHADAVSIRLDEYDKLTLPLI
KHYETNPRFIKINANQPIEDVYKNINNYLKQNK
>UU252 map methionine aminopeptidase (map)
MVIVKTEKDIAAIKEAVRIWKIAREAIYKQAKAGVSLKELDLLAKEVIEANGGIAAFHNY
LGFKGHICISVNECVIHGVPTDYVLKDGDKVTFDVGVKYDNHYCDAAFTIIINNSNVEAL
KISEICKKSIDEAVAIIKPKVTTHAISNAIQKFIEKNGYFVLRDFAGHGCGNEIHEDPLI
PNYRSLLYRNVTLEENMVICIEPMILSGSNAYYIDPNDQWSVKSKNHQMTCHWEHMILIT
KDGCEVLTD
>UU253 infA translation initiation factor IF-1
MADTEKLKMLGKIVEVLQGGNFRVQLENGITIMSHVSGKMRVNKINILPGDTVDVELSPY
DLTRGRITYRHRDN
>UU254 rpL36 ribosomal protein L36
MKVRASVKAICKDCKIVKRSGVVRVICANSKHKQRQG
>UU255 rpS13 ribosomal protein S13
MARILGVDIPNDKRVVISLTYIFGIGKSTSQQILKLANIDENIRVKDLADEQIAEIRRVA
LNFVKANGEKLQLEGDLRRTVAMDIKRLMEIGSYRGIRHRRGLPVRGQRTKTNARTRKGP
RKTVANKKIETR
>UU256 rpS11 ribosomal protein S11
MAKKKKLSFTNGIAYIHATKNNTIITLADEQGSVLSWASSGSIGYKGTKKKTPYSAGIAA
EAAAKAVIDMGLKSVEVHVNGTGASRDTAIRSLQAAGLEVTKIKDVTPIPHNGCRPPKKP
R
>UU257 rpoA DNA-directed RNA polymerase alpha chain
MRKFLKYQLDVPSINSEDKNRTVVKIAPLEIGFGDTLGNALRRICLSSIPGASMFAVKFG
GYSHEFQPYEGVKEDITHIILNLKNLAIKIDELIYSEDYFNNLLIDKWPKMKINFKGPGV
ITAKDIVCPVGFEIVNQDLYIAEVTKPIDVEIEIFAKTGRGRVDFNTNKDFVSTLHIIAT
DSNYSPVLHYAYNVEMIKDSKSSMSEILTIDIATNGTISGSEAIAIAAKIMQAHLEPIVN
IDKTINEMIIMREREEEEKRQNASISIDDLDLTVRAYNALKQSGINTTAELIELTKSQLE
KIKNLGRKSVTEIIQKLTERSLELKKD
>UU258 rpL17 ribosomal protein L17
MSYINKPGKTRAWRKMVSRQQVSDVISHGSIVTTKTKAKESQRHVDHLITLAKKNTLASR
RAAAAILLGTNQHSADDLLRKLFNELGPKYANRAGGYTRVIKLGNRPGDNTEEAVLQLV
>UU259 unique hypothetical unique hypothetical
MNKQKRKISVLTSISLFLIISLSIGLGLGLIKNNENSITSKVQKSSNFFINDLSKQLFLD
VFNQDKLELNAYMYDQNNVSDQQLLDLKFALTLLNPNRLDINDDDTIAIMKNNAKKIIFQ
SLSNNWYWLFTNLKSLEFSYTPYKPNFYAPYINEKQDFTKSSIFDKVININKPLTNYIKI
KQKLFDKENYRSVDVYYLQFGDHLILRLLKFNKKNHFDVRFDTDLFQFNKPIINLELIAK
EMQTSIDYHREDNFKKDILDYKKNYEDYLYYDEKLNSSIYQQGLDKINKEYYEVNNFNFF
NTKKPLFQKFSYQMFLELKDKLGFKRYVLRNIDQKEVRARDHFNDNEKKQQNKNYFRSFD
KELNYFQKYIDHNLDININKISKEAYITQKIIKNLLLDAFNNNDVQITKYLIQQNDKEYQ
NKLIKQLIEFSNYFKNQKTPRDSNEYKQKLNDYEKIFSQNWYFILMNLKHFELSFNNWFT
LPKQINPITKEMLGPSEKYLKRLKKLKPYEDYYFINNYLEKKQEGDTSMLIGSFKDLYIT
KNQSIFNIKIDFSSSENRLSLNPLIYFFPKTKNKLSVDLITSIFHQAIFHQNKEYYQLFE
TDMIDKYEYGIPAQMLLLWRE
>UU260 unique hypothetical unique hypothetical membrane lipoprotein
MFIFFKKNHLLKLSLFFIPLTLISILITSCSTSNLKKQQILTNNEISFFMDKSQNCYVGL
IVDQTLKNDKKTIFNVSLIDEKNTKLNLLVKDYQIKDNKILIRLPRLIKLNDHLIITSNN
ASFIPIRKIINIDNLIDLNIIRTNNQTQDSWIAFLNNKVINNLLITIFPNKKDRDEYIKS
QQEIKIEYAHEIANWLNYYNTVQNDANKAAVFNENTARSKLNNNLFNNVSLSNPFAYEQA
RKFHNTLFNKNWLWFLFNLKRQIFMLYPDDNLFQESSEETAEGLKDSKINNRSSFYRAQS
NEFIDGLYVVESSNLNKKPEELDEYTDFSKTAKFTLLNNEGFVFTISIEENYDKTKKLIS
RKVSLLPWIKTLPRLMFNDHVIKQEFNLANYTENSYDYNAVNFHSPLEIKVYEDQFGGKA
IRFSFVDIDPN
>UU261 unique hypothetical unique hypothetical
MNNYIQQVIDYVNDKTYKNKTYFIKKYAFAFLTSLIIFIFLLVFGLSNYFNPLVSLVGVV
LIFSVLVVFCIHIKIINNYSLNLLKWLRNQKELSYKYIINILDFILNKQLYLNLTIIEVQ
QICIDLEEFKKTNVI
>UU262 conserved hypothetical hypothetical
MSFKTIAYTQKNIKIIKKSKFITIVEPISDKNEVQSLFKKYKEQYYDATHICFAYVIGRE
FNYMKAYDDGEPNGTAGIPILNIIKIKSLTNVIIFVVRYFGGIKLGTGGLIRAYSQCAKE
IIDNCEIIILQKYFYYKVVYKLKNTKFAKQILTSISYEKLIESYEDDRVILKIRINTKIN
IFMSKIEFIFIKHDY
>UU263 unique hypothetical unique hypothetical membrane lipoprotein
MKINFKRTFLLSFIGVIVTPIPIILSCSLTKIKKEDNKNFFNLYLKIKEEASSKVDFVLK
NNHKYNYLLNKADIINNYINYLVNLNLNENSENELLAFTYYELYKLIKDFNYLLKEKTQE
YESWLIKIDNFVKLIKKRQADFLNFKNKNKIIHDIDHIKNNIEEILTNYNQIPDNENIDD
IKLRYKKMIESYDGLYKKTINDEANKIKNIKSDVKNLKHNYFEKIDNGEEYYKLYNREIM
ELFHEANQLHENISSVLQSILNRKLIENKIDNIKREIQEHKKVSQYIKQNGHKNNQDFWD
TWKEDILGKKFIYQTLMDNTNVAIWYGLALKIEDLAKQKFINTKSLELKQLIEKWKLYGQ
ALIRDSLDAANFSGLFFTIKSKTSMLDNWQPSIDPNSLSKKGKYYLLIKKLKDLTNEIEK
KARNANQKLSRFYDSVVKDDVEQIVPYIKAVGYGFYPQEEFGELMYWSNYYLNQLPDVFQ
YYKEKIIKPIIDQIKSKSDSANDVSKLEELYNFKYHYTNIYEPFNQKRDNFYYYSDYKTD
DKGEKIKNSDEMFILTKQVPNHLKNEYDTARLFFRIERTIGEICKKYALTNPLE
>UU264 pacL cation-transporting P-type ATPase
MSFDPENINPSTGLNDEQVLKSRQIYGFNEIKKKKKSHIITKFLKQFLDFMVILLVIAAA
VTLALVIIKPPHDTAELVVQYVEFGIICFILLLNAIFGTIQEVKAEKNTDALSKLASHQV
KVLRNNQIRIINSNQVVMGDVLILEAGDQVPADALLVNSSSLEVDEAILTGESLPVVKNA
KAIVKKNTVIGDCLNQIFSGTYITNGTAKAIVTNIGMNTEIGKIAKLINDQKTKLTPLQK
KINKLSKIIGLFASILCIAVFIIYIYLIGDGNWNISWHPALIMAISLSIAAIPEGIVAIV
TIVLSFGIKEMAKQNALIKRLPAVETLGSANVICSDKTGTLTQNKMTVTKVFTNKLKITD
LIDNESVFNLIKWATIANNGIKNFNEKKQEYEFIGDPTETCIIEAALKLNIDKYKLDQEF
IRIHEFPFDSTRKLMSVVVKHQSDYYLITKGAIDAIDKIVQNPITKDVYEANDFLSKQAL
RILCVAIKKLSSIPTNFNQDELEKCLEFVGLIGMIDPPRPETQEAVKIAIKAGIRPIMIT
GDHINTASAIAKQVGILNEGQEVLNGNELNMMSDNELINNIDRYSVYARVSPTDKIRIVK
AWQHHDKVVSMTGDGVNDAPALKAADIGCAMGITGTDVSKASSDMILIDDNFATIINAVS
LGRSIMDNIKRIIVLLLITNLSGLVSLIFGIIILGINPMSSLQILWINVIAETLPGIALG
LHLADVNLMRHKPLKKSAPIVNKRMWATIFTNGFFVGLISILLFYLGASSHFNFDFMLMR
NEFKELTNLEKIYQDTWSWFGQNHEISNIIHEKILTIKTAIMAGSSLTFVFMGMSLTFNA
LSLRTNHSVFVNFWENCKYVVYSILISIVMIIVIAYTPHLNQIFNMNPYNINGYEWFNIL
PFVLFAIPLSIFEIIKYFRYLKLRSTFDYKNKTYALLNQEIQSTNLKINNTKISYEKQYY
KALLNNLIIKRKILINKCHKEI
>UU265 conserved hypothetical hypothetical
MNFSSFIFKVSDVFKSVIHEASDVVTKADLDNANAHTHSLAVGLGIGIVLFLIAGLIIGY
FISMKIMKRQLKKNPPISKDTIRMIYQQVGRKPSESQINEIYNRAVKQK
>UU266 conserved hypothetical hypothetical ATP/GTP-binding protein
MAKFIKSAHYFDQYPIDKQFEICVIGRSNVGKSSLINALANKKIARTSNTPGRTQLVNFF
DFNNFRLVDLPGYGFAKVSKEKQTDLAAIIDQYLGYRQNLCAVFQICDINVLTNDDVEMS
RYFENQKYAHFVVLNKLDKVNKSYFNNNKHKIAKFLNISTDRLLCVSAQNNINIITLFAL
MKKVVIQAKQEKILSKKEEKMSSEEEIK
>UU267 valS valyl-tRNA synthetase
MKKKLSKKYSFKEVEANKLLFWQENNLFKAQINSTKKPFTIVLPPPNVTGHLHIGHAYDF
TLSDILMRYKKLKGYDSFIIPGTDHAGIATQTKFEKNLKVNAQTNRFNLGRELFLEKLKI
WKDEQINYIHKQWNALGLGLDYSNYLFTLDPIVVQTVREVFVKMFNEHIIYRDKKLVNWD
IQLKTAISNIEVIHKEVEQKLYYIKYLSQDQKDFVVVATSRPETMFGDKYLVINPKDKRY
FHLHNKIFINPINNIEMTVILDDYIDIEFGTGVMKCTPAHDFNDYELAKKHNLEIINIMN
ADGTLNEKCGEFKGLDRLEARSLIIDKLQKNNHLLKVESYRTSVGFSERTNEIVEPYLSH
QWFIKMDSLIKDTIKMQDDCNNKVDFYPNRFNKTLLTWLKNTEDWCISRQLWWGHQIPVW
YHKKTNQIYCDTIPPKDLENWIQDEDVLDTWFSSGMWPLLTTKWNYNSHFFDRYFPTSLI
VTGMDILFFWVSRMMNFSQYLVEKKPFKDVLIHGLIRDSQGRKMSKSLGNGIDPFDIIDK
YGLDAMRLFFASCTTIGEDLNFSTERLGANWNYLNKIWNIAKYIENLDEINDNLNFEDVD
KFCDVNKWILTELSKLTLEINKNMDKYNLVVATKYLYDFIWNTFASYYLEYTKVLLQDLT
LKNETIKTIRYVFNKILIMLQPFAPNISEEIWLCLNQTNNSILLQEYPIINFEFETIIID
KIAKIILEIRKLRLEENINNRINLCFELISPNDAFYKSKIKLVNLLLILVNAEINEIKKT
SSNNYTYELVIDDFILKTSYEKPIDYVFQMKKASEQLNYLENEIQRATNLLNNSGFINKA
PAQLIIKEKNKLINLKKEHANLLKTLTDLKQKVK
>UU268 spoU rRNA methylase
MLNIVLFEPEIILNTGNIARMCVGFDANLHLVRPYGFILDKKRFHKDFIRASTNHLNALK
LYEYDDFNEFINKNNISGDEIYFFTRYGTKTPCDYQYQNIIQHNVYLVFGKESTGIDHNI
LKKYPHNWIRIPTSINLRSLNIANSVAMGIYEVVRQNNFKDLFKYEPHKKFE
>UU269 conserved hypothetical hypothetical
MRLRNNANAPLYLKSQHEYIINDPHLLKDNLGKIFKNPELPLYIEIGMGKGDFIIENALR
NQQINYLGIEKFPTVIVKAHKKALKHKLDNLAMICFDANKILELLNSESVDKIYLNFSDP
WPKKRHAKKRLTHPCFLEKFAVILKQNALVEFKTDNENLFMYTIYDVLLKDLTKYEILFL
TYNLYTLVNNVELLKNIPTEYEKKFVMQGERIKKVNFRFLKNNQ
>UU270 unique hypothetical unique hypothetical
MINKNKKFHFQYFKKDNDQSISTKETLKRYFNFRSQSVKLIIFNLVLTAFFLALFLIGRF
LTKNLDFLNGFSWQLQMGIFVLAIVCIPNFYYKLMYYIIAPLVMLAIGFSAEPFFGYLMP
HYGFGLILFTDVILIIVKKSCQSIKKQIFLSYLLIFSFSIIGYFIVWMGYSIQGTLFYNT
AFIPSMIYNSLVTFGSMAINFVLYIISIPAIVALKNKYLCKLV
>UU271 unique hypothetical unique hypothetical
MFMFDQIFKKRKRHLNFQIFIFFFVLILITFLILWIISGNVQTIIDFIKKKIYDASPQLK
YLTNIQIKPFKNLEEIFDFIIKNKNLIKDLQNEPEILDVIKNNPQILKTLNDNREFLKQI
VEYKPFAEILSKQPEILKFVQNNKELIKQIQNLPELLDLIKKHQNLIDHLKTNEKYIEVI
KANPQMLKDLYHVDDNLFNIIKTSLENDKENNILMLAIKYSVLINNFTKNLTLQEWKQII
EFYKTVDLNKFIVDDNLFNIIKNNNQLFEVFLNNYDYIKNLEDNQKIIDIIQQNPDLIDD
FKKIDFDLLTQKRNFVRALIKIIDYKQPKEIQFLNKKVFLDFFKNKSEITNALNITSLIG
FVLFIVIYTIFIFASFISHILMLKQIKDFNKIFKEAKLKKIYLISTLLLQFLFLILFIIN
FIVLIILVVDYNKLKAIVLNSGIKRKVEDSDARLHFL
>UU272 hit probable HIT protein
MQDCIFCKILKGEIISKIIDENEFAIAILDIQPASDGHMLIIPKKHYRNFSLTDPIYLDG
MMRLAKNMTFVLEEVFPNVLGFNYLMNSNSSAGQVIMHTHLHIIPKQSNGRGFVFKAIKE
EGDISNIDEIYKKIIIKTQKLKKSRLSKHYMV
>UU273 unique hypothetical unique hypothetical
MEQIRNLIDLQIKLKPIQKAFYDAWSKTFINGIDNNKETHEQNKKIILEIYMILKVFLNK
NRDIISKIPLNQVKKIANDILEKEIILEQPLVDYYYQSSSCFILIPYLIQILYQSYHLNK
PIYKIMCKFIIRNNLALFKEWDLIERQTLEIIKLKTNLIEDNNKAINLFSCEQRELQHNR
FVKLFNNFILVYWTKREVKYIEAIRFLMYFIWIPIIFIVLLILILGLYFGLSNSESLKSS
TQFLLDLFIIN
>UU274 hemN oxygen-independent coproporphyrinogen III oxidase
MIFNKKTKHLYIHIPFCNYICIFSDFKRILKTPQTKKFFKNFLENIKMHINNFKIKQFKT
IYLGGGVPNCLNNQELEILLKTISPYVDDNCEYTIECNPELINQTQINLFKKYKINRISL
NVQSMNNDVLKQMNFIHTNQDSKKAINLLHKNGLYNVSCDFLFCISILTLKDLDDVFNFI
LNHKINHVSFYSLEIKEQSLLKKYHITIDEEKEIEQMNYIINKFAGLNFHRYEVCNWTNN
FRYIAKHNLAYWRTEDWAAIGWGAHGYEKNIVYFFDGSIKNPILIKKVLTKHELYQQILM
MGLRLKDGLNLNKKINYEAYSYFKNQLKHVSINKKNHLLIDDLNLLNLTILDIF
>UU275 unique hypothetical unique hypothetical membrane lipoprotein
MGLKKEKKDRSTIQLLFGTIKKRKIANYLIIAFAFLTFALAIIGSFEAIASKYAIGIGSG
LSLFITIAFSVWRILMIHLEKEWNKSEIIWQSVMGAILVLSIIFWIWATTTTTIQYSSLK
EHLLLLKQQDSRANFVVLTQATVDEFGVALKGGLWAWVITSCIYIFINTFNNMFMKEKNS
K
>UU276 conserved hypothetical hypothetical
MGPIIPNTRLIDFKFDRDLLNSAYTAHYFIKTCKIIELHAPNHSVIMQFTHFSKTPIMVC
GTSEVLALLEFCLSKKELKQLKIYYVPDGHVIKPKEALFVIEGPYEIFGWLENIIDSILA
RRSSIATNCYNVLNLINDEQKVIYMSDRSDDYSLQPYDGYAAAVGGMQYFVTQKQVEFLK
DINYECKVIGSMPHALIQQNNGRIDLACEMFAQTFPSDPLIAVIDYNNNVLNDLEQLRYM
FDRLFAVRIDTAKDLIDESLLSTFNNVGNRDLHGCNPYLIALVREYLDNNGGKHIKIIAS
SGIDLNGIKNFNKHNSAIDFYGIGTYLSHLSVHITADLVCLDNVYGAKVGRKIAKNFSEM
ILY
>UU277 rpS21 ribosomal protein S21
MSRGVSVEGDLEKALKKFKRISNETKKDSKRHEYYLSPRIRRKEKIKEANKYRSF
>UU278 argS arginyl tRNA synthetase
MITQKISEELNKALAKMGIHDTQETKILVDKTKNIKFGDFYTNIAMILSKKNNKSSLEIA
KEIANNFEQDLFLEVNLQPPGFLNFKLKAKDHENLLKQIYYEKDRFGQFSKKNITYNIEY
VSANPTGYLHIAHAANAIYGDILANLLKIYGYDVETEYWINDAGNQIDKLAMSVLVRYLQ
LQNINIQLPADAYHGQEIHLVAQTLYQTYKNQFINVRLNEKYEIDDDIANQEIKNFAVKY
LLNEIKNDLASINTFIDTYTSENWIRNSGRILEVLSKIKPYTYTLDGALWLKTTTFGDDK
DRVLIKSDGSYTYFTPDIAYHDYKFNKTNTTKLIDVWGTDHLGYIARLKAAMNALGYDPN
NLEIVCAQVMKLVKNNQEFKLSKRSGQSLTIKDLVEIIGKDALRWFLGSSSMNSHVIIDV
DIALSKNNNNPLYYVQYAHARANQVLNKQVYELDFKTDLLTETRERELLNQLHFYKQTIA
NAANNREPHRISNYLYDLAQIFHNYYANVKINNDNNKVLSAQRYTLVWCVKQVLANGLAI
MKITPYDQMY
>UU279 pgk phosphoglycerate kinase
MNSLNKKSIKDLDVNGKTIVLHLDLNVVVDYENKRILNDRKLRASLPTINYLINHNAKIV
ILSHLGRIKTLADKQSGKYSLEIIVDELRNRVSKNVNRVVFSPLNYGETVVQMVNDLEER
DILILENTRYCDISDEGEYVGLEWDGSEILGQFWGMLGDIFIDDAYGVAHRQLSSNYQTA
KFAKKSALGFLIVNEINHLDIALEVPKSPYLALIGGNRVADKIAAIEVLCERADQVIIGG
GLVYTFLYAQGYNVGLNLVERNMIDDCNNILEKYGKKILICFDFLCNNDFSDTRPIYRKI
DEGLEGLYGLDIGKRSLKFIKHEIYRSKTILLNGPFGVIENIKNYAQGTTEICKSMAKQT
TRGAYTIICDIDTSSHAEYLGLDKYINFISTGGGASLSYIEEGVLDGLETIDNVPLNVLK
KE
>UU280 celM Endo-1,4-beta-glucanase
MSKFNEKEIRNKAIEYMEIYGMSRHEERVASKLKASLKDAGVDYERDNLGSIIFKKTNSN
KGPKILIATHMDEVGFVVQQILDNGQLLLSMVGGVWPNIAIGSVAKVYVDEQRQYTGVFG
HTSIHILEPEARSKAVPVKELFVDCGFNSKQQAIDLGIEIGTEVYMEGPTLNFYDENYIV
GKAVDNRVSVAVLDLLIHSLKDKVIPNQTYFAATVQEEVGLRGAKTVVSKVKPDIGIVID
TTTSHDTYKCPEGDTKLNDGVCIRIKDGGTLVNPKLVKYFEELAIKHNIPLYKYVARGGG
TDAEELQYGPNGGVLTIGLSIPQRYLHAPIGVATVKDIKAAFDLVREFLEVFDENEFEKV
KFK
>UU281 deoD purine-nucleoside phosphorylase
MTAHNQAKLGEIAKVVLMPGDPMRAKWIAETFLENAILVNEVRGMLCYTGTYKGKKISIM
GHGMGIPSIGIYSYELYKFYEVETIIRVGSTGSYKKDLNVNDVVLVEKSYSDSTFASLIG
AQVGDDKVLLPSREVNNLIKNTAKELNLELSLATCHASDVFYNNDFQTLDEIIHRTKSDC
VDMESFGLFANAQILNKNAATLLTVSDSLITGDALSPAERANTFKKMVTLALESAIKLL
>UU282 hupA DNA-binding protein Hu-alpha (HU-2)
MNAKIKAKTRSQMIDELSKMLNIEKKQTKAFMDTYEAFLILELSRAKEVRLGNIGKFKVS
VRAERKGINPKTGETVIIPEKTIPKFTFTKGIKEIINAGISIDNERVSIDDNDFDDDDEF
VEEYIVSENN
>UU283 spoT/relA ppGpp 3'-pyrophosphohydrolase
MNELVKKKLDDLYDFLKQKKYSSQTIELVHKSFDFANYYHGDQTRKSGEPYIIHPIATVR
ILASWDMDESTLVAGMLHDVLEDTNCPEEVMEKTFGKEVTQLVCFVTKVSLYSKNRRNKV
SHTNLEEKYSIQVFMSMTQDIRAMIIKIADRYHNMQTIQYLRLEKAKRIATETLEIYANI
SGRLGMYRVKTDLLDMSFKILDPQNYQLVNDSINKLVENNQKKWNEILARLKNILIANNI
KAEFEWRLKGIYSTYKKITSGYEVKDIHDIYAIRVILDDVYLCYQTLGLVHMNFTYIINT
FKDYISTPKWNLYQSIHTTISYEGTLVEIQIRTTKMNLFANNGLAAHWKYKEQKDNKTEI
LLTVNNVLLRDFLLSTDKGIKTIKDVTTGTIFDVLILNSNKWITVSNGSTLLDVAYKYDI
NNFFNILAIYRNGERSHFDTHVETGDTIKISYSNGIETIRPNWITLANNDVVKLHINNHL
KKYELNKQITKEQFLANAEFFLEGKIMSEEHAIKRLEKEFQVNSINTFLDNIANTDIDLQ
TKYKVFSENKQVSREAINTIKNQAWKWLADSSYFSGLENLYFTDFEISPCCSKIPGINCV
AKIVRNKVEIHRNDCSKVKNSRSKTIVIEWSKEKLENRPRYFKVNLTLKGNWSESVGNVL
CNTLIRMKANISKVDISKNKTARTHDTFLKIYVKNLDHLQKIILELQAKNVINEWRLI
>UU284 pyrG CTP synthetase
MEIDLMKHIQKTKFIFVTGGVYSSLGKGVSASSIGRILVELGYSVAMQKLDPYLNIDPTY
LSPLQHGEVFVTKDGKEADLDLGTYERFINADLNKYASVTSGKIYYEILTKERENGFDGK
TVQTIPHVTSAVIDYIKKIKDSLKTDFIIVEIGGTIGDIESLPFIEAISQFKTIYGVNNV
MFIHCSPLIYIEKVGELKTKPTQHSVKTLRSLGINLDLLLLRTNQKLDEVTIKKLAWSCG
LDIDMIFAAYDVESVYLLPNVLFEQGIHKTILDFFSLPLKNDNINSWIDFTDKITTFKKH
NLVIGLVGKYVELPDAYKSVLASLELAAIELNIDLKIKYIQPQNLNENNINEELKKINGI
VIPSIAGSIKGWPGALLAASYARKNNIPFLAVGTGVNIGIGEFINNVLKLPIEFINLGNG
DFSFLKDAFVKNEIENYRIGEYCSNIQANTITSQIYLKQNQLNERHRHHFEFNNHYINNY
FLNQNWKIGAISVDNNYIDVLEYTKNHFYVLTIFNPEYTSKPSKANPYFINLLKMSLKIK
ES
>UU285 hisS histidyl-tRNA synthetase
MINYSKPRGTIDLYNKEMNDFKLLENFLLSTTKRYGFQQIKTPVFEFAELFMKSAGESSD
LVSKEMYLFKDKSDRWLALRPEGTAGVIRAVVENKLLLNHPLPLKLMYFEPCFRYERPQA
GRQRQFHQFGVEVLGTKNIYYDFELIALADTILKKLMISNYILEINYISSPHNRSLWVKS
LQEYFHLHRTELTPLSQERITTNPLRILDDKLESQKLVVKQAPKISHFLSNEEKEEFNLI
KKMLDDYNIKYYVNEGLVRGLDYYSGLVFEFISTSPKLLGQSTIIGGGRYGELIKQTGGP
NYEGIGFGIGIERLLIALSETNKNILNTDDDKYLIAFFDKELENEAIKLTQILRINNQLN
VDIILSSTKADKIFKLAQRLNVKKLIILAKKEWSDKKIILKDLLNFKQDLLSLDEIKGIR
>UU286 aspS aspartyl-tRNA synthetase
MKVYCGYIGEEHLEKNVILNGWVKKVRKMGNLVFVDLKDRFGIVQIFATKSDGVFNELTQ
LSREDVINVEGLVLLRKNPNNDLKTGRFEIHVKKILIYSKAKTPPLIIEDETDANEEIRF
RYRYLDLRRDVNLKIFELRSKVYQAFRNYLYSQDFIETETPILAKPTPEGARDFYVPTRT
RKFYALPQSPQTFKQLLMVAGFQKYFQITKCFRDEDLRSDRQPEFTQVDIELSFADEIEI
QTLIENLLKYVFKQTINVDLTTPFMRMSYEQAINDYGSDKPDLRFDLKIKTLNTYFENSK
TLFFQKALLNNQSIRAILVPNINLNKKQVQTLEKFAKDKGAKGLSWISIKDEKIIDGSLL
SIQEDHIIYKTIFKDFNLSTGSILLVADTFDIASQALGLVRINLASILNLKKPNIFKFVW
IIDWPLYEYDNEAQRFVAAHHPFTMPTLETLNTFDVNKKDARGRSYDIVLNGYELGGGSV
RIIDQQIQRRMFKSINMSDEEANLKFGFLLTAFEYGVPPHCGIALGLDRLMMILVNSEYI
RDVVAFPKNNNGVDMMLDAPSNMNDEDLKELGLKIKND
>UU287 unique hypothetical unique hypothetical
MINKKIKINPNITYFKQKISNYHEHLLVWNDLYDKLISLTNNIIVDKNNKNIYHQNDKQI
FDFTLCLSGLLSKTLGLNHKSSSLYLTNDDEVAHRFKIKVLHNYFNLYNIEEFFTFMDNQ
IPLENAKNIARLSLIYDLKQHENILKTISNEGLENIDLEFAFINFLRAKISINFAYSYDI
SEVILLLRTGLDLHFFRKWAF
>UU288 unique hypothetical unique hypothetical
MTVAYHNLDINDPKNVLLATQKFFNHINEIIIDYGLDKRDQWIKKIIPFEE
>UU289 msrA peptide methionine sulfoxide reductase
MIKSIWIAGGCFWGIQKYFDSIIGVNHTVVGYSQGNVINPSYEQVCTQTTNHTETVQIDY
DDRFVSLISILEHLYQIIDPFSLNKQGDDVGSQYRSGIYYVDHDDEFIIKDFLLKKQNQT
PKKIMIEVERLRNFNIAEEYHQKYLDKNPNSYCHVDLSLSKKEFR
>UU290 unique hypothetical unique hypothetical
MAVEKIKISKVKLKIVSALFNLLKTNSFNKIKISQIIEVADVSRPSYYRNFSDKISIINY
FIKNIYNWKVVSKLINNNLNINFDEVGFTKFYEISLQISLEFKEYFLILDKNNFSGLIVD
LTTESGFYAIGNMSNNSIDKYLINYLTGFFCNIRMQWLKNGAKESIHDMAVFLTNVLKDN
VIKKLEKYQSCNNIND
>UU291 bsaA glutathione peroxidase
MERLNMKLSDYPVLDIDKKLFNWSKVKNKLVLIVNVASKCGYAKQYEQLEYLYKKYKNKG
FIIVAFPCRQFMFQEFDDNNKIKEFCSTKYNVTFPIMDLTNVVGSNISPLYKQLITEYPW
SPKAKAVKWNFEKFFVKNDEIIGRFESKCEPNDLEEFIKNNL
>UU292 conserved hypothetical hypothetical
MDKKSKKILGLSVASIIAALAIIAPSTYFGLQKQEEGKKDINLDNVTRKIPGETKDDIKV
EDLNNINDQNTDLKLDFSKVSIKPQTKINYLAIGDSITAGFNSELGWEAPGRYDPITNKI
SGLSFPSFIAQYINKVEPNRLASYENLGITGSRIEDWLYMLGAGSDEYFKNQEYRFFDFS
KQMDQQKDNPFKNRLSKFFKNFGYDSKLTPKNNHEVNINDFNGLKEQIKKANLMTITLGA
NDFLRYLDIPKLVSLTNLKGNDLEIKVKEFENNLQKASLEITKNLKKLIALIRTLNSNVS
ITLVSYPLPLLRLQDVIDSSFKLTNKRRLSDEIINILNSAIKKTYDLNNNINYIDAFDEN
DWKENSFNFAKAIFDIHPTELGYKRMAQDIFLKMSLGQNYAQQKTASIANAIYDAWDSEY
FNKDSDSFKQQIGFANNTNQDLVEKTLGSSKGAAFWAKTALENDEELRKSFSNFKNTSTI
VKDWLISNKRRFGSFVNLITSNLTSLGLDKNGYISQFLSKKDADNTNNLYKLASALASTP
YIDMVISGIQNDLDNLDLDKNNIIGTQNISKKILYDVFRKNIINDQNLYELIKGMFHSQL
FNENKSQIKSLIKALLSDLVSSHKLLEIIFGEFATDNLKNNNEFLKNLLIIQNKLTQTKS
LDNIINVFVDALFDNDNEYLLQGPLSNVLAKIVKTNKALLTTRIDNLFNDLFKDQTTLDA
TYNILIRVLGQNIPDFIKTPQASLIIKKILSKGTNLKLINTLKLNTIDLLTDSKTYAGIF
DSSETSIINLIQKSIDFTSKSFISDVLDLLTSDNVDLNEWKEFIKTILNSSTIKNIFNYG
IVNLVSSNTTPLKTSHFDFNVLLKNLIAVLEEKDWTTNQKTKLKSLLRMSVDELLKNPQT
QNFVTSIEDFIANKLGDLVISANNSLLKSNMSDIWKLIKEVVHDLIHSSESYDLIFSIIN
DFIDHPQNYDNLNNINDLLPLILKSTNKELQDKVDILFKKLINNENIPNLVGTLTTNLIV
KNFFVKELTVDQKQKINNFITNILPTIPNLTLYKEIRKQAFEFLTNNINKILVDPKNTLL
ILNDGINKLLSNILPQLSTLIELIDNDKIKDQDFIDVIKIFIDNLDFNKLFVNIKSNNNQ
TTDSTTLNQFYFKFKLNLEPKKLIFDLIKNLLNSPILKVNDNKNNKIKIESNKAKIKSIL
TTSVTNIFENSNLMNFFNNQLSQLFSSIDLFKNLNLSNQQRLNFAKAIVELLNKEKLLSN
LINVLITNLIDHADEYAEATDLATILSLTIKYNQNELKNAFDKLLIGTLKNDNLQDLILR
IFVKLINPNKSYDSISVVSINKLKTFISKFATGISKLDLYQQLKNSIFTVFSNKTKMQQL
LSNDVSVINKTLLEAFNIDTPEKVLKISSLLDINEIDARDYADIIEIILVEIGFNVTSIQ
NNDVNNNLKTIDKKTNDFAFQILKKALNNGVSDQQLQKIKNVVNYLLDDIVKIHDSSSFL
RIQLEQLSHVLVDKITAVLPKSLTIKHKYTKIFSSILNNQDFLQKAKTLLSTILNELIDH
KDKYKDINSFSELISVFFKNKASDLKTQLKDLLNTILKNQTLITNIGQVIIESFKLENKI
SILDSDLEQNTISFINKIFAHITELPIYTNLVDNFFNFFSEYTKSSDTKTLNFNKFKSSL
FQAIIPKISDFASLLDLFKYNEISEQEWKSAITFFIDYLPINNLINSKILPTNSLLFVRN
ISISKTKPELNKIENIILDLFKALSQKAKTFDNNTLTKAKNIIEFTFNKLLTSNNIKNFI
NNLLSNLSPIRSFLKSINVQDKSKHNLLNM
>UU293 unique hypothetical unique hypothetical
MYNDLLDSLFTKLSDKSILNKLLNDDFLSIGSILKEIFNINQPSQLIKVIDIFSIKDITA
QDYVNVLNVIFNDIGFNNQQTKQNITNDQKYDINIYFEYLKALVEHNFSELTKTKLKEIV
KLFVKDVMNDDHHNHLWKKMTSFISHKLSDLLIKKIQVLTPQKNEYQQLVNNLLNGIDFK
NVVQNLIVEGFAKIIDHQQQLKNSQNFGDLIQKVINIDDVWIKKQLKQLLSAITKDINLT
KATSTTIINSYLNYFEIKNLTEEDKRNLINIFDKILKQIPNLLYLQNIVDQSVDFLKVNI
EALINHQPLKNTTWNDFINKNVTDISALSNLLEIFETNEITNNEWNQLITILINHAPIDK
IEEIIRNITSNSIINNKAQKQDIKKQIDKIYLLIKKVLQTQTLNKSHAKTSVVKINETIK
TLIDSLFANQEIKTLISNTLSNWIFSSNLAKILNVDEDQKNSLIKPVVEFIISSNDLKTI
LKTITNSFILHASELANTNSFEELIVKLISFEQTNLKSNLNNFIQKILQNDKIDELLARV
IFKQISPQKKYDQIQQINKDKVVTFIKKLGDNLTKFDLYNKLLDNLFSSITNQTNLTKLL
SEQQDSVINFIKTIFDFSDPKQIISLIDVLKVNEITSNDYIEVIKSILDEIDFNHFFNQA
VKNSNLSNYPLNKHENDNDSKLDINKYYIYVKTLFAHEMDSTSKEKLKTIIDELTKKIVE
NNNKGLLYNLGNGLGEKLSNLIINTFPGLTNLKQNYKTLVQKVFTNQNLFEQVQNLITYA
INSLIDHKNEYQNCKTFGELLTTYINKNQTQIIDKLKEAINKIISGSSSLIDEISTSFAN
TIKTYFKLENLTVEDINKLKSFINFVIKNIFNLEYVNDGLVKLITTLSSNAIKIVDQNTN
FVTVMQNDVISYLTSPQQIAKLLQIVDLDKNDDILNFLKVILSHLPQNAYTILFGNKINL
ITKNTNQKTNRSVIQKYTILDYVKTILNSSYLKKQDTIVKIKHIFKDLLVTISKSSQLNN
YIGELISNTFAQKLSNLSGVDKQYSESFLKESYKFIISDEKLIKIIDEVVNDLVDHKDEY
LKEITNNNQPSINIILNMLIKRNVDQQKVDFVPFIKRYLVIDSSTQFMAQYLFKTLKLEN
TNDQDVKIVQTFVKELINQIDQLDFVNLFIDKIFTLIKENGLDLFTKEEGIKKVNEAMKT
FGLTETTNLLKIAKLVEPNKIKPQTIGDLINLVFEKSPLAEDFESITQDKNPLYYGLKNL
KEDSLNAVLFASGKKKIGEAAKVSEINMLDAIQHLINKLWSARAEYAKNHPNLEYEQDNP
YMRSLIHLGIVMQWYVHETYFRNVSGGLWWTGSDSLSGEGRVYLLLKADMGSESEKRVRS
MIMGNRGAMLWNTPKEWNYNKNDFLYMITYWKWRTNSRFNDSKEKNKATYIFKALKRGYG
EKVKTMK
>UU294 unique hypothetical unique hypothetical
MIQKAKFYAGYISRLRFIQKLRYEIQNEKKTLNKIIKVVNDADISTLYDFKDKNLTIYTK
TFYFHNYQFVNANKKNYFISKKTIKSVITENLLDIGFTWTIIYNDQTKTYIRPTDFMTKN
FIDYKKNENKIATRSKILYDMIVKNESLNINHSEYESLLVNNEWKRYYENMINIFLYQYY
NEGIKNDIDFLNHFLLKDALK
>UU295 conserved hypothetical hypothetical
MPRKHLIASGINKKQQQQAKIWMKCAKEIKAAAKMGGPNPEANSRLKVAIERALNNNLSR
DSIERNINGASKDIDNLKELTYEGYGPNGLAIIVRALTDNEQRTISAIRGYFSKLQGQIA
KPNSVSMLFNECGQLLINKETKSLDEWFEILIDQSIIDINEDDKIIEILVKPEDFSTVKL
ILEKNNADIKSAEIKLIPNDFISLDEYARERLVRFVNACENDDDISWVITNYEEEL
>UU296 unique hypothetical unique hypothetical
MSNYELRRRIIMSNIDVKTNFWKLNQKNKKILFRVLGYSSLSVTIITPLIYKISYNKQYS
FITKSIRELKTIDTNFVSSYSDFYILQKSSISNDLYNYNLINNYHDFEKLIKNDLNFDKY
NSALIYEKIKVSLLEKYNENFFKNNDLLYVSYNSLDSKYFLTSILSFDYNNLYLPFLNTK
SIFNDEYDNKNFYTDSALSTTKTEVKFFSINKKYNIKLKQIKIYSIETAKDLFLYKNYVR
KNNKPI
>UU297 conserved hypothetical hypothetical
MNNKNNGMHLEVLINKSISLFNLQYQAFFKKRCVDIIIKNIDNSYVQGKIKQKSETDYYG
FYKGDYFDFEAKQTNKNSFLIKQIQPHQLAHLYLIHKNSGFSFLIICFINYNLYFIITFQ
QLINYYQKTKRKSIPFQWFKDQCIELEIIFPGVINFKKMINDLKLKYYDD
>UU298 efp translation elongation factor P
MATIIQAKDLRAGHTFLYKGNIYQVIENSFNKTAMREGIVKCKVKNLRTGAITIEVLTGE
KLEQAVIEKSKMTFSYDDGSGYVFMDNDTYEQISIPYSQLSWEKNFIEEGTEVSVMRYDG
ELMGVSLPDQLVVTIIEAEEAVQGNSVQNATKRAWLESKWEFQVPQFIKSGEKVIINPSN
GQYVGRAK
>UU299 unique hypothetical unique hypothetical
MQYITINNTKSGKILISKSNIKKFIEQKFNLIVNKKFVIKNIDIVQYDESLVDISIIISL
FDIHQKVDLDEVRDVQNHLASFIYSNLGVDTKSVNIGIDL
>UU300 nusB transcription termination factor
MKTQWAKRVKLFQFIYHWLITKKNKPIALKCALVDFDLDLNWINVGEYILDNYEQLTKMI
KPLISKDWTFERLSYVEQALLLSAYGEYLVLKTPKKIIIDQTLITTHNYSNNESYKFINA
ILDQLLN
>UU301 conserved hypothetical hypothetical
MQRYFVSKIKDKKVYFYDSDVHHIKNVMRMRLHDKVIVINKTKAFVAEIINLEPLHATII
KPYTLNCELATKIDLFQASIKPNNFEWIVQKACELGVNSIYQTIFKRTYNHSLIKTNRIL
TIIKEACEQARRNHLVNYYAQFSFNELLKYLRDYDLILIAYENEKQNLLNNAFKEELTYQ
KIALVIGPEGGFEQMEINLLKQFDNAICISLTKTILRSETASLYLLANLVNKLI
>UU302 unique hypothetical unique hypothetical
MKQRLINYIIVLIGILCIVSLVVGFAVWFSPNKNFDTLTQNKIDGNEVKRLYNPNNGIFL
EQLEGFSKYNIAGYVVPIVFVILSFILLFLYYFLNKKSRSKADFPISEKFIITLQLPLFI
>UU303 unique hypothetical unique hypothetical
MQEGDFYATDRDPFLTYWKELKPSFYAKKSVYIAFLTIIIAFAVSIIGFVNYFSLKIALE
QTQKATLEVQKQKEEQKNQLSNGVYFDQDLNLLNEYDKLVLYQKNNLSSIVFLAINDQEQ
ILMQKDQVVVNSLNIEQKVKYREQATRIVFEKQAEHNDHLVTSGNF
>UU304 greA transcription elongation factor
MAKYTISKHRLEELQLELREILDVKWPAITKQLQDAREQGDLSENADYDAAKNEQAALKK
RKDEIEEILENYELIEDVLRSTDEVSIGSTIEIYNYQKDCEEVITLVGSMDSDPFANKIS
IDTPLGKALVKQKKGTEVTVHTLASPYKVKIIKIID
>UU305 conserved hypothetical hypothetical
MQKKYIKNTLGFDTNLFIYQDKKMFNYSIDTILLANFISLSSKTKKILEIGTNNAALSIF
LALRKEDIKIDAIEIQIEAINLALLNVSQNHFEKQINIIHADFNQYWKDFDKSENNKYDA
IICNPPFYKQDKIIPSTKNPLKTLALYEITLNFEQIMQGCAKIIKQKGNLAMVIPTTRLV
DLLEIMRKYQFEPKRIKMIYPRIYEQSNLVLIEARYKSGWGTHFEPNLYLHYEDKQNHQY
TEEVLNWYKPIKFKK
>UU306 nfo endonuclease IV
MDKYNLIIGSHVSLKAKDFFYGSVKEALSYGSNTFMVYTGAPQNTKRQPIKSFKIEEAHN
LLKKHNINLDDLIVHAPYIINPCSSKKNVRELAKEFLIQEIQRTESMGITKLVLHPGSRL
EQNEDIALEQVYTMLNDIFSTINTNVIVCLETMAGKGSEIGVNIKQLKTIIDNVHSKKNI
GVCLDTCHMNDSGLILDYYNFNQYLKEFDAQIGINYIKVLHINDSKNPCGANKDRHENLG
YGTIGFANLINIIYHPLLNNIPKILETPWFNVNDELIPLYKHEIKMIRDCKWYDIKNKLL
SKK
>UU307 conserved hypothetical hypothetical ATP/GTP-binding protein
MNNNQVDDELDLENFNYQKALEIPNIKAINLTEEEFNLYFWDIVEVYRSYLNNLNNQNDS
YYIYQLNRNEYNHLCLVVVKKENKVDKIKRNYILNTIKNMDYNISLADDSQIFSKKTEIL
DANLLAERNKLINFFLEEARKNKKNTLIKNNNQQPKSAFIYGDFSVGKSIITQAYTNTIS
LKYNLKIAYITLNDLFKNVIQFFNYKDTSDLVINELVNLLSNVDVLVIDDFSSVNLNYWS
ISTILMPIIENRLKSTRQTIFISNFSIEQLINSTKNTTNIEEQKTKLRLFNRIEYLTYGN
IFKITGPSVFKVVNNS
>UU308 conserved hypothetical hypothetical
MDIVIKKNCNFVKNDDHLYSFYTPLIGMQAVALYSWFVNRENIFNKKGTINLTHEYLLDE
LNISINTYNELITKLINVDLIKIYSFENNSQQVIEVFRPLKFSEFINIEKFNEELKNNVS
LNHYNVLNLLNKENNIDTNRLIDLSAQFKTNHFNNLENKLDKIKKIILKEYGLSLQIDES
TKLCLINFFKKYKFSIDQMLNLIKNNLINNIDFLTIDLNKLELTIFSNMEFEKNKTKFQY
YNIERDFNIFNKNSNLDRFKNVINDYNNFKPSDFLKHIRKEKLSLKDKEAINLLTYDKSL
SDPIVNVILDFVLFKNLGRLNVKYLKRIKETVLGINIKDEYEMIKFFQNKKNDHKELICE
DSDNANTFKNTNFIEVKFGDL
>UU309 unique hypothetical unique hypothetical
MFEQVFFLASINDKKIIRWLYERYHKIFLKYINEQLNFKFYTLEIEANDLKTIIYEIFLK
IFQVTRIKSLNQFIGFVKRQIYFYLVYLLRKSLSNKNLVNHLNNNNFENYELISTNSDEV
GAELNNRFLIYEFLRSIQKENLFLYHFTILIIKGYNTKEISEILKINSAKIYYYKALLKK
YIKKLL
>UU310 rpS20 ribosomal protein S20
MANIVSNEKTYRHTQKVRKENHAKMSKLRTIVKKTRSSNEQAQLNEAYKVIDTTASKGVI
HKNKANRLKSRTAKAFKTNLEVTA
>UU311 ard1 N-acetyltransferase complex, probable ribosomal protein-alanine-acetyltransferase subunit
MLKNLLIRPADQKDLNDIAIFENRFFLNDCYSMRNLEEIFHNSNYQIIIVEYEQKNIAYL
IYMKSVDFNEILKIGVDENYRNLKIGSLLIDLLKQKKQNILLEVSDLNTNALNFYLKHGF
IKQNIRKRYYANGSDAILMIWKYNQT
>UU312 conserved hypothetical hypothetical
MNSTYQLFIDVTSRKCILAIYKNFKIHTSIIVDTNNNLTDIIVEHLNNLLKITNLQYQDL
EAIYLNTGPGSFTGIRVGAIVAKTICTIFNKIKLFINDSLNIIANGKNDVFVYLDAKGNK
SYVITITNNIQNEYKIITNKELQNELKNTSLTIIDANQIDYHDLIYNLKFDNFKLTNILD
FRLNYVKKPLN
>UU313 rluD pseudouridine synthase (uracil hydrolase)
MKILYSLMSSQRIDKFLVENTNYSRTLIKKMLDQNLILVNDNFISKASYLLKKNDYIQIN
NELPIVQEQKKLLPFVYSLEIIFEDQDLLIVNKPSGMLVHPTSFHEQNTLANALKYYLKT
DNFYITHRLDKNTSGLIIICKNQIALNSLQQQFMQKTIRKSYYAIVHNRFDMQHLHFMIN
EPIGHSYQDKLRMKTGNSKNTKEAISIVKVLEQYKNTALVEVSIITGRTHQIRVHMRYIN
HPVYNDPLYGISKHTTEYEQYLHSFYISFNHPSTNKKVEFKINMPKEFMELIRELKANE
>UU314 lspA conserved hypothetical protein (possible signal peptidase II - lspA)
MLQKIKNSNFYIIIKKFNQSLRKINFFEKIILKINNKSIRDYFLSITSLDVIFYKIINFI
IVALIVLLSGFLVREWAIDLVVKTKETHHGPIFHFTLNNGIALGRINNHSGIVYTLQSIP
IILGFLSFIFLKNSCYYVPLLFLLFGGLGNIIDRSIPEFELFNALPNIFHNSLINPNSVG
GGDDVINGVVDYWKFVNSIINLFDVYIVVGVCVLVVILVIRFIIKWKNDSDNQDIIKKVA
DENDLEINEISNKPFGYDDLKKS
>UU315 ppa inorganic pyrophosphatase
MKLNVTIEIPKNSNIKYEYDRATKEIMVDRILHGSMVYPHNYGFLKEALDYDGDELDVLV
FADQAFQPGIKVPARVLGAMKMIDGGETDTKLLAVIDVDPRYKHINNFKDIPLHWLAEVQ
DFFENYKNLQNKKVKILGFEDEIWAQKEYEECVLLMKEYGHLKKDEFVTKMMKERPEKYI
K
>UU316 unique hypothetical unique hypothetical
MKNFSKNRNINNFKNPLRVIEGIVREIKNNELQIDFVNSHKKGVCKFINLTDYHWNTISS
RFLINSKHLFLVSKFDPIRHVYWLNYKIIHPIEIKNKRRSYPTLSHDRNLRIFLNNLLEK
ENELKN
>UU317 conserved hypothetical hypothetical
MFRNLIKNVYRYLLKSKASFIGLCLLLFVSIFSFSMLTNLSKTLTRSYTNLVNRQKLHDI
TVNESYIEDQKDIKQAQFNKLLEELKVFYAQKGLNFDWTRSNSLIVNSTKDDITYKIVQY
STSKTINTFDKQTSERLIKNSFSDIDLYGILNNAKVDVIDLIKTKTLNASFVINNLKELD
NKQKSNLVKLAKVDNYDVSISQQARLYLLKNIVYGAWPSKTNNLYKKFKKAYEYSLEDKN
YDPLIGNIKLNNKANFDILEAKEISTQFILMLYPSKKGISINGNVNTIVKGHRITFSFEP
AGIPIPVYFDVKSAYALVGLGAFLSNHNKQKYPMYLWQKALVDHEEQQSFEKWFNSLDEK
YIIHIDNTPYLILDSGITPDFMYPIISFTSVIPNPKKEGLVYVNLNGYARIYDAFRSNPI
ENNLQIRITNQKHQSVDISILKKIVKNLNDQIKKDAIMNWPTSLDAAYLKDDTNNHITPS
PLRLVFINKITNTIQTFSVLITLFILILTIFVIVIIINRFLAQNKINIGISIANGVPRWK
IILSFAFIGLIPCVIGGLCGYLTAYFTQNLAINIFSGYWLIPTVLENFNFGALITVIIFP
FLLFFILIVGLGYWSIRKPPIDLMRGTETFKISKIVYVIKFPFKYISGFNKYLITLSFSS
ITRIIIFSIMIALSFGSIMFLTGTRGKIKQTIDATLQTKKYRYGIDLITPTDQGGQYISL
STNQIGSTLNDNDNHELTQKYESSDYKDFINSPLFKNLQNLKLIGAKDDQRRIYDLNYIA
NAFQVKQFLDFNFGIGDVNSGSSSNPWSITKSLIPENNLQILNETYKKWCSKLINDHSIF
SKQLIEKGVNELAYDILNIRNSYDPNEYFNYFTFKSIVDTYLKRFNKSFLDQHVTYEILV
RVHNNLFNYKNIYGKLVFKNNQWIINFKDNNFPIDDQNFVSAIYYKKPNEQNYDLKKYIF
KNDDLIYDEVYFERNSKQNYHKLTYQTFSSYFRARFLKFDPEGDFDYYLPLKYFNATIVR
KELLENAINNEILFKNDENKIIKKINFKSDNDIVVTKINDLTYQVKNIINQQIYLYSPKP
IKRSYRIDPAKATNAIKTGLSIKLDNDFINLVLLTHPSINPSYADVWSGITFNMVGFDYL
TKNDKTQLNEFDEPYIWIDAQINKINNQKYEEAKNPKIIGIIKNSKLVHLLSNKKQINNL
LFNKNDEQVAIINRVAAKYYNLKIGDHFSFVANNQTNRYTKDYIKKQITLKVVGIIDTYQ
GIEIYTGIKNAAEILGMHSSPYADKSLYDEYDGAFNGIFTNKNNPAMLTRIISIYSPSGL
YPISETWKKDAPTINLIKNILSDKYTTYELNNKWDPKSLVLNSRLSLTKALGYKNFDELK
LDARNIYDDNHNYLGLRDEQAQAEWVIDKLISIYGRDTYSSTLNNVEVVDVLFAVLETAS
KTIQTVEIVVIFLILFIIILVLVLISINSLSDTLKVAKLLKNIGYSDLKNAKLFLMAFLP
SLIIGSIISIPLVIVVMQVFSEIIFNSLNVLLTTSFIWWHFLIILLIVAIIFLLMWAIAI
WILRRSNIADASKRN
>UU318 nusA N-utilization substance protein a
MSNSFKSKEFIEYFKDTAKQNEIEFEVLSSIIKEAFEKAYLRTHPGENFETNIDLKQGTI
NCFRNLVVVENEKVHNEDLETCLDDAVEILLDDARKINANAQIGDLIKQHISIDNFKSIE
VGQIGSLLRQKITEIHNKRVADFWKPSLMKMIRAKVAEVNYNKQRNEITGVKVELDDQWK
TLGYLSRKDRIGDEKFKVGETYDFLIKEVKEQSRLWPILLSRTEPELVEEILKREVVDIK
NGNIEIKKIARIAGFKTKVAVSTNLLNIEPVAVVVGNKGLTITSISKQLNNERIDIIRYA
DDKRIFIANAIGLDKLKGLLVQENESGQRSAIAIVSKDDLPSVIGRGGANIRLIAKITEW
NIDVKTIEQAFEENILYEKFDEKIYRSWNIESINKKNVTNDEMLALIDSIEDDKIEQDVQ
LNHPLKQQEKKVVSSNDEDGENDETQLEYLEGFEDFKF
>UU319 unique hypothetical unique hypothetical
MAMKVNERTCVFSKEKYPKDHLVRFVIINGELIFSLNYHRGYYLMIQKNTNIQKVCQFLK
KRFMIKNEEQVYRILEQLIQSLI
>UU320 infB translation initiation factor IF-2
MAKKNIKQKKDNRIAIDVKKHIKKVDVGVFDGTFVFTSPLSISELAPKLNKSPNEIIMRY
FKKGVVYNLNTILDEEQIGELCLEYDLDFKIEKNVNTENLLENIYFDDLEIDLVARAPIV
TIMGHVDHGKTTLLDTIRKSSITASEAGGITQHIGAYQIIKDNRAITFIDTPGHEAFTEM
RARGANLTDIVILVVAADDGIKMQTEEAIDHAKAANVPIIVFVNKMDKYEANPEKVLNQL
SAKEIVAEELGGDVVFVKGSALKNEGISELLDSILLIAELNNYKANPNRLAYGTTIEANL
DKGHGPLATLLVQNGTLRKGDYLVVGSTYGKIRNMFDEYDNEIEIALPSKPVKVSGFEEV
PTAGDKFLALADEKQARAIANDVKQKKMRLERAMLQSSDIRTKIANGELKNINLIIKADV
QGSLEALKGIFSSINIEGVTTTLIRSAIGTISESDVRLAQTSDAIIIGFNVRASRIIKDL
ADSVGVQIMNYDIIYKFKEDLELWMKGTLDPIIIEEVIGEAKVLKLFKHSQVGTICGCRV
INGKIKRNALVRVLRDGIVIYNSKIATLQHNKDSVNEVIADKECGLTIANFNDIKENDII
EVYIKVEKKHDEVK
>UU321 rbfA ribosome binding factor A
MANEVRVARLESLIKDVINNALANEINDKIAKLARVTAVRLSNDLSVAKIFLDAHKRESM
LKVLENVNKVSGLLRSKLAAEWTSYKVPELRFVIDETIDYANHIDELFKKIKQQEN
>UU322 unique hypothetical unique hypothetical membrane lipoprotein
MLIILMNYLKKLNNKKINYPMLKKQNKNKEQHWLEKHLRQKTGLIISWSIIFGVLVLLSI
GFGLILHFFNSNNLSIQLSFIINLNKYLVNITKILDYIGFALIYLPIIFLLGCWITGING
VHESLYYHVFIWLFYFISVILLIITICLSIATHIYY
>UU323 conserved hypothetical hypothetical
MLSFVKELNFEINQKKYFIKIYLQPRIKYIKIKIINHQIVCLINHLKLINIAEEFIKNNK
LKILKIYENDLKKIKYDEQSLDWIILLGIKFTTIKIKNNNFHCQFNFQKQIIYLYDQNQN
LTNTKLLYQKILIYLAEIIFPQIIKNAQNITTLTVKKYVFGFYKSQWGVYNKIKHTIGLS
YFLVHYDQDIINYVVIHELAHIKYQHHQKSFWDFVLKYCKNAKIYNNQLKF
>UU324 lepA GTP-binding membrane protein
MDKKFIRNFSIIAHIDHGKSTLSDRIIEFTNTLSKREMTNQILDSMDIERERGITIKLNA
VQIKYHAKDKHEYLIHLIDTPGHVDFTYEVSRSLAACEGAILVVDAAQGIEAQTLSNVYL
ALENNLEIVPTINKIDLPSADPNRVKKEIEDVIGLDTADVPLISAKTGLNIQDVLEAIIK
HVPPPLDAKDDAKLQALIFDSFYDSYKGVVCLVRVKQGTIKVGDKIRMMANNKDYIVSEL
GIRTPKIVNKTELVAGEVGWVAAAIKTVKDINVGDTITHTNNPADKPLPGYKKILPMVYC
GLYPIDTSQYDDLKEAMAKISLSDAALTYEYETSQALGFGIRCGFLGLLHMDVIRERIAR
EFNIELILTAPSVIYKIELTNNQEISIDSPAKMPEPTSIKLIKEPFVKLAIITPDNYVGA
IMELCQSRRGIYDDLEVIDGTRRKLIYKMPLAEIMYSFFDSLKSITKGYATMDYELIGYQ
AEKLVKIDIMLNGNKVDALSIIAHRDFAYGKSKIICERLKEVIPKHQFEIPIQASIGSKI
IARETIKAVRKDVIAKCYGGDVSRKKKLLEQQKEGKKRLKAIGNVDVPQDAFVKVLSEN
>UU325 conserved hypothetical hypothetical
MDLWKEQDENGISPNVSNERKVVVASNGEKTLYIFIIVISIISIIGWIFLLVWWFNTKNH
LIQTKNSVNEASSSIQVAQTKRFDLLNKMIEQTKSYYKYEEKVLDEITKNRSIQMSNDIN
KNEEVLNKLQNLVNVQFERYPDLKSSNILMELMSTSSYLENEIASSRRAYNSRATDWNIM
IFQFMTVIVAEKLKLETFPIYAANKQERKDVDMKSLSDF
>UU326 unique hypothetical unique hypothetical
MEKTIIQLEFNEEELASIKKIKDKMDPNNNLELNVFLKDLIKDLARDYLNFSNQSFESIA
KQMNDLKDLIGNVANDPSSFDFNSVMNEFQKFSKSQKDEEKEIKNDTEIKTATKPTKKS
>UU327 spoU rRNA methylase
MLKIITSNKNEEIIHFYRLIHDKKYREAN